P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
2.230e-08 | -17.62 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 48 |
HIF3A,NTRK2,NRCAM,PARD3,GPC5,SLC1A2,NAV3,NKAIN3,PAMR1,GLIS3,RORA,NRG3,LSAMP,SLC4A4,BMPR1B,NEBL,PTPRZ1,SPON1,CPE,SOX5,ATP13A4,ADCY2,GPM6A,CTNND2,CSGALNACT1,MGAT4C,FMN2,HPSE2,TNIK |
2.230e-08 | -17.62 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 29 | 16828 | 48 |
HPSE2,CSGALNACT1,MGAT4C,FMN2,TNIK,SPON1,GPM6A,ATP13A4,SOX5,CPE,ADCY2,CTNND2,NRG3,LSAMP,PAMR1,RORA,GLIS3,SLC4A4,PTPRZ1,BMPR1B,NEBL,HIF3A,GPC5,NKAIN3,NAV3,SLC1A2,NTRK2,PARD3,NRCAM |
3.024e-08 | -17.31 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 30 | 16828 | 48 |
NTRK2,EFEMP1,PARD3,TRPS1,GPC5,NAV3,NKAIN3,SLC1A2,DTNA,MAP3K5,AQP4,NEBL,RORA,NRG3,LSAMP,DPP10,CLU,CTNND2,SPON1,GPM6A,ATP13A4,ADCY2,CPE,SOX5,ATP1A2,MACF1,TNIK,CSGALNACT1,FMN2,HPSE2 |
7.610e-08 | -16.39 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 16 | 16828 | 48 |
NPAS3,BMPR1B,TNIK,DCLK2,HPSE2,NRG3,LSAMP,NTRK2,PARD3,SLC1A2,NKAIN3,RPS6KA2,SOX5,ADCY2,MAP3K5,ATP1A2 |
7.610e-08 | -16.39 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 16 | 16828 | 48 |
RPS6KA2,NKAIN3,SLC1A2,NTRK2,PARD3,ATP1A2,MAP3K5,SOX5,ADCY2,TNIK,NPAS3,BMPR1B,NRG3,HPSE2,DCLK2,LSAMP |
8.128e-08 | -16.33 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 48 |
MAP3K5,DTNA,MSI2,GPC5,NRCAM,TRPM3,PARD3,EFEMP1,NTRK2,LSAMP,NRG3,PAMR1,BMPR1B,PTPRZ1,SLC4A4,MACF1,ADCY2,CPE,SPON1,CTNND2,CLU,HPSE2,FMN2,MGAT4C,TNIK,PITPNC1,NPAS3 |
8.128e-08 | -16.33 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 27 | 16828 | 48 |
SLC4A4,PTPRZ1,BMPR1B,PAMR1,NRG3,LSAMP,NTRK2,EFEMP1,PARD3,TRPM3,NRCAM,GPC5,MSI2,DTNA,MAP3K5,NPAS3,PITPNC1,TNIK,MGAT4C,FMN2,HPSE2,CLU,CTNND2,SPON1,CPE,ADCY2,MACF1 |
8.476e-08 | -16.28 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 43 | 16828 | 48 |
CLU,CTNND2,DPP10,MACF1,GPM6A,CPE,SOX5,ATP13A4,ADCY2,SPON1,TNIK,PITPNC1,NPAS3,HPSE2,FMN2,RFX4,CSGALNACT1,RPS6KA2,NAV3,NKAIN3,SLC1A2,GPC5,TRPS1,ABLIM1,PARD3,TRPM3,NRCAM,NTRK2,EFEMP1,HIF3A,MAP3K5,MSI2,DTNA,PTPRZ1,NEBL,BMPR1B,SLC4A4,LSAMP,SORBS1,NRG3,DCLK2,RORA,GLIS3 |
8.519e-08 | -16.28 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 21 | 16828 | 48 |
RFX4,FMN2,CSGALNACT1,LSAMP,HPSE2,NRG3,BMPR1B,NPAS3,ATP13A4,MAP3K5,CPE,SOX5,ADCY2,GPM6A,SPON1,PARD3,NTRK2,SLC1A2,CTNND2,NKAIN3,GPC5 |
8.519e-08 | -16.28 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 21 | 16828 | 48 |
HPSE2,NRG3,LSAMP,CSGALNACT1,RFX4,FMN2,NPAS3,BMPR1B,SPON1,ADCY2,SOX5,ATP13A4,MAP3K5,CPE,GPM6A,GPC5,CTNND2,SLC1A2,NKAIN3,NTRK2,PARD3 |
1.359e-07 | -15.81 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 24 | 16828 | 48 |
NEBL,RFX4,FMN2,NRG3,HPSE2,LSAMP,NTRK2,EFEMP1,PARD3,TRPM3,GPC5,TRPS1,NAV3,NKAIN3,CTNND2,SLC1A2,SPON1,GPM6A,CPE,ADCY2,SOX5,ATP13A4,MAP3K5,HIF3A |
1.498e-07 | -15.71 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 13 | 16828 | 48 |
CTNND2,ABLIM1,GPC5,NRCAM,PARD3,DPP10,NTRK2,CPE,NEBL,PTPRZ1,NPAS3,NRG3,HPSE2 |
1.498e-07 | -15.71 | system development | biological process | GO:0048731 | 3533 | 26 | 18204 | 49 |
PTPRZ1,RFX4,TRPS1,LSAMP,TNIK,CTNND2,DCLK2,SOX5,ATP1A2,NRG3,CLU,NEBL,MSI2,HIF3A,CSGALNACT1,CTNNA2,EFEMP1,CPE,NAV3,PARD3,BMPR1B,RORA,SLC1A2,GPM6A,NTRK2,NRCAM |
2.036e-07 | -15.41 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 12 | 16828 | 48 |
NRCAM,PARD3,DPP10,NTRK2,CTNND2,ABLIM1,CPE,NEBL,PTPRZ1,NPAS3,HPSE2,NRG3 |
2.070e-07 | -15.39 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 12 | 16828 | 48 |
HPSE2,NRG3,NPAS3,PTPRZ1,NEBL,CPE,NTRK2,DPP10,PARD3,NRCAM,ABLIM1,CTNND2 |
2.083e-07 | -15.38 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma | 1263 | 16 | 16828 | 48 |
NEBL,TNIK,FMN2,PAMR1,NRG3,HPSE2,NTRK2,CTNND2,RPS6KA2,NAV3,TRPS1,ABLIM1,ATP13A4,ADCY2,GPM6A,MACF1 |
2.083e-07 | -15.38 | plasma_cell_myeloma | COSMIC cancer mutations | plasma_cell_myeloma | 1263 | 16 | 16828 | 48 |
MACF1,ATP13A4,ADCY2,GPM6A,CTNND2,RPS6KA2,NAV3,TRPS1,ABLIM1,NTRK2,HPSE2,NRG3,FMN2,PAMR1,TNIK,NEBL |
2.363e-07 | -15.26 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 20 | 16828 | 48 |
GPM6A,MSI2,AQP4,MACF1,PARD3,TRPM3,DPP10,RPS6KA2,NAV3,TRPS1,GPC5,ABLIM1,FMN2,RORA,CSGALNACT1,LSAMP,RBMS3,NRG3,PTPRZ1,NEBL |
3.120e-07 | -14.98 | nervous system development | biological process | GO:0007399 | 2185 | 20 | 18204 | 49 |
NRCAM,CTNNA2,NTRK2,MSI2,GPM6A,SLC1A2,CLU,RORA,BMPR1B,NRG3,ATP1A2,PARD3,SOX5,NAV3,DCLK2,LSAMP,TNIK,CTNND2,RFX4,PTPRZ1 |
4.239e-07 | -14.67 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 18 | 16828 | 48 |
NTRK2,DPP10,PARD3,TRPM3,TRPS1,GPC5,NAV3,RPS6KA2,CTNND2,DTNA,GPM6A,ATP13A4,SOX5,MAP3K5,NEBL,TNIK,NRG3,LSAMP |
5.280e-07 | -14.45 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 14 | 19454 | 50 |
AQP4,MSI2,PTPRZ1,CPE,ABLIM1,GPM6A,LSAMP,TRPM3,ATP1A2,SLC4A4,SORBS1,TRPS1,MACF1,CLU |
5.302e-07 | -14.45 | face | COSMIC cancer mutations | face | 2139 | 20 | 16828 | 48 |
PTPRZ1,NEBL,CSGALNACT1,FMN2,RORA,NRG3,LSAMP,RBMS3,DPP10,PARD3,TRPM3,ABLIM1,TRPS1,GPC5,RPS6KA2,NAV3,MSI2,GPM6A,MACF1,AQP4 |
5.510e-07 | -14.41 | cell periphery | cellular component | GO:0071944 | 6020 | 33 | 19108 | 50 |
PTPRZ1,CTNND2,CLU,DTNA,TRPM3,SLC1A2,EFEMP1,GPM6A,HPSE2,ADCY2,MACF1,TNIK,SLC4A4,GPC5,ATP1A2,AQP4,PARD3,MAP3K5,SORBS1,DPP10,LSAMP,BMPR1B,NKAIN3,NRCAM,CTNNA2,FMN2,CPE,SPON1,NRG3,NTRK2,MAPK10,HIF3A,ATP13A4 |
6.796e-07 | -14.20 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 26 | 16828 | 48 |
HPSE2,FMN2,CSGALNACT1,TNIK,MACF1,ATP1A2,GPM6A,SOX5,ADCY2,ATP13A4,CPE,SPON1,CLU,CTNND2,LSAMP,NRG3,RORA,NEBL,AQP4,MAP3K5,NAV3,NKAIN3,SLC1A2,GPC5,PARD3,EFEMP1 |
7.347e-07 | -14.12 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 15 | 16828 | 48 |
GPC5,CTNND2,NKAIN3,DPP10,EFEMP1,PARD3,AQP4,SPON1,SOX5,ADCY2,TNIK,NRG3,HPSE2,LSAMP,RORA |
1.085e-06 | -13.73 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 12 | 16828 | 48 |
NRG3,HPSE2,LSAMP,ATP1A2,ADCY2,SOX5,MAP3K5,GPC5,NKAIN3,SLC1A2,NTRK2,PARD3 |
1.375e-06 | -13.50 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 35 | 16828 | 48 |
AQP4,HIF3A,MAP3K5,NAV3,RPS6KA2,TRPS1,ABLIM1,GPC5,TRPM3,PARD3,SORBS1,DCLK2,NRG3,GLIS3,BMPR1B,NEBL,PTPRZ1,SLC4A4,MACF1,ATP1A2,CPE,ATP13A4,ADCY2,SOX5,GPM6A,SPON1,CTNND2,DPP10,HPSE2,FMN2,MGAT4C,CSGALNACT1,TNIK,PITPNC1,NPAS3 |
1.387e-06 | -13.49 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 37 | 16828 | 48 |
MAP3K5,ABLIM1,GPC5,TRPS1,NAV3,NKAIN3,RPS6KA2,SLC1A2,NTRK2,PARD3,TRPM3,NRG3,DCLK2,SORBS1,LSAMP,PAMR1,RORA,GLIS3,SLC4A4,PTPRZ1,NEBL,MACF1,SPON1,GPM6A,SOX5,ATP13A4,ADCY2,CPE,CTNND2,DPP10,HPSE2,CSGALNACT1,FMN2,RFX4,TNIK,NPAS3,PITPNC1 |
1.470e-06 | -13.43 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 22 | 16828 | 48 |
LSAMP,NRG3,NEBL,HIF3A,MAP3K5,NKAIN3,NAV3,SLC1A2,TRPS1,GPC5,PARD3,NTRK2,EFEMP1,HPSE2,RFX4,FMN2,GPM6A,SOX5,ADCY2,CPE,SPON1,CTNND2 |
1.499e-06 | -13.41 | central nervous system development | biological process | GO:0007417 | 995 | 13 | 18204 | 49 |
CLU,RORA,BMPR1B,CTNNA2,NRCAM,SLC1A2,MSI2,NTRK2,RFX4,PTPRZ1,NRG3,ATP1A2,DCLK2 |
1.525e-06 | -13.39 | multicellular organism development | biological process | GO:0007275 | 3957 | 26 | 18204 | 49 |
SOX5,DCLK2,ATP1A2,NRG3,PTPRZ1,LSAMP,TNIK,CTNND2,TRPS1,RFX4,HIF3A,MSI2,CTNNA2,CSGALNACT1,NEBL,CLU,NAV3,PARD3,EFEMP1,CPE,NTRK2,GPM6A,SLC1A2,NRCAM,BMPR1B,RORA |
1.623e-06 | -13.33 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 8 | 19454 | 50 |
CTNNA2,PARD3,TNIK,NEBL,DTNA,ABLIM1,SORBS1,MACF1 |
2.063e-06 | -13.09 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 19 | 18204 | 49 |
SOX5,PARD3,NRG3,EFEMP1,PTPRZ1,CTNND2,TNIK,CPE,ABLIM1,NTRK2,HIF3A,GPM6A,NRCAM,CTNNA2,CSGALNACT1,BMPR1B,NEBL,RORA,CLU |
2.170e-06 | -13.04 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 3 | 18204 | 49 |
NRCAM,ATP1A2,NTRK2 |
2.170e-06 | -13.04 | action potential propagation | biological process | GO:0098870 | 10 | 3 | 18204 | 49 |
NTRK2,NRCAM,ATP1A2 |
2.712e-06 | -12.82 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 48 |
SLC4A4,PTPRZ1,NEBL,BMPR1B,NRG3,DCLK2,LSAMP,PAMR1,GLIS3,RORA,GPC5,ABLIM1,TRPS1,RPS6KA2,NKAIN3,SLC1A2,NTRK2,EFEMP1,PARD3,TRPM3,NRCAM,MAP3K5,TNIK,HPSE2,CSGALNACT1,FMN2,RFX4,CLU,CTNND2,DPP10,ATP1A2,MACF1,SPON1,GPM6A,CPE,ADCY2,ATP13A4,SOX5 |
3.650e-06 | -12.52 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 12 | 19454 | 50 |
SORBS1,GPM6A,ABLIM1,SLC1A2,MAPK10,LSAMP,CLU,NEBL,TNIK,ATP1A2,CTNNA2,CTNND2 |
4.119e-06 | -12.40 | OCLN (occludin) | protein interactions | 100506658 | 495 | 9 | 19454 | 50 |
NTRK2,EFEMP1,MACF1,ABLIM1,FMN2,DTNA,RPS6KA2,PARD3,TNIK |
4.189e-06 | -12.38 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 47 | 16828 | 48 |
NPAS3,TNIK,CSGALNACT1,HPSE2,SPON1,ATP13A4,ADCY2,GPM6A,ATP1A2,SLC4A4,BMPR1B,PAMR1,RORA,DCLK2,NRG3,EFEMP1,NTRK2,TRPM3,PARD3,TRPS1,GPC5,NAV3,DTNA,MSI2,HIF3A,PITPNC1,MGAT4C,FMN2,RFX4,DPP10,CTNND2,CLU,SOX5,CPE,MACF1,NEBL,PTPRZ1,GLIS3,SORBS1,LSAMP,NRCAM,ABLIM1,SLC1A2,NKAIN3,RPS6KA2,MAP3K5,AQP4 |
4.791e-06 | -12.25 | plasma membrane | cellular component | GO:0005886 | 5538 | 30 | 19108 | 50 |
CTNNA2,FMN2,NKAIN3,NRCAM,ATP13A4,MAPK10,HIF3A,CPE,NRG3,NTRK2,SLC4A4,GPC5,LSAMP,BMPR1B,SORBS1,DPP10,MAP3K5,ATP1A2,AQP4,PARD3,GPM6A,SLC1A2,TNIK,MACF1,ADCY2,HPSE2,PTPRZ1,TRPM3,DTNA,CTNND2 |
4.968e-06 | -12.21 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 21 | 16828 | 48 |
DTNA,ATP13A4,ATP1A2,MACF1,DPP10,EFEMP1,NTRK2,NRCAM,GPC5,SLC1A2,CTNND2,RPS6KA2,CLU,FMN2,RFX4,NRG3,SORBS1,SLC4A4,NPAS3,PITPNC1,PTPRZ1 |
7.103e-06 | -11.85 | neurogenesis | biological process | GO:0022008 | 1334 | 14 | 18204 | 49 |
CLU,RORA,BMPR1B,NRCAM,CTNNA2,GPM6A,NTRK2,TNIK,CTNND2,PTPRZ1,PARD3,DCLK2,SOX5,NAV3 |
8.691e-06 | -11.65 | trunk | COSMIC cancer mutations | trunk | 3554 | 24 | 16828 | 48 |
HPSE2,MGAT4C,NPAS3,ATP1A2,MACF1,CPE,ATP13A4,SOX5,CTNND2,DPP10,NRG3,DCLK2,LSAMP,GLIS3,PTPRZ1,NEBL,HIF3A,MAP3K5,ABLIM1,TRPS1,RPS6KA2,NTRK2,PARD3,NRCAM |
8.945e-06 | -11.62 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 35 | 16828 | 48 |
NRCAM,TRPM3,PARD3,ABLIM1,TRPS1,GPC5,SLC1A2,NAV3,RPS6KA2,DTNA,MAP3K5,HIF3A,SLC4A4,NEBL,PTPRZ1,PAMR1,RORA,DCLK2,NRG3,SORBS1,LSAMP,CTNND2,SPON1,ATP13A4,SOX5,ADCY2,GPM6A,ATP1A2,MACF1,PITPNC1,TNIK,CSGALNACT1,MGAT4C,RFX4,FMN2 |
1.209e-05 | -11.32 | nodular | COSMIC cancer mutations | nodular | 1515 | 15 | 16828 | 48 |
NEBL,PTPRZ1,SLC4A4,NPAS3,GLIS3,FMN2,DCLK2,NTRK2,CTNND2,ABLIM1,CPE,ATP13A4,MACF1,HIF3A,ATP1A2 |
1.231e-05 | -11.31 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 4 | 18204 | 49 |
SOX5,BMPR1B,EFEMP1,TRPS1 |
1.278e-05 | -11.27 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 31 | 16828 | 48 |
PAMR1,NRG3,SORBS1,LSAMP,SLC4A4,PTPRZ1,NEBL,DTNA,MAP3K5,NTRK2,PARD3,TRPM3,NRCAM,GPC5,TRPS1,NAV3,NKAIN3,MGAT4C,FMN2,HPSE2,NPAS3,SPON1,GPM6A,ADCY2,SOX5,ATP13A4,ATP1A2,MACF1,DPP10,CLU,CTNND2 |
1.278e-05 | -11.27 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 31 | 16828 | 48 |
NPAS3,FMN2,MGAT4C,HPSE2,DPP10,CLU,CTNND2,GPM6A,SOX5,ADCY2,ATP13A4,SPON1,MACF1,ATP1A2,PTPRZ1,NEBL,SLC4A4,PAMR1,LSAMP,SORBS1,NRG3,PARD3,NRCAM,TRPM3,NTRK2,NAV3,NKAIN3,TRPS1,GPC5,MAP3K5,DTNA |
1.404e-05 | -11.17 | mouth | COSMIC cancer mutations | mouth | 9004 | 40 | 16828 | 48 |
DTNA,MAP3K5,HIF3A,EFEMP1,NTRK2,TRPM3,NRCAM,PARD3,GPC5,ABLIM1,TRPS1,SLC1A2,NAV3,RPS6KA2,PAMR1,RORA,DCLK2,NRG3,LSAMP,SORBS1,SLC4A4,NEBL,PTPRZ1,SPON1,ATP13A4,SOX5,ADCY2,GPM6A,ATP1A2,MACF1,CTNND2,CLU,MGAT4C,CSGALNACT1,RFX4,FMN2,HPSE2,NPAS3,PITPNC1,TNIK |
1.423e-05 | -11.16 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 12 | 16828 | 48 |
EFEMP1,PARD3,GPC5,NKAIN3,CTNND2,SPON1,RORA,SOX5,ADCY2,NRG3,HPSE2,LSAMP |
1.696e-05 | -10.98 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 9 | 16828 | 48 |
GPC5,NKAIN3,CTNND2,NRG3,LSAMP,FMN2,GPM6A,ADCY2,SOX5 |
2.698e-05 | -10.52 | anatomical structure development | biological process | GO:0048856 | 5207 | 28 | 18204 | 49 |
BMPR1B,RORA,SLC1A2,GPM6A,NTRK2,NRCAM,EFEMP1,ABLIM1,CPE,NAV3,PARD3,CLU,NEBL,MSI2,HIF3A,CSGALNACT1,CTNNA2,PTPRZ1,TRPS1,RFX4,TNIK,LSAMP,CTNND2,DCLK2,SOX5,NRG3,ATP1A2,FMN2 |
3.986e-05 | -10.13 | scalp | COSMIC cancer mutations | scalp | 2110 | 17 | 16828 | 48 |
PTPRZ1,NEBL,SLC4A4,SORBS1,LSAMP,RBMS3,RORA,FMN2,RPS6KA2,NAV3,GPC5,TRPS1,NRCAM,MACF1,ATP1A2,SOX5,ATP13A4 |
4.197e-05 | -10.08 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 8 | 18204 | 49 |
PTPRZ1,GPM6A,BMPR1B,PARD3,TNIK,NRCAM,CTNNA2,CTNND2 |
4.245e-05 | -10.07 | generation of neurons | biological process | GO:0048699 | 1158 | 12 | 18204 | 49 |
BMPR1B,RORA,NTRK2,GPM6A,CTNNA2,NRCAM,PTPRZ1,TNIK,CTNND2,SOX5,DCLK2,PARD3 |
4.399e-05 | -10.03 | regulation of cartilage development | biological process | GO:0061035 | 73 | 4 | 18204 | 49 |
TRPS1,SOX5,EFEMP1,BMPR1B |
4.512e-05 | -10.01 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 8 | 18204 | 49 |
PARD3,CTNNA2,TNIK,NRCAM,CTNND2,PTPRZ1,GPM6A,BMPR1B |
4.567e-05 | -9.99 | skin-trunk-malignant_melanoma-nodular | COSMIC cancer mutations | skin-trunk-malignant_melanoma-nodular | 1291 | 13 | 16828 | 48 |
NTRK2,ABLIM1,CTNND2,CPE,ATP13A4,ATP1A2,MACF1,HIF3A,NPAS3,NEBL,PTPRZ1,GLIS3,DCLK2 |
4.847e-05 | -9.93 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 8 | 18204 | 49 |
TNIK,CTNND2,BMPR1B,PTPRZ1,NRCAM,CTNNA2,PARD3,GPM6A |
5.891e-05 | -9.74 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 14 | 16828 | 48 |
RORA,FMN2,LSAMP,HPSE2,NRG3,NEBL,ADCY2,SOX5,SPON1,PARD3,NTRK2,CTNND2,NKAIN3,GPC5 |
5.891e-05 | -9.74 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 14 | 16828 | 48 |
SPON1,ADCY2,SOX5,GPC5,CTNND2,NKAIN3,NTRK2,PARD3,HPSE2,NRG3,LSAMP,FMN2,RORA,NEBL |
6.375e-05 | -9.66 | negative regulation of amyloid-beta formation | biological process | GO:1902430 | 29 | 3 | 18204 | 49 |
NTRK2,CLU,SPON1 |
6.877e-05 | -9.58 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 41 | 16828 | 48 |
TNIK,PITPNC1,NPAS3,HPSE2,FMN2,RFX4,CSGALNACT1,MGAT4C,CLU,CTNND2,DPP10,MACF1,ATP1A2,GPM6A,ATP13A4,SOX5,CPE,SPON1,PTPRZ1,NEBL,BMPR1B,SLC4A4,SORBS1,NRG3,DCLK2,RORA,PAMR1,RPS6KA2,NAV3,NKAIN3,GPC5,TRPS1,ABLIM1,PARD3,NRCAM,TRPM3,NTRK2,HIF3A,MAP3K5,MSI2,DTNA |
6.988e-05 | -9.57 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 41 | 16828 | 48 |
HIF3A,MSI2,DTNA,MAP3K5,TRPS1,GPC5,ABLIM1,RPS6KA2,NKAIN3,NAV3,NTRK2,PARD3,NRCAM,TRPM3,NRG3,DCLK2,SORBS1,PAMR1,RORA,SLC4A4,PTPRZ1,BMPR1B,NEBL,ATP1A2,MACF1,SPON1,GPM6A,SOX5,ATP13A4,CPE,CLU,CTNND2,DPP10,HPSE2,MGAT4C,CSGALNACT1,FMN2,RFX4,TNIK,NPAS3,PITPNC1 |
7.360e-05 | -9.52 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 42 | 16828 | 48 |
GLIS3,RORA,PAMR1,SORBS1,LSAMP,DCLK2,NRG3,NEBL,BMPR1B,PTPRZ1,SLC4A4,MAP3K5,DTNA,HIF3A,NRCAM,TRPM3,PARD3,EFEMP1,NTRK2,SLC1A2,NAV3,NKAIN3,TRPS1,GPC5,ABLIM1,RFX4,FMN2,MGAT4C,CSGALNACT1,HPSE2,PITPNC1,NPAS3,TNIK,CPE,ATP13A4,SOX5,ADCY2,GPM6A,SPON1,MACF1,ATP1A2,CTNND2 |
7.360e-05 | -9.52 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 42 | 16828 | 48 |
FMN2,RFX4,CSGALNACT1,MGAT4C,HPSE2,PITPNC1,NPAS3,TNIK,CPE,SOX5,ADCY2,ATP13A4,GPM6A,SPON1,MACF1,ATP1A2,CTNND2,RORA,GLIS3,PAMR1,LSAMP,SORBS1,DCLK2,NRG3,BMPR1B,NEBL,PTPRZ1,SLC4A4,MAP3K5,DTNA,HIF3A,TRPM3,NRCAM,PARD3,EFEMP1,NTRK2,SLC1A2,NAV3,NKAIN3,TRPS1,GPC5,ABLIM1 |
7.813e-05 | -9.46 | negative regulation of amyloid precursor protein catabolic process | biological process | GO:1902992 | 31 | 3 | 18204 | 49 |
SPON1,CLU,NTRK2 |
7.817e-05 | -9.46 | cell morphogenesis | biological process | GO:0000902 | 687 | 9 | 18204 | 49 |
GPM6A,CTNNA2,NRCAM,PARD3,BMPR1B,PTPRZ1,TNIK,CTNND2,CLU |
7.981e-05 | -9.44 | neuron development | biological process | GO:0048666 | 859 | 10 | 18204 | 49 |
BMPR1B,PTPRZ1,CTNND2,TNIK,NTRK2,DCLK2,GPM6A,CTNNA2,NRCAM,PARD3 |
8.349e-05 | -9.39 | multicellular organismal process | biological process | GO:0032501 | 6177 | 30 | 18204 | 49 |
BMPR1B,RORA,GPM6A,SLC1A2,NTRK2,NRCAM,EFEMP1,CPE,ABLIM1,NAV3,PARD3,CLU,DTNA,NEBL,MSI2,HIF3A,CSGALNACT1,CTNNA2,PTPRZ1,AQP4,TRPS1,RFX4,LSAMP,TNIK,CTNND2,SLC4A4,DCLK2,SOX5,NRG3,ATP1A2 |
9.307e-05 | -9.28 | telencephalon development | biological process | GO:0021537 | 276 | 6 | 18204 | 49 |
NRG3,ATP1A2,RFX4,DCLK2,SLC1A2,NTRK2 |
9.591e-05 | -9.25 | Bile secretion | KEGG pathways | hsa04976 | 71 | 4 | 7161 | 25 |
AQP4,ADCY2,ATP1A2,SLC4A4 |
9.591e-05 | -9.25 | Bile secretion | KEGG pathways | ko04976 | 71 | 4 | 7161 | 25 |
SLC4A4,ATP1A2,ADCY2,AQP4 |
9.955e-05 | -9.21 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 22 | 16828 | 48 |
CTNND2,RPS6KA2,NAV3,ABLIM1,GPC5,TRPM3,PARD3,DPP10,MACF1,ATP1A2,ADCY2,SOX5,GPM6A,SPON1,TNIK,NEBL,PTPRZ1,SLC4A4,NRG3,HPSE2,FMN2,PAMR1 |
1.004e-04 | -9.21 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 22 | 16828 | 48 |
ATP1A2,MACF1,SPON1,SOX5,ADCY2,GPM6A,GPC5,ABLIM1,CTNND2,RPS6KA2,NAV3,DPP10,TRPM3,PARD3,NRG3,HPSE2,PAMR1,FMN2,TNIK,SLC4A4,NEBL,PTPRZ1 |
1.034e-04 | -9.18 | negative regulation of amide metabolic process | biological process | GO:0034249 | 34 | 3 | 18204 | 49 |
NTRK2,SPON1,CLU |
1.112e-04 | -9.10 | neuron differentiation | biological process | GO:0030182 | 1081 | 11 | 18204 | 49 |
CTNNA2,NRCAM,PARD3,NTRK2,DCLK2,GPM6A,CTNND2,TNIK,RORA,BMPR1B,PTPRZ1 |
1.166e-04 | -9.06 | brain development | biological process | GO:0007420 | 724 | 9 | 18204 | 49 |
NTRK2,DCLK2,SLC1A2,NRCAM,CTNNA2,ATP1A2,NRG3,RORA,RFX4 |
1.167e-04 | -9.06 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 4 | 19454 | 50 |
SORBS1,PARD3,NTRK2,RPS6KA2 |
1.261e-04 | -8.98 | neuron projection | cellular component | GO:0043005 | 1331 | 12 | 19108 | 50 |
DTNA,CLU,BMPR1B,PARD3,ATP1A2,CTNND2,NRCAM,GPM6A,CTNNA2,SLC1A2,NTRK2,ADCY2 |
1.374e-04 | -8.89 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 6 | 19454 | 50 |
ABLIM1,MACF1,PARD3,TNIK,DTNA,FMN2 |
1.402e-04 | -8.87 | humerus | COSMIC cancer mutations | humerus | 546 | 8 | 16828 | 48 |
NKAIN3,GPC5,NEBL,HIF3A,GPM6A,FMN2,SOX5,ADCY2 |
1.449e-04 | -8.84 | protein kinase activity | molecular function | GO:0004672 | 577 | 8 | 18094 | 49 |
NTRK2,MAPK10,DCLK2,RPS6KA2,MAP3K5,EFEMP1,TNIK,BMPR1B |
1.490e-04 | -8.81 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 7 | 19454 | 50 |
SORBS1,SOX5,ABLIM1,MACF1,FMN2,PARD3,DTNA |
1.504e-04 | -8.80 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 16 | 19108 | 50 |
MACF1,ADCY2,NTRK2,CTNNA2,FMN2,GPM6A,NRCAM,SLC1A2,BMPR1B,CLU,DTNA,AQP4,ATP1A2,CTNND2,PARD3,ABLIM1 |
1.520e-04 | -8.79 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 31 | 16828 | 48 |
MAP3K5,ABLIM1,GPC5,RPS6KA2,NAV3,NTRK2,TRPM3,NRCAM,PARD3,DCLK2,NRG3,PAMR1,RORA,SLC4A4,BMPR1B,PTPRZ1,ATP1A2,MACF1,SPON1,CPE,SOX5,ATP13A4,ADCY2,CTNND2,CLU,DPP10,HPSE2,RFX4,FMN2,TNIK,PITPNC1 |
1.520e-04 | -8.79 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 31 | 16828 | 48 |
TNIK,PITPNC1,HPSE2,FMN2,RFX4,CTNND2,CLU,DPP10,ATP1A2,MACF1,SPON1,SOX5,CPE,ATP13A4,ADCY2,SLC4A4,BMPR1B,PTPRZ1,DCLK2,NRG3,PAMR1,RORA,GPC5,ABLIM1,NAV3,RPS6KA2,NTRK2,NRCAM,TRPM3,PARD3,MAP3K5 |
1.612e-04 | -8.73 | bone | COSMIC cancer mutations | bone | 8157 | 36 | 16828 | 48 |
RORA,GLIS3,PAMR1,LSAMP,SORBS1,DCLK2,NRG3,NEBL,PTPRZ1,SLC4A4,MAP3K5,DTNA,HIF3A,TRPM3,NRCAM,PARD3,NTRK2,NKAIN3,NAV3,TRPS1,GPC5,ABLIM1,FMN2,CSGALNACT1,HPSE2,NPAS3,TNIK,ATP13A4,SOX5,CPE,ADCY2,GPM6A,SPON1,MACF1,ATP1A2,CTNND2 |
1.687e-04 | -8.69 | developmental process | biological process | GO:0032502 | 5716 | 28 | 18204 | 49 |
EFEMP1,CPE,ABLIM1,NAV3,PARD3,BMPR1B,RORA,GPM6A,SLC1A2,NTRK2,NRCAM,PTPRZ1,TRPS1,RFX4,TNIK,LSAMP,CTNND2,DCLK2,SOX5,ATP1A2,NRG3,FMN2,CLU,NEBL,MSI2,HIF3A,CSGALNACT1,CTNNA2 |
1.729e-04 | -8.66 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 4 | 16828 | 48 |
CTNND2,NKAIN3,LSAMP,GPM6A |
1.730e-04 | -8.66 | Ser/Thr_kinase_AS | interpro domains | IPR008271 | 308 | 6 | 18521 | 50 |
MAPK10,MAP3K5,DCLK2,TNIK,BMPR1B,RPS6KA2 |
1.929e-04 | -8.55 | head development | biological process | GO:0060322 | 774 | 9 | 18204 | 49 |
RFX4,RORA,SLC1A2,DCLK2,NTRK2,ATP1A2,NRG3,NRCAM,CTNNA2 |
2.033e-04 | -8.50 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 6 | 16828 | 48 |
FMN2,GPM6A,ADCY2,SOX5,GPC5,NKAIN3 |
2.075e-04 | -8.48 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 24 | 16828 | 48 |
TNIK,HPSE2,RFX4,FMN2,CSGALNACT1,CTNND2,DPP10,MACF1,ADCY2,SOX5,ATP13A4,GPM6A,PTPRZ1,SLC4A4,SORBS1,NRG3,NAV3,RPS6KA2,TRPS1,TRPM3,NRCAM,PARD3,NTRK2,HIF3A |
2.215e-04 | -8.42 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 15 | 16828 | 48 |
TNIK,BMPR1B,NEBL,SLC4A4,NPAS3,RBMS3,HPSE2,FMN2,RORA,MGAT4C,CSGALNACT1,NAV3,MACF1,SOX5,GPM6A |
2.241e-04 | -8.40 | larynx | COSMIC cancer mutations | larynx | 1948 | 15 | 16828 | 48 |
MACF1,GPM6A,SOX5,NAV3,RBMS3,HPSE2,RORA,FMN2,MGAT4C,CSGALNACT1,TNIK,NEBL,BMPR1B,SLC4A4,NPAS3 |
2.276e-04 | -8.39 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 9 | 16828 | 48 |
DTNA,SOX5,DPP10,NTRK2,NEBL,PARD3,TRPS1,CTNND2,NAV3 |
2.393e-04 | -8.34 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 16 | 16828 | 48 |
GPM6A,ADCY2,SOX5,SPON1,PARD3,NTRK2,NKAIN3,SLC1A2,CTNND2,GPC5,FMN2,LSAMP,NRG3,HPSE2,PTPRZ1,NEBL |
2.393e-04 | -8.34 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 16 | 16828 | 48 |
FMN2,LSAMP,NRG3,HPSE2,PTPRZ1,NEBL,GPM6A,SOX5,ADCY2,SPON1,PARD3,NTRK2,NKAIN3,SLC1A2,CTNND2,GPC5 |
2.647e-04 | -8.24 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 16 | 16828 | 48 |
FMN2,LSAMP,NRG3,HPSE2,NEBL,PTPRZ1,ADCY2,SOX5,GPM6A,SPON1,PARD3,NTRK2,CTNND2,SLC1A2,NKAIN3,GPC5 |
2.647e-04 | -8.24 | cell projection | cellular component | GO:0042995 | 2398 | 16 | 19108 | 50 |
ADCY2,NTRK2,MACF1,SLC1A2,FMN2,CTNNA2,GPM6A,NRCAM,PARD3,AQP4,ATP1A2,CTNND2,BMPR1B,DTNA,CLU,ABLIM1 |
2.660e-04 | -8.23 | cytoskeletal protein binding | molecular function | GO:0008092 | 989 | 10 | 18094 | 49 |
CTNNA2,SORBS1,MACF1,CLU,DCLK2,NAV3,NRCAM,NEBL,FMN2,ABLIM1 |
2.863e-04 | -8.16 | Prot_kinase_dom | interpro domains | IPR000719 | 480 | 7 | 18521 | 50 |
DCLK2,MAP3K5,NTRK2,MAPK10,TNIK,BMPR1B,RPS6KA2 |
2.911e-04 | -8.14 | regulation of amyloid-beta formation | biological process | GO:1902003 | 48 | 3 | 18204 | 49 |
NTRK2,CLU,SPON1 |
2.945e-04 | -8.13 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 6 | 19454 | 50 |
MACF1,SORBS1,RPS6KA2,NEBL,PARD3,TNIK |
3.047e-04 | -8.10 | bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | bronchioloalveolar_adenocarcinoma | 778 | 9 | 16828 | 48 |
ADCY2,SOX5,MAP3K5,DCLK2,BMPR1B,NTRK2,CTNND2,RPS6KA2,TNIK |
3.047e-04 | -8.10 | lung-carcinoma-bronchioloalveolar_adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-bronchioloalveolar_adenocarcinoma | 778 | 9 | 16828 | 48 |
ADCY2,SOX5,MAP3K5,DCLK2,NTRK2,BMPR1B,TNIK,CTNND2,RPS6KA2 |
3.162e-04 | -8.06 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 4 | 19454 | 50 |
MACF1,DTNA,PARD3,ABLIM1 |
3.251e-04 | -8.03 | synapse | cellular component | GO:0045202 | 1473 | 12 | 19108 | 50 |
RPS6KA2,NRCAM,GPM6A,SLC1A2,TNIK,NTRK2,NRG3,PTPRZ1,DTNA,CLU,CTNND2,ATP1A2 |
3.432e-04 | -7.98 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 33 | 16828 | 48 |
CSGALNACT1,MGAT4C,FMN2,RFX4,HPSE2,TNIK,SPON1,GPM6A,ATP13A4,CPE,ADCY2,SOX5,MACF1,DPP10,CLU,CTNND2,PAMR1,RORA,GLIS3,NRG3,LSAMP,PTPRZ1,BMPR1B,NEBL,MAP3K5,NTRK2,EFEMP1,PARD3,GPC5,ABLIM1,NKAIN3,NAV3,SLC1A2 |
3.702e-04 | -7.90 | EZR (ezrin) | protein interactions | 7430 | 526 | 7 | 19454 | 50 |
DTNA,TNIK,NEBL,MAPK10,MACF1,ABLIM1,SORBS1 |
3.708e-04 | -7.90 | protein phosphorylation | biological process | GO:0006468 | 503 | 7 | 18204 | 49 |
TNIK,EFEMP1,MAPK10,BMPR1B,MAP3K5,NTRK2,RPS6KA2 |
3.740e-04 | -7.89 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 7 | 16828 | 48 |
NRG3,GPC5,LSAMP,CTNND2,GPM6A,ATP13A4,TRPM3 |
3.883e-04 | -7.85 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 13 | 16828 | 48 |
SOX5,ATP13A4,ATP1A2,MACF1,NRCAM,GPC5,TRPS1,NAV3,RORA,RBMS3,LSAMP,SLC4A4,PTPRZ1 |
3.885e-04 | -7.85 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 17 | 16828 | 48 |
LSAMP,HPSE2,NRG3,RORA,FMN2,TNIK,PTPRZ1,ADCY2,SOX5,CPE,ATP13A4,GPM6A,SPON1,CTNND2,NKAIN3,GPC5,PARD3 |
3.923e-04 | -7.84 | cell junction | cellular component | GO:0030054 | 2224 | 15 | 19108 | 50 |
RPS6KA2,CTNNA2,GPM6A,NRCAM,SLC1A2,TNIK,NRG3,NTRK2,PTPRZ1,CLU,SORBS1,DTNA,CTNND2,ATP1A2,PARD3 |
3.988e-04 | -7.83 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 4 | 19454 | 50 |
DTNA,NTRK2,PARD3,ABLIM1 |
4.290e-04 | -7.75 | testis-germ_cell_tumour-non_seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-non_seminoma | 487 | 7 | 16828 | 48 |
TNIK,RPS6KA2,NTRK2,BMPR1B,DCLK2,MACF1,MAP3K5 |
4.337e-04 | -7.74 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 13 | 18204 | 49 |
ATP1A2,RPS6KA2,DCLK2,TNIK,MAPK10,EFEMP1,PTPRZ1,MAP3K5,CSGALNACT1,NTRK2,RORA,BMPR1B,ADCY2 |
4.357e-04 | -7.74 | regulation of amyloid precursor protein catabolic process | biological process | GO:1902991 | 55 | 3 | 18204 | 49 |
NTRK2,SPON1,CLU |
4.561e-04 | -7.69 | non_seminoma | COSMIC cancer mutations | non_seminoma | 492 | 7 | 16828 | 48 |
MACF1,RPS6KA2,DCLK2,TNIK,MAP3K5,BMPR1B,NTRK2 |
4.667e-04 | -7.67 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 8 | 18094 | 49 |
NTRK2,MAPK10,DCLK2,MAP3K5,RPS6KA2,EFEMP1,BMPR1B,TNIK |
4.796e-04 | -7.64 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 49 |
BMPR1B,GPM6A,PTPRZ1,CTNND2,NRCAM,TNIK,CTNNA2,PARD3 |
4.797e-04 | -7.64 | Kinase-like_dom_sf | interpro domains | IPR011009 | 523 | 7 | 18521 | 50 |
TNIK,BMPR1B,MAPK10,DCLK2,MAP3K5,NTRK2,RPS6KA2 |
4.928e-04 | -7.62 | NAKATPASE | prints domains | PR00121 | 9 | 2 | 5227 | 20 |
ATP13A4,ATP1A2 |
5.005e-04 | -7.60 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 19 | 16828 | 48 |
NPAS3,PTPRZ1,TNIK,FMN2,RORA,NRG3,HPSE2,LSAMP,PARD3,GPC5,NKAIN3,CTNND2,SLC1A2,SPON1,GPM6A,ATP13A4,ADCY2,CPE,SOX5 |
5.017e-04 | -7.60 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 48 | 16828 | 48 |
SLC4A4,BMPR1B,NRG3,DCLK2,PAMR1,RORA,GPC5,TRPS1,NAV3,NTRK2,EFEMP1,PARD3,TRPM3,HIF3A,MSI2,DTNA,TNIK,NPAS3,HPSE2,RBMS3,CSGALNACT1,ATP1A2,SPON1,GPM6A,ATP13A4,ADCY2,PTPRZ1,NEBL,SORBS1,LSAMP,GLIS3,ABLIM1,NKAIN3,RPS6KA2,SLC1A2,NRCAM,AQP4,MAP3K5,PITPNC1,MGAT4C,RFX4,FMN2,CLU,CTNND2,DPP10,MACF1,CPE,SOX5 |
5.099e-04 | -7.58 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 48 |
FMN2,RFX4,SLC4A4,PITPNC1,ATP1A2,ATP13A4,CLU,RPS6KA2,CTNND2,SLC1A2,NTRK2,DPP10 |
5.099e-04 | -7.58 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 48 |
SLC4A4,PITPNC1,FMN2,RFX4,NTRK2,DPP10,CLU,RPS6KA2,SLC1A2,CTNND2,ATP13A4,ATP1A2 |
5.100e-04 | -7.58 | Protein_kinase_ATP_BS | interpro domains | IPR017441 | 377 | 6 | 18521 | 50 |
RPS6KA2,BMPR1B,TNIK,NTRK2,MAP3K5,DCLK2 |
5.158e-04 | -7.57 | tibia | COSMIC cancer mutations | tibia | 836 | 9 | 16828 | 48 |
CTNND2,NKAIN3,ABLIM1,TNIK,TRPM3,MACF1,LSAMP,CPE,GPM6A |
5.507e-04 | -7.50 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 49 |
NRCAM,CTNNA2,GPM6A,MSI2,NTRK2,RORA,CLU,NEBL,BMPR1B,PARD3,FMN2,DCLK2,CTNND2,TNIK,PTPRZ1 |
5.630e-04 | -7.48 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 3 | 18204 | 49 |
NTRK2,NRCAM,ATP1A2 |
5.776e-04 | -7.46 | PLXNA4 (plexin A4) | protein interactions | 91584 | 14 | 2 | 19454 | 50 |
CLU,GPM6A |
5.887e-04 | -7.44 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 22 | 16828 | 48 |
RFX4,FMN2,NPAS3,PITPNC1,TNIK,GPM6A,ADCY2,ATP1A2,MACF1,DPP10,CTNND2,GLIS3,SLC4A4,PTPRZ1,NEBL,HIF3A,AQP4,NTRK2,PARD3,TRPS1,NAV3,SLC1A2 |
5.909e-04 | -7.43 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 22 | 16828 | 48 |
GPM6A,ADCY2,ATP1A2,HIF3A,MACF1,AQP4,NTRK2,DPP10,PARD3,TRPS1,NAV3,SLC1A2,CTNND2,GLIS3,RFX4,FMN2,SLC4A4,NPAS3,PTPRZ1,NEBL,PITPNC1,TNIK |
6.050e-04 | -7.41 | PROTEIN_KINASE_ST | prosite domains | PS00108 | 308 | 6 | 12186 | 42 |
DCLK2,RPS6KA2,MAPK10,BMPR1B,MAP3K5,TNIK |
6.100e-04 | -7.40 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 20 | 16828 | 48 |
SPON1,ATP13A4,ADCY2,MAP3K5,ATP1A2,MACF1,EFEMP1,PARD3,TRPM3,GPC5,RPS6KA2,CTNND2,MGAT4C,GLIS3,FMN2,RFX4,NRG3,PTPRZ1,PITPNC1,NEBL |
6.321e-04 | -7.37 | Transferase(Phosphotransferase) domain 1 | gene3d domains | 1.10.510.10 | 490 | 7 | 14470 | 44 |
DCLK2,BMPR1B,RPS6KA2,MAP3K5,MAPK10,NTRK2,TNIK |
6.327e-04 | -7.37 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 2 | 18204 | 49 |
ATP1A2,SLC4A4 |
6.557e-04 | -7.33 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 28 | 16828 | 48 |
FMN2,HPSE2,NPAS3,SPON1,GPM6A,ADCY2,SOX5,MACF1,DPP10,CLU,CTNND2,PAMR1,GLIS3,RORA,NRG3,LSAMP,SORBS1,PTPRZ1,NEBL,MAP3K5,AQP4,NTRK2,PARD3,TRPM3,GPC5,TRPS1,NKAIN3,SLC1A2 |
6.654e-04 | -7.32 | TIAM2 (TIAM Rac1 associated GEF 2) | protein interactions | 26230 | 15 | 2 | 19454 | 50 |
PARD3,TNIK |
6.654e-04 | -7.32 | RNASE13 (ribonuclease A family member 13 (inactive)) | protein interactions | 440163 | 15 | 2 | 19454 | 50 |
CLU,CPE |
6.693e-04 | -7.31 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 22 | 16828 | 48 |
DPP10,CTNND2,GPM6A,ADCY2,MACF1,ATP1A2,PITPNC1,NPAS3,TNIK,RFX4,FMN2,PARD3,NTRK2,NAV3,SLC1A2,TRPS1,HIF3A,AQP4,PTPRZ1,NEBL,SLC4A4,GLIS3 |
6.697e-04 | -7.31 | phosphorylation | biological process | GO:0016310 | 729 | 8 | 18204 | 49 |
TNIK,EFEMP1,BMPR1B,MAPK10,MAP3K5,DCLK2,RPS6KA2,NTRK2 |
6.818e-04 | -7.29 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 5 | 16828 | 48 |
GPC5,NRG3,HPSE2,NPAS3,ADCY2 |
6.818e-04 | -7.29 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 5 | 16828 | 48 |
ADCY2,NPAS3,GPC5,HPSE2,NRG3 |
7.001e-04 | -7.26 | Neurotrophin signaling pathway | KEGG pathways | hsa04722 | 119 | 4 | 7161 | 25 |
RPS6KA2,MAP3K5,NTRK2,MAPK10 |
7.001e-04 | -7.26 | Neurotrophin signaling pathway | KEGG pathways | ko04722 | 119 | 4 | 7161 | 25 |
MAPK10,NTRK2,MAP3K5,RPS6KA2 |
7.496e-04 | -7.20 | main axon | cellular component | GO:0044304 | 68 | 3 | 19108 | 50 |
NRCAM,SLC1A2,PARD3 |
7.564e-04 | -7.19 | forebrain development | biological process | GO:0030900 | 408 | 6 | 18204 | 49 |
NRG3,ATP1A2,NTRK2,DCLK2,SLC1A2,RFX4 |
7.592e-04 | -7.18 | CNTNAP2 (contactin associated protein 2) | protein interactions | 26047 | 16 | 2 | 19454 | 50 |
MACF1,CPE |
7.616e-04 | -7.18 | kinase activity | molecular function | GO:0016301 | 739 | 8 | 18094 | 49 |
DCLK2,NTRK2,MAPK10,EFEMP1,TNIK,BMPR1B,RPS6KA2,MAP3K5 |
7.661e-04 | -7.17 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 32 | 16828 | 48 |
LSAMP,DCLK2,NRG3,RORA,NEBL,PTPRZ1,SLC4A4,AQP4,MAP3K5,SLC1A2,RPS6KA2,NAV3,TRPS1,NRCAM,TRPM3,PARD3,NTRK2,HPSE2,RFX4,FMN2,CSGALNACT1,PITPNC1,NPAS3,MACF1,ATP1A2,SOX5,ADCY2,ATP13A4,SPON1,CTNND2,CLU,DPP10 |
7.661e-04 | -7.17 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 32 | 16828 | 48 |
CLU,CTNND2,DPP10,ATP1A2,MACF1,SPON1,ADCY2,ATP13A4,SOX5,NPAS3,PITPNC1,HPSE2,CSGALNACT1,RFX4,FMN2,TRPS1,NAV3,RPS6KA2,SLC1A2,NTRK2,PARD3,TRPM3,NRCAM,AQP4,MAP3K5,SLC4A4,PTPRZ1,NEBL,NRG3,DCLK2,LSAMP,RORA |
8.042e-04 | -7.13 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 46 | 16828 | 48 |
CSGALNACT1,RBMS3,HPSE2,NPAS3,TNIK,GPM6A,ATP13A4,ADCY2,SPON1,ATP1A2,RORA,PAMR1,NRG3,DCLK2,BMPR1B,SLC4A4,MSI2,DTNA,HIF3A,PARD3,TRPM3,NTRK2,EFEMP1,NAV3,GPC5,TRPS1,RFX4,FMN2,MGAT4C,PITPNC1,SOX5,MACF1,DPP10,CLU,CTNND2,GLIS3,SORBS1,LSAMP,PTPRZ1,NEBL,MAP3K5,NRCAM,NKAIN3,RPS6KA2,SLC1A2,ABLIM1 |
8.074e-04 | -7.12 | ANK2 (ankyrin 2) | protein interactions | 287 | 71 | 3 | 19454 | 50 |
GPM6A,TNIK,NRCAM |
8.090e-04 | -7.12 | animal organ development | biological process | GO:0048513 | 2846 | 17 | 18204 | 49 |
CTNNA2,NRCAM,CSGALNACT1,NTRK2,GPM6A,SLC1A2,NEBL,RORA,BMPR1B,ATP1A2,NRG3,SOX5,DCLK2,CPE,ABLIM1,RFX4,EFEMP1 |
8.233e-04 | -7.10 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 32 | 16828 | 48 |
HPSE2,CSGALNACT1,RFX4,FMN2,CTNND2,CLU,DPP10,ATP1A2,MACF1,SPON1,SOX5,ATP13A4,CPE,ADCY2,GPM6A,SLC4A4,NEBL,BMPR1B,NRG3,LSAMP,PAMR1,GLIS3,RORA,GPC5,ABLIM1,SLC1A2,NKAIN3,EFEMP1,NTRK2,NRCAM,PARD3,MAP3K5 |
8.315e-04 | -7.09 | asymmetric cell division | biological process | GO:0008356 | 16 | 2 | 18204 | 49 |
SOX5,PARD3 |
8.364e-04 | -7.09 | kidney-Wilms_tumour | COSMIC cancer mutations | kidney-Wilms_tumour | 545 | 7 | 16828 | 48 |
DCLK2,TNIK,RPS6KA2,NTRK2,FMN2,BMPR1B,MAP3K5 |
8.443e-04 | -7.08 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 10 | 18204 | 49 |
PARD3,NRCAM,CTNNA2,GPM6A,ABLIM1,RFX4,TNIK,CTNND2,PTPRZ1,BMPR1B |
8.454e-04 | -7.08 | Wilms_tumour | COSMIC cancer mutations | Wilms_tumour | 546 | 7 | 16828 | 48 |
MAP3K5,FMN2,DCLK2,NTRK2,BMPR1B,TNIK,RPS6KA2 |
9.082e-04 | -7.00 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 48 |
NTRK2,DPP10,PARD3,TRPM3,NRCAM,RPS6KA2,MSI2,MAP3K5,ADCY2,ATP1A2,HIF3A,MACF1,SLC4A4,NPAS3,NEBL,BMPR1B,FMN2,NRG3 |
9.082e-04 | -7.00 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 18 | 16828 | 48 |
NRG3,FMN2,BMPR1B,NEBL,SLC4A4,NPAS3,MACF1,HIF3A,ATP1A2,MAP3K5,ADCY2,MSI2,RPS6KA2,TRPM3,NRCAM,PARD3,DPP10,NTRK2 |
9.860e-04 | -6.92 | cell junction assembly | biological process | GO:0034329 | 285 | 5 | 18204 | 49 |
GPM6A,SORBS1,NRG3,PARD3,NRCAM |
1.000e-03 | -6.91 | protein serine/threonine kinase activity | molecular function | GO:0004674 | 428 | 6 | 18094 | 49 |
DCLK2,MAPK10,TNIK,BMPR1B,RPS6KA2,MAP3K5 |
1.003e-03 | -6.90 | testis | COSMIC cancer mutations | testis | 733 | 8 | 16828 | 48 |
BMPR1B,NTRK2,RPS6KA2,TNIK,TRPS1,MAP3K5,MACF1,DCLK2 |
1.022e-03 | -6.89 | ADGRL2 (adhesion G protein-coupled receptor L2) | protein interactions | 23266 | 77 | 3 | 19454 | 50 |
PARD3,RPS6KA2,NTRK2 |
1.063e-03 | -6.85 | ATPase_P-typ_cation-transptr_N | interpro domains | IPR004014 | 18 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
1.067e-03 | -6.84 | mucosal | COSMIC cancer mutations | mucosal | 2009 | 14 | 16828 | 48 |
CTNND2,ABLIM1,PARD3,EFEMP1,ATP1A2,CPE,ATP13A4,BMPR1B,NEBL,SORBS1,NRG3,RORA,FMN2,MGAT4C |
1.067e-03 | -6.84 | skin-mucosal-malignant_melanoma | COSMIC cancer mutations | skin-mucosal-malignant_melanoma | 2009 | 14 | 16828 | 48 |
NEBL,BMPR1B,NRG3,SORBS1,MGAT4C,RORA,FMN2,ABLIM1,CTNND2,EFEMP1,PARD3,ATP1A2,ATP13A4,CPE |
1.075e-03 | -6.84 | actin binding | molecular function | GO:0003779 | 434 | 6 | 18094 | 49 |
CTNNA2,MACF1,SORBS1,NEBL,FMN2,ABLIM1 |
1.080e-03 | -6.83 | prostate | COSMIC cancer mutations | prostate | 13883 | 47 | 16828 | 48 |
PITPNC1,FMN2,RFX4,MGAT4C,DPP10,CLU,CTNND2,SOX5,CPE,MACF1,PTPRZ1,NEBL,GLIS3,LSAMP,SORBS1,NRCAM,RPS6KA2,NKAIN3,SLC1A2,ABLIM1,MAP3K5,AQP4,NPAS3,TNIK,CSGALNACT1,HPSE2,GPM6A,ATP13A4,ADCY2,SPON1,ATP1A2,BMPR1B,SLC4A4,RORA,PAMR1,NRG3,DCLK2,PARD3,TRPM3,NTRK2,EFEMP1,NAV3,TRPS1,GPC5,MSI2,DTNA,HIF3A |
1.088e-03 | -6.82 | dendrite | cellular component | GO:0030425 | 620 | 7 | 19108 | 50 |
ATP1A2,CTNND2,NTRK2,ADCY2,CLU,BMPR1B,GPM6A |
1.105e-03 | -6.81 | Cation_ATPase_N | pfam domains | PF00690 | 18 | 2 | 17795 | 49 |
ATP1A2,ATP13A4 |
1.108e-03 | -6.80 | dendritic tree | cellular component | GO:0097447 | 622 | 7 | 19108 | 50 |
GPM6A,NTRK2,CTNND2,ATP1A2,ADCY2,CLU,BMPR1B |
1.115e-03 | -6.80 | astrocyte projection | cellular component | GO:0097449 | 19 | 2 | 19108 | 50 |
SLC1A2,AQP4 |
1.137e-03 | -6.78 | animal organ morphogenesis | biological process | GO:0009887 | 988 | 9 | 18204 | 49 |
NTRK2,SOX5,CTNNA2,NRG3,CSGALNACT1,EFEMP1,BMPR1B,CPE,ABLIM1 |
1.147e-03 | -6.77 | PROTEIN_KINASE_DOM | prosite domains | PS50011 | 480 | 7 | 12186 | 42 |
RPS6KA2,BMPR1B,MAP3K5,TNIK,MAPK10,NTRK2,DCLK2 |
1.154e-03 | -6.76 | cell projection organization | biological process | GO:0030030 | 1200 | 10 | 18204 | 49 |
CTNND2,TNIK,RFX4,ABLIM1,BMPR1B,PTPRZ1,CTNNA2,NRCAM,PARD3,GPM6A |
1.158e-03 | -6.76 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 6 | 18204 | 49 |
BMPR1B,PTPRZ1,NRCAM,CTNNA2,CTNND2,PARD3 |
1.179e-03 | -6.74 | cartilage condensation | biological process | GO:0001502 | 19 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.186e-03 | -6.74 | PAS_fold | interpro domains | IPR013767 | 19 | 2 | 18521 | 50 |
NPAS3,HIF3A |
1.233e-03 | -6.70 | PAS | pfam domains | PF00989 | 19 | 2 | 17795 | 49 |
NPAS3,HIF3A |
1.246e-03 | -6.69 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 28 | 16828 | 48 |
HPSE2,RFX4,FMN2,MGAT4C,CLU,DPP10,MACF1,ATP1A2,ATP13A4,ADCY2,GPM6A,NEBL,PTPRZ1,SLC4A4,SORBS1,NRG3,GLIS3,NAV3,TRPS1,ABLIM1,GPC5,TRPM3,NRCAM,PARD3,NTRK2,HIF3A,MAP3K5,DTNA |
1.254e-03 | -6.68 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 28 | 16828 | 48 |
FMN2,RFX4,MGAT4C,HPSE2,DPP10,CLU,ADCY2,ATP13A4,GPM6A,MACF1,ATP1A2,NEBL,PTPRZ1,SLC4A4,GLIS3,SORBS1,NRG3,NRCAM,TRPM3,PARD3,NTRK2,NAV3,GPC5,ABLIM1,TRPS1,MAP3K5,DTNA,HIF3A |
1.274e-03 | -6.67 | central nervous system neuron differentiation | biological process | GO:0021953 | 176 | 4 | 18204 | 49 |
NTRK2,BMPR1B,DCLK2,RORA |
1.307e-03 | -6.64 | positive regulation of chondrocyte differentiation | biological process | GO:0032332 | 20 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.318e-03 | -6.63 | TENM1 (teneurin transmembrane protein 1) | protein interactions | 10178 | 21 | 2 | 19454 | 50 |
SORBS1,MACF1 |
1.325e-03 | -6.63 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 26 | 18204 | 49 |
SLC4A4,SOX5,FMN2,GPC5,PTPRZ1,GLIS3,RFX4,MACF1,TNIK,NPAS3,DPP10,SORBS1,CLU,RPS6KA2,NAV3,PARD3,GPM6A,SLC1A2,NTRK2,HPSE2,MAP3K5,NRCAM,SPON1,BMPR1B,RORA,RBMS3 |
1.330e-03 | -6.62 | kidney-carcinoma-chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-chromophobe_renal_cell_carcinoma | 430 | 6 | 16828 | 48 |
BMPR1B,NTRK2,RPS6KA2,TNIK,MAP3K5,DCLK2 |
1.330e-03 | -6.62 | chromophobe_renal_cell_carcinoma | COSMIC cancer mutations | chromophobe_renal_cell_carcinoma | 430 | 6 | 16828 | 48 |
MAP3K5,BMPR1B,NTRK2,RPS6KA2,DCLK2,TNIK |
1.343e-03 | -6.61 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 12 | 18204 | 49 |
ATP1A2,RPS6KA2,DCLK2,TNIK,EFEMP1,MAPK10,PTPRZ1,MAP3K5,NTRK2,RORA,BMPR1B,ADCY2 |
1.349e-03 | -6.61 | regulation of amide metabolic process | biological process | GO:0034248 | 81 | 3 | 18204 | 49 |
CLU,SPON1,NTRK2 |
1.373e-03 | -6.59 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 3 | 18094 | 49 |
BMPR1B,EFEMP1,NTRK2 |
1.429e-03 | -6.55 | axon | cellular component | GO:0030424 | 650 | 7 | 19108 | 50 |
NRCAM,GPM6A,CTNNA2,SLC1A2,DTNA,NTRK2,PARD3 |
1.443e-03 | -6.54 | cell aggregation | biological process | GO:0098743 | 21 | 2 | 18204 | 49 |
SOX5,BMPR1B |
1.443e-03 | -6.54 | retinal ganglion cell axon guidance | biological process | GO:0031290 | 21 | 2 | 18204 | 49 |
BMPR1B,NRCAM |
1.463e-03 | -6.53 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 29 | 16828 | 48 |
SLC4A4,PAMR1,RORA,NRG3,SORBS1,EFEMP1,PARD3,NRCAM,TRPM3,TRPS1,GPC5,ABLIM1,NAV3,SLC1A2,MAP3K5,HIF3A,NPAS3,PITPNC1,MGAT4C,RFX4,FMN2,HPSE2,CLU,CTNND2,SPON1,GPM6A,SOX5,ADCY2,MACF1 |
1.468e-03 | -6.52 | adherens junction | cellular component | GO:0005912 | 188 | 4 | 19108 | 50 |
PARD3,CTNND2,SORBS1,CTNNA2 |
1.481e-03 | -6.52 | contractile actin filament bundle | cellular component | GO:0097517 | 86 | 3 | 19108 | 50 |
SORBS1,NEBL,ABLIM1 |
1.481e-03 | -6.52 | stress fiber | cellular component | GO:0001725 | 86 | 3 | 19108 | 50 |
SORBS1,ABLIM1,NEBL |
1.484e-03 | -6.51 | ROR2 (receptor tyrosine kinase like orphan receptor 2) | protein interactions | 4920 | 327 | 5 | 19454 | 50 |
SORBS1,PARD3,TNIK,DTNA,RPS6KA2 |
1.517e-03 | -6.49 | plasma membrane region | cellular component | GO:0098590 | 1278 | 10 | 19108 | 50 |
GPM6A,NRCAM,SLC1A2,SLC4A4,TNIK,SORBS1,MACF1,AQP4,ATP1A2,PARD3 |
1.548e-03 | -6.47 | SFN (stratifin) | protein interactions | 2810 | 671 | 7 | 19454 | 50 |
MACF1,MAP3K5,SORBS1,ABLIM1,PARD3,TNIK,FMN2 |
1.550e-03 | -6.47 | Cation_ATPase_N | smart domains | SM00831 | 16 | 2 | 9717 | 36 |
ATP1A2,ATP13A4 |
1.550e-03 | -6.47 | oligodendrocyte differentiation | biological process | GO:0048709 | 85 | 3 | 18204 | 49 |
CLU,PTPRZ1,NTRK2 |
1.571e-03 | -6.46 | ATP binding | molecular function | GO:0005524 | 1467 | 11 | 18094 | 49 |
BMPR1B,DCLK2,NAV3,MAP3K5,ATP13A4,RPS6KA2,ATP1A2,TNIK,NTRK2,MAPK10,ADCY2 |
1.577e-03 | -6.45 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 12 | 16828 | 48 |
PTPRZ1,RORA,FMN2,SORBS1,DPP10,NRCAM,ABLIM1,CTNND2,NAV3,DTNA,CPE,MACF1 |
1.577e-03 | -6.45 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 12 | 16828 | 48 |
NAV3,CTNND2,ABLIM1,PTPRZ1,NRCAM,DPP10,SORBS1,MACF1,RORA,FMN2,CPE,DTNA |
1.582e-03 | -6.45 | TIMM10B (translocase of inner mitochondrial membrane 10B) | protein interactions | 26515 | 23 | 2 | 19454 | 50 |
HPSE2,MSI2 |
1.584e-03 | -6.45 | S_TKc | smart domains | SM00220 | 348 | 6 | 9717 | 36 |
RPS6KA2,MAP3K5,DCLK2,BMPR1B,MAPK10,TNIK |
1.603e-03 | -6.44 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 3 | 18204 | 49 |
ATP1A2,SLC4A4,SLC1A2 |
1.603e-03 | -6.44 | vascular transport | biological process | GO:0010232 | 86 | 3 | 18204 | 49 |
SLC1A2,SLC4A4,ATP1A2 |
1.701e-03 | -6.38 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 17 | 16828 | 48 |
NPAS3,PTPRZ1,NEBL,BMPR1B,HPSE2,DCLK2,NTRK2,PARD3,TRPM3,GPC5,NAV3,CTNND2,GPM6A,SOX5,ADCY2,HIF3A,MACF1 |
1.722e-03 | -6.36 | PROTEIN_KINASE_ATP | prosite domains | PS00107 | 377 | 6 | 12186 | 42 |
DCLK2,NTRK2,TNIK,MAP3K5,BMPR1B,RPS6KA2 |
1.782e-03 | -6.33 | HS-GAG degradation | REACTOME pathways | R-HSA-2024096 | 21 | 2 | 10285 | 31 |
GPC5,HPSE2 |
1.787e-03 | -6.33 | Insulin Signaling | WikiPathways | WP481 | 161 | 4 | 5310 | 18 |
MAPK10,RPS6KA2,MAP3K5,SORBS1 |
1.793e-03 | -6.32 | ovary-carcinoma-mucinous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-mucinous_carcinoma | 456 | 6 | 16828 | 48 |
NTRK2,BMPR1B,TNIK,RPS6KA2,MAP3K5,DCLK2 |
1.797e-03 | -6.32 | actomyosin | cellular component | GO:0042641 | 92 | 3 | 19108 | 50 |
SORBS1,ABLIM1,NEBL |
1.824e-03 | -6.31 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 16 | 16828 | 48 |
NRG3,HPSE2,FMN2,RFX4,CSGALNACT1,PTPRZ1,ATP1A2,SOX5,MAP3K5,ADCY2,CTNND2,SLC1A2,NRCAM,TRPM3,EFEMP1,NTRK2 |
1.833e-03 | -6.30 | mucinous_carcinoma | COSMIC cancer mutations | mucinous_carcinoma | 458 | 6 | 16828 | 48 |
RPS6KA2,DCLK2,TNIK,BMPR1B,MAP3K5,NTRK2 |
1.909e-03 | -6.26 | P-type ion transporter activity | molecular function | GO:0015662 | 24 | 2 | 18094 | 49 |
ATP1A2,ATP13A4 |
1.909e-03 | -6.26 | P-type transmembrane transporter activity | molecular function | GO:0140358 | 24 | 2 | 18094 | 49 |
ATP13A4,ATP1A2 |
1.913e-03 | -6.26 | Adherens junction | KEGG pathways | ko04520 | 72 | 3 | 7161 | 25 |
CTNNA2,PARD3,SORBS1 |
1.913e-03 | -6.26 | Adherens junction | KEGG pathways | hsa04520 | 72 | 3 | 7161 | 25 |
PARD3,SORBS1,CTNNA2 |
1.913e-03 | -6.26 | human chr4q31.23-q31.3 | chromosome location | human chr4q31.23-q31.3 | 1 | 1 | 26134 | 50 |
DCLK2 |
1.913e-03 | -6.26 | human chr10p11.22-p11.21 | chromosome location | human chr10p11.22-p11.21 | 1 | 1 | 26134 | 50 |
PARD3 |
1.913e-03 | -6.26 | human chr9q21.12-q21.13 | chromosome location | human chr9q21.12-q21.13 | 1 | 1 | 26134 | 50 |
TRPM3 |
1.913e-03 | -6.26 | human chr12q21.31-q21.32 | chromosome location | human chr12q21.31-q21.32 | 1 | 1 | 26134 | 50 |
MGAT4C |
1.913e-03 | -6.26 | human chr3q26.2-q26.31 | chromosome location | human chr3q26.2-q26.31 | 1 | 1 | 26134 | 50 |
TNIK |
1.957e-03 | -6.24 | ovary-carcinoma-endometrioid_carcinoma | COSMIC cancer mutations | ovary-carcinoma-endometrioid_carcinoma | 464 | 6 | 16828 | 48 |
NTRK2,BMPR1B,MAP3K5,DCLK2,TNIK,RPS6KA2 |
1.970e-03 | -6.23 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 16 | 16828 | 48 |
ATP1A2,ATP13A4,SOX5,MAP3K5,TRPS1,RPS6KA2,CTNND2,DPP10,PARD3,NRCAM,HPSE2,NRG3,LSAMP,MGAT4C,PTPRZ1,NEBL |
2.023e-03 | -6.20 | NRCAM (neuronal cell adhesion molecule) | protein interactions | 4897 | 26 | 2 | 19454 | 50 |
MACF1,NRCAM |
2.030e-03 | -6.20 | actin filament bundle | cellular component | GO:0032432 | 96 | 3 | 19108 | 50 |
SORBS1,NEBL,ABLIM1 |
2.047e-03 | -6.19 | positive regulation of amyloid precursor protein catabolic process | biological process | GO:1902993 | 25 | 2 | 18204 | 49 |
SPON1,CLU |
2.112e-03 | -6.16 | cell surface | cellular component | GO:0009986 | 896 | 8 | 19108 | 50 |
MAP3K5,ATP1A2,AQP4,CLU,SLC4A4,SLC1A2,GPC5,NRCAM |
2.176e-03 | -6.13 | adenyl ribonucleotide binding | molecular function | GO:0032559 | 1528 | 11 | 18094 | 49 |
DCLK2,NAV3,BMPR1B,ADCY2,MAPK10,NTRK2,TNIK,ATP1A2,MAP3K5,RPS6KA2,ATP13A4 |
2.181e-03 | -6.13 | HPCAL4 (hippocalcin like 4) | protein interactions | 51440 | 27 | 2 | 19454 | 50 |
GPM6A,AQP4 |
2.181e-03 | -6.13 | KCNJ12 (potassium inwardly rectifying channel subfamily J member 12) | protein interactions | 3768 | 27 | 2 | 19454 | 50 |
DTNA,ABLIM1 |
2.185e-03 | -6.13 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 7 | 19454 | 50 |
ABLIM1,MACF1,FMN2,TNIK,MSI2,PARD3,DTNA |
2.265e-03 | -6.09 | testis-germ_cell_tumour-seminoma | COSMIC cancer mutations | testis-germ_cell_tumour-seminoma | 648 | 7 | 16828 | 48 |
RPS6KA2,TRPS1,TNIK,BMPR1B,NTRK2,DCLK2,MAP3K5 |
2.272e-03 | -6.09 | actin cytoskeleton | cellular component | GO:0015629 | 520 | 6 | 19108 | 50 |
ABLIM1,NEBL,CTNNA2,FMN2,MACF1,SORBS1 |
2.359e-03 | -6.05 | MAPK (JNK) signaling | KEGG pathways | hsa_M00688 | 21 | 2 | 7161 | 25 |
MAPK10,MAP3K5 |
2.359e-03 | -6.05 | MAPK (JNK) signaling | KEGG pathways | M00688 | 21 | 2 | 7161 | 25 |
MAPK10,MAP3K5 |
2.393e-03 | -6.04 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 22 | 16828 | 48 |
RFX4,FMN2,MGAT4C,MACF1,ATP1A2,GPM6A,SOX5,ADCY2,SPON1,CLU,CTNND2,DPP10,NRG3,GLIS3,PTPRZ1,HIF3A,MAP3K5,DTNA,ABLIM1,TRPS1,PARD3,TRPM3 |
2.393e-03 | -6.04 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 22 | 16828 | 48 |
DPP10,CLU,CTNND2,SPON1,GPM6A,ADCY2,SOX5,ATP1A2,MACF1,MGAT4C,RFX4,FMN2,PARD3,TRPM3,TRPS1,ABLIM1,DTNA,MAP3K5,HIF3A,PTPRZ1,GLIS3,NRG3 |
2.415e-03 | -6.03 | poly(U) RNA binding | molecular function | GO:0008266 | 27 | 2 | 18094 | 49 |
MSI2,RBMS3 |
2.424e-03 | -6.02 | HUNK (hormonally up-regulated Neu-associated kinase) | protein interactions | 30811 | 104 | 3 | 19454 | 50 |
SORBS1,ABLIM1,CLU |
2.455e-03 | -6.01 | NTRK3 (neurotrophic receptor tyrosine kinase 3) | protein interactions | 4916 | 367 | 5 | 19454 | 50 |
NTRK2,PARD3,ABLIM1,TNIK,CLU |
2.499e-03 | -5.99 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 21 | 16828 | 48 |
SLC4A4,NEBL,NRG3,CSGALNACT1,MGAT4C,PAMR1,RORA,FMN2,RFX4,GPC5,TRPS1,ABLIM1,NAV3,SLC1A2,CTNND2,PARD3,NRCAM,ATP1A2,MACF1,MAP3K5,ATP13A4 |
2.526e-03 | -5.98 | actin filament binding | molecular function | GO:0051015 | 211 | 4 | 18094 | 49 |
NEBL,ABLIM1,CTNNA2,MACF1 |
2.545e-03 | -5.97 | lung-carcinoma-large_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-large_cell_carcinoma | 849 | 8 | 16828 | 48 |
NTRK2,DPP10,PTPRZ1,BMPR1B,TNIK,RPS6KA2,MAP3K5,DCLK2 |
2.545e-03 | -5.97 | large_cell_carcinoma | COSMIC cancer mutations | large_cell_carcinoma | 849 | 8 | 16828 | 48 |
MAP3K5,DCLK2,DPP10,NTRK2,BMPR1B,PTPRZ1,TNIK,RPS6KA2 |
2.570e-03 | -5.96 | Dynlt1 (dynein light chain Tctex-type 1) | protein interactions | 83462 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | Agtrap (angiotensin II, type I receptor-associated protein) | protein interactions | 11610 | 1 | 1 | 19454 | 50 |
PITPNC1 |
2.570e-03 | -5.96 | Lztr1 (leucine-zipper-like transcriptional regulator, 1) | protein interactions | 66863 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | Bdnf (brain derived neurotrophic factor) | protein interactions | 12064 | 1 | 1 | 19454 | 50 |
NTRK2 |
2.570e-03 | -5.96 | Hipk3 (homeodomain interacting protein kinase 3) | protein interactions | 15259 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Isl1 (ISL1 transcription factor, LIM/homeodomain) | protein interactions | 16392 | 1 | 1 | 19454 | 50 |
GLIS3 |
2.570e-03 | -5.96 | Dcaf7 (DDB1 and CUL4 associated factor 7) | protein interactions | 71833 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.570e-03 | -5.96 | 1700006A11Rik (RIKEN cDNA 1700006A11 gene) | protein interactions | 71824 | 1 | 1 | 19454 | 50 |
BMPR1B |
2.585e-03 | -5.96 | Pkinase | pfam domains | PF00069 | 347 | 5 | 17795 | 49 |
RPS6KA2,TNIK,MAP3K5,MAPK10,DCLK2 |
2.593e-03 | -5.95 | Calcium-transporting ATPase, transmembrane domain | gene3d domains | 1.20.1110.10 | 25 | 2 | 14470 | 44 |
ATP1A2,ATP13A4 |
2.617e-03 | -5.95 | perinuclear endoplasmic reticulum lumen | cellular component | GO:0099020 | 1 | 1 | 19108 | 50 |
CLU |
2.690e-03 | -5.92 | Cellular Senescence | REACTOME pathways | R-HSA-2559583 | 196 | 4 | 10285 | 31 |
RPS6KA2,MAP3K5,TNIK,MAPK10 |
2.692e-03 | -5.92 | trans-synaptic signaling by neuropeptide | biological process | GO:0099540 | 1 | 1 | 18204 | 49 |
NTRK2 |
2.692e-03 | -5.92 | regulation of neuronal signal transduction | biological process | GO:1902847 | 1 | 1 | 18204 | 49 |
CLU |
2.692e-03 | -5.92 | homologous chromosome movement towards spindle pole in meiosis I anaphase | biological process | GO:0051758 | 1 | 1 | 18204 | 49 |
FMN2 |
2.692e-03 | -5.92 | negative regulation of calcium:sodium antiporter activity | biological process | GO:1903280 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | biological process | GO:0099551 | 1 | 1 | 18204 | 49 |
NTRK2 |
2.692e-03 | -5.92 | chemorepulsion involved in interneuron migration from the subpallium to the cortex | biological process | GO:0021842 | 1 | 1 | 18204 | 49 |
NRG3 |
2.692e-03 | -5.92 | olfactory cortex development | biological process | GO:0021989 | 1 | 1 | 18204 | 49 |
ATP1A2 |
2.692e-03 | -5.92 | positive regulation of neurofibrillary tangle assembly | biological process | GO:1902998 | 1 | 1 | 18204 | 49 |
CLU |
2.692e-03 | -5.92 | directional guidance of interneurons involved in migration from the subpallium to the cortex | biological process | GO:0021840 | 1 | 1 | 18204 | 49 |
NRG3 |
2.700e-03 | -5.91 | RSK3_STKc | interpro domains | IPR042766 | 1 | 1 | 18521 | 50 |
RPS6KA2 |
2.700e-03 | -5.91 | SORBS1_SH3_1 | interpro domains | IPR035610 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | NTRK2 | interpro domains | IPR020455 | 1 | 1 | 18521 | 50 |
NTRK2 |
2.700e-03 | -5.91 | TRPS1 | interpro domains | IPR028440 | 1 | 1 | 18521 | 50 |
TRPS1 |
2.700e-03 | -5.91 | Nebulette_SH3 | interpro domains | IPR035631 | 1 | 1 | 18521 | 50 |
NEBL |
2.700e-03 | -5.91 | M14_CPE_CPD | interpro domains | IPR034232 | 1 | 1 | 18521 | 50 |
CPE |
2.700e-03 | -5.91 | Clusterin | interpro domains | IPR016016 | 1 | 1 | 18521 | 50 |
CLU |
2.700e-03 | -5.91 | RBMS3_RRM2 | interpro domains | IPR034406 | 1 | 1 | 18521 | 50 |
RBMS3 |
2.700e-03 | -5.91 | SORBS1_SH3_2 | interpro domains | IPR035611 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | SORBS1_SH3 | interpro domains | IPR035606 | 1 | 1 | 18521 | 50 |
SORBS1 |
2.700e-03 | -5.91 | Clusterin_CS | interpro domains | IPR033986 | 1 | 1 | 18521 | 50 |
CLU |
2.708e-03 | -5.91 | peptidoglycan glycosyltransferase activity | molecular function | GO:0008955 | 1 | 1 | 18094 | 49 |
CSGALNACT1 |
2.708e-03 | -5.91 | brain-derived neurotrophic factor receptor activity | molecular function | GO:0060175 | 1 | 1 | 18094 | 49 |
NTRK2 |
2.724e-03 | -5.91 | transferase activity, transferring phosphorus-containing groups | molecular function | GO:0016772 | 903 | 8 | 18094 | 49 |
NTRK2,MAPK10,DCLK2,RPS6KA2,MAP3K5,EFEMP1,TNIK,BMPR1B |
2.747e-03 | -5.90 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 27 | 18204 | 49 |
DPP10,NPAS3,CLU,SORBS1,FMN2,ATP1A2,SOX5,SLC4A4,TNIK,GLIS3,MACF1,RFX4,PTPRZ1,GPC5,MAP3K5,NRCAM,SPON1,NTRK2,HPSE2,GPM6A,SLC1A2,RBMS3,RORA,BMPR1B,PARD3,RPS6KA2,NAV3 |
2.751e-03 | -5.90 | myelination in peripheral nervous system | biological process | GO:0022011 | 29 | 2 | 18204 | 49 |
NTRK2,PARD3 |
2.751e-03 | -5.90 | peripheral nervous system axon ensheathment | biological process | GO:0032292 | 29 | 2 | 18204 | 49 |
PARD3,NTRK2 |
2.827e-03 | -5.87 | glial cell differentiation | biological process | GO:0010001 | 219 | 4 | 18204 | 49 |
PARD3,CLU,PTPRZ1,NTRK2 |
2.830e-03 | -5.87 | Proximal tubule bicarbonate reclamation | KEGG pathways | ko04964 | 23 | 2 | 7161 | 25 |
ATP1A2,SLC4A4 |
2.830e-03 | -5.87 | Proximal tubule bicarbonate reclamation | KEGG pathways | hsa04964 | 23 | 2 | 7161 | 25 |
SLC4A4,ATP1A2 |
2.853e-03 | -5.86 | cell communication | biological process | GO:0007154 | 5010 | 23 | 18204 | 49 |
BMPR1B,RORA,SLC1A2,NTRK2,NRCAM,MAP3K5,PITPNC1,EFEMP1,MAPK10,CPE,RPS6KA2,PARD3,ADCY2,SORBS1,CLU,DTNA,MACF1,TNIK,CTNND2,DCLK2,NRG3,ATP1A2,FMN2 |
2.863e-03 | -5.86 | DST (dystonin) | protein interactions | 667 | 230 | 4 | 19454 | 50 |
TNIK,PARD3,NTRK2,ATP1A2 |
2.888e-03 | -5.85 | protein serine kinase activity | molecular function | GO:0106310 | 362 | 5 | 18094 | 49 |
MAP3K5,MAPK10,RPS6KA2,DCLK2,TNIK |
2.897e-03 | -5.84 | germ_cell_tumour | COSMIC cancer mutations | germ_cell_tumour | 867 | 8 | 16828 | 48 |
MAP3K5,DCLK2,MACF1,NTRK2,BMPR1B,TRPS1,TNIK,RPS6KA2 |
2.901e-03 | -5.84 | lung-carcinoid-endocrine_tumour | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour | 502 | 6 | 16828 | 48 |
TNIK,DCLK2,RPS6KA2,NTRK2,BMPR1B,MAP3K5 |
2.916e-03 | -5.84 | cell junction organization | biological process | GO:0034330 | 532 | 6 | 18204 | 49 |
CTNND2,NRCAM,PARD3,NRG3,SORBS1,GPM6A |
2.942e-03 | -5.83 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 2 | 18204 | 49 |
SLC1A2,ATP1A2 |
2.950e-03 | -5.83 | axonogenesis | biological process | GO:0007409 | 366 | 5 | 18204 | 49 |
PTPRZ1,BMPR1B,PARD3,NRCAM,CTNNA2 |
2.978e-03 | -5.82 | poly-pyrimidine tract binding | molecular function | GO:0008187 | 30 | 2 | 18094 | 49 |
RBMS3,MSI2 |
3.040e-03 | -5.80 | beta-catenin binding | molecular function | GO:0008013 | 107 | 3 | 18094 | 49 |
RORA,CTNND2,CTNNA2 |
3.055e-03 | -5.79 | CDH1 (cadherin 1) | protein interactions | 999 | 757 | 7 | 19454 | 50 |
NEBL,PARD3,CTNND2,CTNNA2,MACF1,SORBS1,ABLIM1 |
3.076e-03 | -5.78 | lung-carcinoid-endocrine_tumour-atypical | COSMIC cancer mutations | lung-carcinoid-endocrine_tumour-atypical | 508 | 6 | 16828 | 48 |
DCLK2,TNIK,RPS6KA2,NTRK2,BMPR1B,MAP3K5 |
3.093e-03 | -5.78 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 4 | 19454 | 50 |
NTRK2,DTNA,MACF1,PARD3 |
3.195e-03 | -5.75 | ion binding | molecular function | GO:0043167 | 6007 | 26 | 18094 | 49 |
EFEMP1,DCLK2,NAV3,PARD3,SLC1A2,PITPNC1,TNIK,ATP1A2,MAP3K5,RPS6KA2,ATP13A4,ADCY2,PAMR1,GLIS3,TRPS1,NTRK2,BMPR1B,CSGALNACT1,MACF1,DTNA,MGAT4C,RORA,SPON1,CPE,MAPK10,ABLIM1 |
3.222e-03 | -5.74 | SMAD7 (SMAD family member 7) | protein interactions | 4092 | 115 | 3 | 19454 | 50 |
PARD3,SOX5,BMPR1B |
3.224e-03 | -5.74 | human chr11p13 | chromosome location | human chr11p13 | 44 | 2 | 26134 | 50 |
PAMR1,SLC1A2 |
3.237e-03 | -5.73 | LCOR (ligand dependent nuclear receptor corepressor) | protein interactions | 84458 | 238 | 4 | 19454 | 50 |
NAV3,CLU,NRCAM,MACF1 |
3.249e-03 | -5.73 | NTM (neurotrimin) | protein interactions | 50863 | 33 | 2 | 19454 | 50 |
GPM6A,LSAMP |
3.253e-03 | -5.73 | extracellular matrix | cellular component | GO:0031012 | 559 | 6 | 19108 | 50 |
GPC5,EFEMP1,SPON1,HPSE2,CLU,PTPRZ1 |
3.253e-03 | -5.73 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 14 | 16828 | 48 |
HPSE2,NRG3,RFX4,FMN2,PTPRZ1,ATP1A2,SOX5,MAP3K5,CTNND2,SLC1A2,TRPM3,NRCAM,NTRK2,EFEMP1 |
3.282e-03 | -5.72 | external encapsulating structure | cellular component | GO:0030312 | 560 | 6 | 19108 | 50 |
EFEMP1,GPC5,HPSE2,SPON1,PTPRZ1,CLU |
3.282e-03 | -5.72 | E1-E2_ATPase | pfam domains | PF00122 | 31 | 2 | 17795 | 49 |
ATP1A2,ATP13A4 |
3.291e-03 | -5.72 | atypical | COSMIC cancer mutations | atypical | 515 | 6 | 16828 | 48 |
TNIK,RPS6KA2,NTRK2,BMPR1B,DCLK2,MAP3K5 |
3.330e-03 | -5.70 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 3 | 16828 | 48 |
NRG3,GPC5,PARD3 |
3.344e-03 | -5.70 | positive regulation of cartilage development | biological process | GO:0061036 | 32 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
3.394e-03 | -5.69 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 7 | 10285 | 31 |
AQP4,ADCY2,ATP1A2,SLC1A2,ATP13A4,SLC4A4,TRPM3 |
3.442e-03 | -5.67 | adenyl nucleotide binding | molecular function | GO:0030554 | 1620 | 11 | 18094 | 49 |
NAV3,DCLK2,ADCY2,MAPK10,NTRK2,BMPR1B,ATP1A2,TNIK,MAP3K5,RPS6KA2,ATP13A4 |
3.447e-03 | -5.67 | CLUSTERIN_1 | prosite domains | PS00492 | 1 | 1 | 12186 | 42 |
CLU |
3.447e-03 | -5.67 | CLUSTERIN_2 | prosite domains | PS00493 | 1 | 1 | 12186 | 42 |
CLU |
3.485e-03 | -5.66 | seminoma | COSMIC cancer mutations | seminoma | 700 | 7 | 16828 | 48 |
DCLK2,MAP3K5,RPS6KA2,TRPS1,TNIK,BMPR1B,NTRK2 |
3.495e-03 | -5.66 | Cation_ATPase | pfam domains | PF13246 | 32 | 2 | 17795 | 49 |
ATP1A2,ATP13A4 |
3.705e-03 | -5.60 | DELLA | smart domains | SM01129 | 1 | 1 | 9717 | 36 |
MACF1 |
3.749e-03 | -5.59 | membrane | cellular component | GO:0016020 | 9220 | 34 | 19108 | 50 |
ATP13A4,NRG3,NTRK2,CPE,HIF3A,MAPK10,NRCAM,NKAIN3,FMN2,CTNNA2,MGAT4C,DPP10,SORBS1,BMPR1B,LSAMP,PARD3,AQP4,ATP1A2,MAP3K5,GPC5,SLC4A4,CSGALNACT1,MACF1,TNIK,HPSE2,ADCY2,GPM6A,SLC1A2,DTNA,CLU,NAV3,TRPM3,CTNND2,PTPRZ1 |
3.792e-03 | -5.57 | PAS | interpro domains | IPR000014 | 34 | 2 | 18521 | 50 |
HIF3A,NPAS3 |
3.792e-03 | -5.57 | PAS-like_dom_sf | interpro domains | IPR035965 | 34 | 2 | 18521 | 50 |
HIF3A,NPAS3 |
3.795e-03 | -5.57 | PAS | smart domains | SM00091 | 25 | 2 | 9717 | 36 |
HIF3A,NPAS3 |
3.822e-03 | -5.57 | regulation of cellular process | biological process | GO:0050794 | 11468 | 40 | 18204 | 49 |
CPE,PITPNC1,MAPK10,EFEMP1,PARD3,NAV3,RPS6KA2,RORA,RBMS3,BMPR1B,SPON1,NRCAM,MAP3K5,GPM6A,SLC1A2,HPSE2,NTRK2,RFX4,MACF1,TRPS1,GLIS3,CTNND2,TNIK,GPC5,PTPRZ1,ATP1A2,NRG3,FMN2,SLC4A4,DCLK2,SOX5,CLU,DTNA,ADCY2,SORBS1,DPP10,CTNNA2,MSI2,NPAS3,HIF3A |
3.826e-03 | -5.57 | NTKRECEPTOR2 | prints domains | PR01941 | 1 | 1 | 5227 | 20 |
NTRK2 |
3.826e-03 | -5.57 | AQUAPORIN4 | prints domains | PR02016 | 1 | 1 | 5227 | 20 |
AQP4 |
3.846e-03 | -5.56 | Progesterone-mediated oocyte maturation | KEGG pathways | ko04914 | 92 | 3 | 7161 | 25 |
ADCY2,RPS6KA2,MAPK10 |
3.846e-03 | -5.56 | Progesterone-mediated oocyte maturation | KEGG pathways | hsa04914 | 92 | 3 | 7161 | 25 |
MAPK10,ADCY2,RPS6KA2 |
3.866e-03 | -5.56 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 6 | 18094 | 49 |
NRCAM,CPE,CTNND2,MACF1,CTNNA2,PTPRZ1 |
3.872e-03 | -5.55 | MAPK targets/ Nuclear events mediated by MAP kinases | REACTOME pathways | R-HSA-450282 | 31 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.937e-03 | -5.54 | synapse assembly | biological process | GO:0007416 | 118 | 3 | 18204 | 49 |
NRCAM,NRG3,GPM6A |
3.947e-03 | -5.53 | TRAF2 (TNF receptor associated factor 2) | protein interactions | 7186 | 592 | 6 | 19454 | 50 |
TNIK,NEBL,MAP3K5,EFEMP1,ABLIM1,SOX5 |
4.052e-03 | -5.51 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 42 | 16828 | 48 |
HIF3A,DTNA,MAP3K5,ABLIM1,GPC5,TRPS1,NAV3,RPS6KA2,SLC1A2,NTRK2,PARD3,NRCAM,TRPM3,NRG3,DCLK2,LSAMP,SORBS1,PAMR1,GLIS3,RORA,SLC4A4,PTPRZ1,NEBL,BMPR1B,ATP1A2,MACF1,SPON1,GPM6A,SOX5,ADCY2,CPE,ATP13A4,CTNND2,DPP10,HPSE2,CSGALNACT1,MGAT4C,RFX4,FMN2,TNIK,NPAS3,PITPNC1 |
4.093e-03 | -5.50 | cervix | COSMIC cancer mutations | cervix | 11793 | 42 | 16828 | 48 |
GPM6A,CPE,ATP13A4,SOX5,ADCY2,SPON1,MACF1,ATP1A2,DPP10,CTNND2,RFX4,FMN2,MGAT4C,CSGALNACT1,HPSE2,PITPNC1,NPAS3,TNIK,MAP3K5,DTNA,HIF3A,PARD3,TRPM3,NRCAM,NTRK2,NAV3,RPS6KA2,SLC1A2,ABLIM1,TRPS1,GPC5,RORA,GLIS3,PAMR1,LSAMP,SORBS1,NRG3,DCLK2,PTPRZ1,BMPR1B,NEBL,SLC4A4 |
4.210e-03 | -5.47 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 3 | 7161 | 25 |
ATP1A2,ADCY2,SLC4A4 |
4.210e-03 | -5.47 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 3 | 7161 | 25 |
ATP1A2,ADCY2,SLC4A4 |
4.215e-03 | -5.47 | glial cell projection | cellular component | GO:0097386 | 37 | 2 | 19108 | 50 |
SLC1A2,AQP4 |
4.244e-03 | -5.46 | P_typ_ATPase | interpro domains | IPR001757 | 36 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.244e-03 | -5.46 | ATPase_P-typ_cyto_dom_N | interpro domains | IPR023299 | 36 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.244e-03 | -5.46 | ATPase_P-typ_transduc_dom_A_sf | interpro domains | IPR008250 | 36 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.244e-03 | -5.46 | ATPase_P-typ_P_site | interpro domains | IPR018303 | 36 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.244e-03 | -5.46 | P_typ_ATPase_HD_dom | interpro domains | IPR044492 | 36 | 2 | 18521 | 50 |
ATP13A4,ATP1A2 |
4.281e-03 | -5.45 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 49 |
CTNNA2,NRCAM,GPM6A,NTRK2 |
4.344e-03 | -5.44 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 5 | 19108 | 50 |
GPM6A,NRCAM,TNIK,NRG3,SLC1A2 |
4.432e-03 | -5.42 | chondroitin biosynthesis | BIOCYC pathways | HUMAN_PWY-6566 | 2 | 1 | 902 | 2 |
CSGALNACT1 |
4.451e-03 | -5.41 | positive regulation of glucose import | biological process | GO:0046326 | 37 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
4.478e-03 | -5.41 | ATPase_P-typ_TM_dom_sf | interpro domains | IPR023298 | 37 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
4.481e-03 | -5.41 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 13 | 16828 | 48 |
PTPRZ1,BMPR1B,SLC4A4,TNIK,DCLK2,NTRK2,RPS6KA2,TRPS1,ADCY2,SOX5,MAP3K5,DTNA,ATP1A2 |
4.494e-03 | -5.41 | DIRAS3 (DIRAS family GTPase 3) | protein interactions | 9077 | 261 | 4 | 19454 | 50 |
FMN2,PARD3,MACF1,DTNA |
4.506e-03 | -5.40 | cellular component assembly | biological process | GO:0022607 | 2472 | 14 | 18204 | 49 |
AQP4,ABLIM1,RFX4,TNIK,TRPM3,NRG3,PARD3,FMN2,SORBS1,CLU,NEBL,GPM6A,SLC1A2,NRCAM |
4.523e-03 | -5.40 | action potential | biological process | GO:0001508 | 124 | 3 | 18204 | 49 |
NTRK2,ATP1A2,NRCAM |
4.530e-03 | -5.40 | ovary-carcinoma | COSMIC cancer mutations | ovary-carcinoma | 933 | 8 | 16828 | 48 |
NTRK2,BMPR1B,TNIK,RPS6KA2,MAP3K5,ATP1A2,DCLK2,MACF1 |
4.602e-03 | -5.38 | FGFR1 (fibroblast growth factor receptor 1) | protein interactions | 2260 | 611 | 6 | 19454 | 50 |
DTNA,RPS6KA2,PARD3,TNIK,CLU,ABLIM1 |
4.662e-03 | -5.37 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 49 |
GPM6A,NTRK2,CTNNA2,NRCAM |
4.744e-03 | -5.35 | DZIP1 (DAZ interacting zinc finger protein 1) | protein interactions | 22873 | 40 | 2 | 19454 | 50 |
PARD3,NTRK2 |
4.745e-03 | -5.35 | PAS | prosite domains | PS50112 | 30 | 2 | 12186 | 42 |
HIF3A,NPAS3 |
4.783e-03 | -5.34 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 6 | 16828 | 48 |
CTNND2,NAV3,TRPS1,NTRK2,SLC4A4,ADCY2 |
4.867e-03 | -5.33 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 6 | 16828 | 48 |
TRPS1,NAV3,CTNND2,NTRK2,SLC4A4,ADCY2 |
4.942e-03 | -5.31 | myelination | biological process | GO:0042552 | 128 | 3 | 18204 | 49 |
NTRK2,CLU,PARD3 |
4.942e-03 | -5.31 | glial cell development | biological process | GO:0021782 | 128 | 3 | 18204 | 49 |
NTRK2,CLU,PARD3 |
4.980e-03 | -5.30 | RASSF7 (Ras association domain family member 7) | protein interactions | 8045 | 41 | 2 | 19454 | 50 |
PARD3,CLU |
5.080e-03 | -5.28 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 48 |
SLC1A2,GPC5,PARD3,TRPM3,DPP10,MACF1,FMN2,ATP13A4 |
5.080e-03 | -5.28 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 8 | 16828 | 48 |
FMN2,ATP13A4,MACF1,PARD3,TRPM3,DPP10,SLC1A2,GPC5 |
5.099e-03 | -5.28 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 5 | 19108 | 50 |
SPON1,EFEMP1,GPC5,CLU,PTPRZ1 |
5.134e-03 | -5.27 | Zmym2 (zinc finger, MYM-type 2) | protein interactions | 76007 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Kdm4c (lysine (K)-specific demethylase 4C) | protein interactions | 76804 | 2 | 1 | 19454 | 50 |
GLIS3 |
5.134e-03 | -5.27 | Irf7 (interferon regulatory factor 7) | protein interactions | 54123 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Mknk2 (MAP kinase-interacting serine/threonine kinase 2) | protein interactions | 17347 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Sh3kbp1 (SH3-domain kinase binding protein 1) | protein interactions | 58194 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bcr (BCR activator of RhoGEF and GTPase) | protein interactions | 110279 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1a (FK506 binding protein 1a) | protein interactions | 14225 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Klhl1 (kelch-like 1) | protein interactions | 93688 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Ppp3cc (protein phosphatase 3, catalytic subunit, gamma isoform) | protein interactions | 19057 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Bmpr2 (bone morphogenetic protein receptor type 2) | protein interactions | 12168 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fbxo34 (F-box protein 34) | protein interactions | 78938 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.134e-03 | -5.27 | Fkbp1b (FK506 binding protein 1b) | protein interactions | 14226 | 2 | 1 | 19454 | 50 |
BMPR1B |
5.148e-03 | -5.27 | small molecule binding | molecular function | GO:0036094 | 6197 | 26 | 18094 | 49 |
GLIS3,PAMR1,TRPS1,ADCY2,NTRK2,PITPNC1,TNIK,ATP1A2,MAP3K5,ATP13A4,RPS6KA2,NAV3,DCLK2,SLC1A2,PARD3,EFEMP1,SPON1,MAPK10,ABLIM1,CPE,MGAT4C,RORA,BMPR1B,CSGALNACT1,MACF1,DTNA |
5.160e-03 | -5.27 | axon ensheathment | biological process | GO:0008366 | 130 | 3 | 18204 | 49 |
NTRK2,CLU,PARD3 |
5.160e-03 | -5.27 | ensheathment of neurons | biological process | GO:0007272 | 130 | 3 | 18204 | 49 |
CLU,PARD3,NTRK2 |
5.187e-03 | -5.26 | cyclic purine nucleotide metabolic process | biological process | GO:0052652 | 40 | 2 | 18204 | 49 |
RORA,ADCY2 |
5.198e-03 | -5.26 | RDX (radixin) | protein interactions | 5962 | 272 | 4 | 19454 | 50 |
MAPK10,MACF1,NEBL,ABLIM1 |
5.260e-03 | -5.25 | biological regulation | biological process | GO:0065007 | 12501 | 42 | 18204 | 49 |
SORBS1,ADCY2,DTNA,CLU,HIF3A,NPAS3,MSI2,CTNNA2,DPP10,PTPRZ1,GPC5,AQP4,TNIK,CTNND2,GLIS3,RFX4,MACF1,TRPS1,SOX5,SLC4A4,DCLK2,FMN2,NRG3,ATP1A2,BMPR1B,RBMS3,RORA,NTRK2,HPSE2,SLC1A2,GPM6A,NRCAM,MAP3K5,SPON1,MAPK10,EFEMP1,PITPNC1,CPE,RPS6KA2,NKAIN3,NAV3,PARD3 |
5.265e-03 | -5.25 | FLOT2 (flotillin 2) | protein interactions | 2319 | 273 | 4 | 19454 | 50 |
RPS6KA2,NTRK2,PARD3,SOX5 |
5.288e-03 | -5.24 | axon development | biological process | GO:0061564 | 420 | 5 | 18204 | 49 |
BMPR1B,PTPRZ1,NRCAM,CTNNA2,PARD3 |
5.331e-03 | -5.23 | Calcium-transporting ATPase, cytoplasmic transduction domain A | gene3d domains | 2.70.150.10 | 36 | 2 | 14470 | 44 |
ATP13A4,ATP1A2 |
5.331e-03 | -5.23 | Calcium-transporting ATPase, cytoplasmic domain N | gene3d domains | 3.40.1110.10 | 36 | 2 | 14470 | 44 |
ATP13A4,ATP1A2 |
5.376e-03 | -5.23 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | biological process | GO:0050653 | 2 | 1 | 18204 | 49 |
CSGALNACT1 |
5.376e-03 | -5.23 | UDP-glucuronate metabolic process | biological process | GO:0046398 | 2 | 1 | 18204 | 49 |
CSGALNACT1 |
5.376e-03 | -5.23 | regulation of neurofibrillary tangle assembly | biological process | GO:1902996 | 2 | 1 | 18204 | 49 |
CLU |
5.376e-03 | -5.23 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress | biological process | GO:0036480 | 2 | 1 | 18204 | 49 |
MAP3K5 |
5.392e-03 | -5.22 | Alpha_CARP_receptor-type | interpro domains | IPR041887 | 2 | 1 | 18521 | 50 |
PTPRZ1 |
5.392e-03 | -5.22 | Distrobrevin | interpro domains | IPR017432 | 2 | 1 | 18521 | 50 |
DTNA |
5.392e-03 | -5.22 | Spondin_N_sf | interpro domains | IPR038678 | 2 | 1 | 18521 | 50 |
SPON1 |
5.392e-03 | -5.22 | Clusterin-like | interpro domains | IPR000753 | 2 | 1 | 18521 | 50 |
CLU |
5.392e-03 | -5.22 | Clusterin_C | interpro domains | IPR016015 | 2 | 1 | 18521 | 50 |
CLU |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Spondin_N | interpro domains | IPR009465 | 2 | 1 | 18521 | 50 |
SPON1 |
5.392e-03 | -5.22 | Clusterin_N | interpro domains | IPR016014 | 2 | 1 | 18521 | 50 |
CLU |
5.392e-03 | -5.22 | Formin_Cappuccino_subfam | interpro domains | IPR001265 | 2 | 1 | 18521 | 50 |
FMN2 |
5.392e-03 | -5.22 | Glyco_hydro_79 | interpro domains | IPR005199 | 2 | 1 | 18521 | 50 |
HPSE2 |
5.392e-03 | -5.22 | Par3/HAL_N | interpro domains | IPR021922 | 2 | 1 | 18521 | 50 |
PARD3 |
5.409e-03 | -5.22 | heparanase activity | molecular function | GO:0030305 | 2 | 1 | 18094 | 49 |
HPSE2 |
5.432e-03 | -5.22 | Ig_I-set | interpro domains | IPR013098 | 132 | 3 | 18521 | 50 |
NRCAM,LSAMP,NTRK2 |
5.443e-03 | -5.21 | cyclic nucleotide metabolic process | biological process | GO:0009187 | 41 | 2 | 18204 | 49 |
ADCY2,RORA |
5.467e-03 | -5.21 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 4 | 16828 | 48 |
MGAT4C,GLIS3,PTPRZ1,MACF1 |
5.500e-03 | -5.20 | Par3_HAL_N_term | pfam domains | PF12053 | 2 | 1 | 17795 | 49 |
PARD3 |
5.500e-03 | -5.20 | Clusterin | pfam domains | PF01093 | 2 | 1 | 17795 | 49 |
CLU |
5.500e-03 | -5.20 | Glyco_hydro_79n | pfam domains | PF03662 | 2 | 1 | 17795 | 49 |
HPSE2 |
5.500e-03 | -5.20 | Reeler | pfam domains | PF02014 | 2 | 1 | 17795 | 49 |
SPON1 |
5.500e-03 | -5.20 | Spond_N | pfam domains | PF06468 | 2 | 1 | 17795 | 49 |
SPON1 |
5.544e-03 | -5.20 | small_intestine | COSMIC cancer mutations | small_intestine | 250 | 4 | 16828 | 48 |
TNIK,MACF1,MGAT4C,CSGALNACT1 |
5.609e-03 | -5.18 | regulation of biological process | biological process | GO:0050789 | 12079 | 41 | 18204 | 49 |
RORA,RBMS3,BMPR1B,SPON1,MAP3K5,NRCAM,SLC1A2,GPM6A,HPSE2,NTRK2,CPE,PITPNC1,EFEMP1,MAPK10,PARD3,NKAIN3,NAV3,RPS6KA2,CLU,DTNA,ADCY2,SORBS1,DPP10,CTNNA2,MSI2,NPAS3,HIF3A,RFX4,TRPS1,MACF1,GLIS3,CTNND2,TNIK,PTPRZ1,GPC5,ATP1A2,NRG3,FMN2,DCLK2,SLC4A4,SOX5 |
5.611e-03 | -5.18 | cytoskeleton organization | biological process | GO:0007010 | 1251 | 9 | 18204 | 49 |
DCLK2,PARD3,CTNNA2,FMN2,SORBS1,ABLIM1,MACF1,TNIK,NEBL |
5.706e-03 | -5.17 | Schwann cell development | biological process | GO:0014044 | 42 | 2 | 18204 | 49 |
PARD3,NTRK2 |
5.731e-03 | -5.16 | I-set | pfam domains | PF07679 | 132 | 3 | 17795 | 49 |
LSAMP,NRCAM,NTRK2 |
5.885e-03 | -5.14 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 40 | 16828 | 48 |
GPC5,ABLIM1,RPS6KA2,NAV3,NKAIN3,SLC1A2,NTRK2,EFEMP1,PARD3,TRPM3,HIF3A,MSI2,DTNA,MAP3K5,SLC4A4,PTPRZ1,BMPR1B,NEBL,NRG3,DCLK2,LSAMP,PAMR1,GLIS3,RORA,CTNND2,DPP10,ATP1A2,MACF1,SPON1,CPE,SOX5,ADCY2,ATP13A4,TNIK,NPAS3,HPSE2,RBMS3,CSGALNACT1,FMN2,RFX4 |
5.908e-03 | -5.13 | signal transduction | biological process | GO:0007165 | 4637 | 21 | 18204 | 49 |
DCLK2,RPS6KA2,NRG3,ATP1A2,PARD3,FMN2,PITPNC1,EFEMP1,MAPK10,CPE,MACF1,TNIK,CTNND2,NTRK2,MAP3K5,ADCY2,SORBS1,BMPR1B,RORA,CLU,DTNA |
5.922e-03 | -5.13 | SLC6A15 (solute carrier family 6 member 15) | protein interactions | 55117 | 143 | 3 | 19454 | 50 |
PARD3,RPS6KA2,NTRK2 |
5.941e-03 | -5.13 | rhythmic process | biological process | GO:0048511 | 270 | 4 | 18204 | 49 |
BMPR1B,NTRK2,MAPK10,RORA |
5.946e-03 | -5.12 | spleen | COSMIC cancer mutations | spleen | 408 | 5 | 16828 | 48 |
ADCY2,MAP3K5,PTPRZ1,SORBS1,TNIK |
6.001e-03 | -5.12 | YWHAH (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta) | protein interactions | 7533 | 1083 | 8 | 19454 | 50 |
ABLIM1,SORBS1,MACF1,FMN2,DCLK2,PARD3,MAP3K5,PITPNC1 |
6.010e-03 | -5.11 | Glycosaminoglycan metabolism | REACTOME pathways | R-HSA-1630316 | 124 | 3 | 10285 | 31 |
HPSE2,CSGALNACT1,GPC5 |
6.020e-03 | -5.11 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 7 | 19108 | 50 |
BMPR1B,GPM6A,CLU,ADCY2,NTRK2,ATP1A2,CTNND2 |
6.044e-03 | -5.11 | protein serine/threonine/tyrosine kinase activity | molecular function | GO:0004712 | 43 | 2 | 18094 | 49 |
MAPK10,RPS6KA2 |
6.066e-03 | -5.11 | signaling | biological process | GO:0023052 | 4968 | 22 | 18204 | 49 |
MAPK10,EFEMP1,PITPNC1,TNIK,CTNND2,MACF1,CPE,RPS6KA2,DCLK2,FMN2,NRG3,ATP1A2,PARD3,SORBS1,BMPR1B,ADCY2,DTNA,CLU,RORA,NTRK2,SLC1A2,MAP3K5 |
6.073e-03 | -5.10 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 44 |
CTNNA2 |
6.073e-03 | -5.10 | F-spondin domain | gene3d domains | 2.60.40.2130 | 2 | 1 | 14470 | 44 |
SPON1 |
6.102e-03 | -5.10 | sarcolemma | cellular component | GO:0042383 | 142 | 3 | 19108 | 50 |
DTNA,AQP4,ATP1A2 |
6.108e-03 | -5.10 | LCK (LCK proto-oncogene, Src family tyrosine kinase) | protein interactions | 3932 | 455 | 5 | 19454 | 50 |
FMN2,CTNND2,MACF1,DTNA,PARD3 |
6.190e-03 | -5.08 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 4 | 16828 | 48 |
PTPRZ1,FMN2,ATP13A4,SLC4A4 |
6.234e-03 | -5.08 | EXTL2 (exostosin like glycosyltransferase 2) | protein interactions | 2135 | 46 | 2 | 19454 | 50 |
CLU,MGAT4C |
6.247e-03 | -5.08 | positive regulation of glucose transmembrane transport | biological process | GO:0010828 | 44 | 2 | 18204 | 49 |
SORBS1,SLC1A2 |
6.272e-03 | -5.07 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 4 | 19454 | 50 |
NTRK2,DTNA,SORBS1,PARD3 |
6.272e-03 | -5.07 | DSCR9 (Down syndrome critical region 9) | protein interactions | 257203 | 146 | 3 | 19454 | 50 |
CLU,MACF1,EFEMP1 |
6.283e-03 | -5.07 | Oxidative Stress Induced Senescence | REACTOME pathways | R-HSA-2559580 | 126 | 3 | 10285 | 31 |
MAPK10,MAP3K5,TNIK |
6.334e-03 | -5.06 | gliogenesis | biological process | GO:0042063 | 275 | 4 | 18204 | 49 |
PARD3,CLU,NTRK2,PTPRZ1 |
6.348e-03 | -5.06 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 4 | 19454 | 50 |
NEBL,SORBS1,PARD3,FMN2 |
6.387e-03 | -5.05 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 4 | 18094 | 49 |
ATP1A2,SLC4A4,ATP13A4,SLC1A2 |
6.467e-03 | -5.04 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 39 | 16828 | 48 |
CLU,CTNND2,DPP10,ATP1A2,MACF1,SOX5,CPE,ADCY2,ATP13A4,TNIK,NPAS3,HPSE2,CSGALNACT1,MGAT4C,FMN2,TRPS1,GPC5,NAV3,RPS6KA2,SLC1A2,NTRK2,EFEMP1,PARD3,TRPM3,NRCAM,MSI2,DTNA,MAP3K5,SLC4A4,PTPRZ1,NEBL,BMPR1B,NRG3,DCLK2,SORBS1,LSAMP,PAMR1,RORA,GLIS3 |
6.500e-03 | -5.04 | BDNF (brain derived neurotrophic factor) | protein interactions | 627 | 47 | 2 | 19454 | 50 |
CPE,NTRK2 |
6.500e-03 | -5.04 | CNTN1 (contactin 1) | protein interactions | 1272 | 47 | 2 | 19454 | 50 |
GPM6A,PTPRZ1 |
6.527e-03 | -5.03 | acidic amino acid transport | biological process | GO:0015800 | 45 | 2 | 18204 | 49 |
SLC1A2,NTRK2 |
6.550e-03 | -5.03 | postsynapse | cellular component | GO:0098794 | 646 | 6 | 19108 | 50 |
CTNND2,ATP1A2,NTRK2,TNIK,GPM6A,NRCAM |
6.550e-03 | -5.03 | PAS domain | gene3d domains | 3.30.450.20 | 40 | 2 | 14470 | 44 |
HIF3A,NPAS3 |
6.588e-03 | -5.02 | neuron migration | biological process | GO:0001764 | 142 | 3 | 18204 | 49 |
NTRK2,GPM6A,NRCAM |
6.601e-03 | -5.02 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 5 | 18204 | 49 |
NTRK2,MACF1,NRCAM,CTNNA2,TNIK |
6.642e-03 | -5.01 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 10 | 16828 | 48 |
SORBS1,LSAMP,FMN2,CTNND2,TNIK,GPC5,TRPS1,PARD3,TRPM3,SLC4A4 |
6.702e-03 | -5.01 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 48 |
DPP10,CLU,CTNND2,GPM6A,SOX5,ADCY2,ATP13A4,CPE,SPON1,MACF1,ATP1A2,PITPNC1,NPAS3,TNIK,FMN2,MGAT4C,CSGALNACT1,HPSE2,PARD3,TRPM3,NRCAM,NTRK2,EFEMP1,NKAIN3,NAV3,RPS6KA2,SLC1A2,GPC5,ABLIM1,TRPS1,MAP3K5,MSI2,DTNA,HIF3A,AQP4,PTPRZ1,BMPR1B,NEBL,SLC4A4,GLIS3,RORA,PAMR1,SORBS1,LSAMP,NRG3,DCLK2 |
6.702e-03 | -5.01 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 46 | 16828 | 48 |
NRCAM,ABLIM1,SLC1A2,RPS6KA2,NKAIN3,MAP3K5,AQP4,NEBL,PTPRZ1,GLIS3,SORBS1,LSAMP,DPP10,CTNND2,CLU,SOX5,CPE,MACF1,PITPNC1,MGAT4C,FMN2,EFEMP1,NTRK2,TRPM3,PARD3,TRPS1,GPC5,NAV3,DTNA,MSI2,HIF3A,SLC4A4,BMPR1B,PAMR1,RORA,DCLK2,NRG3,SPON1,ATP13A4,ADCY2,GPM6A,ATP1A2,NPAS3,TNIK,CSGALNACT1,HPSE2 |
6.705e-03 | -5.00 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 5 | 18094 | 49 |
TRPM3,SLC1A2,SLC4A4,GPM6A,ATP1A2 |
6.783e-03 | -4.99 | ATPASE_E1_E2 | prosite domains | PS00154 | 36 | 2 | 12186 | 42 |
ATP13A4,ATP1A2 |
6.812e-03 | -4.99 | regulation of myelination | biological process | GO:0031641 | 46 | 2 | 18204 | 49 |
PARD3,PTPRZ1 |
6.817e-03 | -4.99 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 6 | 18094 | 49 |
ATP1A2,SLC4A4,GPM6A,ATP13A4,SLC1A2,TRPM3 |
6.881e-03 | -4.98 | TNIK (TRAF2 and NCK interacting kinase) | protein interactions | 23043 | 151 | 3 | 19454 | 50 |
CLU,TNIK,MACF1 |
6.882e-03 | -4.98 | SPONDIN | prosite domains | PS51020 | 2 | 1 | 12186 | 42 |
SPON1 |
6.919e-03 | -4.97 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 50 |
ATP1A2,ADCY2,SLC1A2,SORBS1 |
6.997e-03 | -4.96 | Wnt signaling pathway | biological process | GO:0016055 | 283 | 4 | 18204 | 49 |
CTNND2,TNIK,MACF1,CPE |
7.086e-03 | -4.95 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 50 |
SORBS1,ADCY2,SLC1A2,ATP1A2 |
7.099e-03 | -4.95 | Amyotrophic lateral sclerosis (ALS) | WikiPathways | WP2447 | 38 | 2 | 5310 | 18 |
MAP3K5,SLC1A2 |
7.103e-03 | -4.95 | Schwann cell differentiation | biological process | GO:0014037 | 47 | 2 | 18204 | 49 |
NTRK2,PARD3 |
7.103e-03 | -4.95 | regulation of neuron migration | biological process | GO:2001222 | 47 | 2 | 18204 | 49 |
CTNNA2,NRG3 |
7.110e-03 | -4.95 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 13 | 16828 | 48 |
TNIK,TRPS1,RPS6KA2,NTRK2,SLC4A4,PTPRZ1,BMPR1B,ATP1A2,DCLK2,DTNA,ADCY2,SOX5,MAP3K5 |
7.272e-03 | -4.92 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 3 | 16828 | 48 |
PARD3,NRG3,GPC5 |
7.295e-03 | -4.92 | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-small_intestine-lymphoid_neoplasm-enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 48 |
MGAT4C,MACF1 |
7.295e-03 | -4.92 | enteropathy_type_T_cell_lymphoma | COSMIC cancer mutations | enteropathy_type_T_cell_lymphoma | 45 | 2 | 16828 | 48 |
MGAT4C,MACF1 |
7.330e-03 | -4.92 | MAGI3 (membrane associated guanylate kinase, WW and PDZ domain containing 3) | protein interactions | 260425 | 50 | 2 | 19454 | 50 |
NRCAM,PARD3 |
7.352e-03 | -4.91 | Vasopressin regulates renal water homeostasis via Aquaporins | REACTOME pathways | R-HSA-432040 | 43 | 2 | 10285 | 31 |
AQP4,ADCY2 |
7.396e-03 | -4.91 | CLa | smart domains | SM00035 | 2 | 1 | 9717 | 36 |
CLU |
7.396e-03 | -4.91 | CLb | smart domains | SM00030 | 2 | 1 | 9717 | 36 |
CLU |
7.525e-03 | -4.89 | CEP19 (centrosomal protein 19) | protein interactions | 84984 | 156 | 3 | 19454 | 50 |
PARD3,ABLIM1,FMN2 |
7.617e-03 | -4.88 | FAM171B (family with sequence similarity 171 member B) | protein interactions | 165215 | 51 | 2 | 19454 | 50 |
NTRK2,PARD3 |
7.631e-03 | -4.88 | human chr8q23.3 | chromosome location | human chr8q23.3 | 4 | 1 | 26134 | 50 |
TRPS1 |
7.639e-03 | -4.87 | FORMIN | prints domains | PR00828 | 2 | 1 | 5227 | 20 |
FMN2 |
7.674e-03 | -4.87 | CATATPASE | prints domains | PR00119 | 35 | 2 | 5227 | 20 |
ATP1A2,ATP13A4 |
7.691e-03 | -4.87 | Plekhb1 (pleckstrin homology domain containing, family B (evectins) member 1) | protein interactions | 27276 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | IL34 (interleukin 34) | protein interactions | 146433 | 3 | 1 | 19454 | 50 |
PTPRZ1 |
7.691e-03 | -4.87 | Rb1cc1 (RB1-inducible coiled-coil 1) | protein interactions | 12421 | 3 | 1 | 19454 | 50 |
MAP3K5 |
7.691e-03 | -4.87 | Rap2a (RAS related protein 2a) | protein interactions | 76108 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Chn1 (chimerin 1) | protein interactions | 108699 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Fbxw5 (F-box and WD-40 domain protein 5) | protein interactions | 30839 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Atg16l1 (autophagy related 16 like 1) | protein interactions | 77040 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Usp45 (ubiquitin specific petidase 45) | protein interactions | 77593 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Stk35 (serine/threonine kinase 35) | protein interactions | 67333 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.691e-03 | -4.87 | Lep (leptin) | protein interactions | 16846 | 3 | 1 | 19454 | 50 |
CLU |
7.691e-03 | -4.87 | Gstm1 (glutathione S-transferase, mu 1) | protein interactions | 14862 | 3 | 1 | 19454 | 50 |
MAP3K5 |
7.691e-03 | -4.87 | BCO1 (beta-carotene oxygenase 1) | protein interactions | 53630 | 3 | 1 | 19454 | 50 |
ABLIM1 |
7.691e-03 | -4.87 | Spop (speckle-type BTB/POZ protein) | protein interactions | 20747 | 3 | 1 | 19454 | 50 |
GLIS3 |
7.691e-03 | -4.87 | Smad6 (SMAD family member 6) | protein interactions | 17130 | 3 | 1 | 19454 | 50 |
BMPR1B |
7.749e-03 | -4.86 | purine ribonucleoside triphosphate binding | molecular function | GO:0035639 | 1804 | 11 | 18094 | 49 |
MAP3K5,RPS6KA2,ATP13A4,BMPR1B,TNIK,ATP1A2,MAPK10,NTRK2,NAV3,DCLK2,ADCY2 |
7.847e-03 | -4.85 | protein localization to membrane | biological process | GO:0072657 | 462 | 5 | 18204 | 49 |
TNIK,DPP10,CPE,PARD3,MACF1 |
7.909e-03 | -4.84 | AMHR2 (anti-Mullerian hormone receptor type 2) | protein interactions | 269 | 52 | 2 | 19454 | 50 |
RPS6KA2,BMPR1B |
7.909e-03 | -4.84 | SH2B2 (SH2B adaptor protein 2) | protein interactions | 10603 | 52 | 2 | 19454 | 50 |
SORBS1,NTRK2 |
8.030e-03 | -4.82 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 30 | 16828 | 48 |
FMN2,CSGALNACT1,NPAS3,TNIK,SOX5,ATP13A4,ADCY2,MACF1,ATP1A2,CTNND2,RORA,GLIS3,PAMR1,SORBS1,NRG3,DCLK2,PTPRZ1,NEBL,SLC4A4,MAP3K5,DTNA,HIF3A,PARD3,TRPM3,NRCAM,NTRK2,NKAIN3,NAV3,TRPS1,ABLIM1 |
8.045e-03 | -4.82 | stomach-carcinoma | COSMIC cancer mutations | stomach-carcinoma | 439 | 5 | 16828 | 48 |
BMPR1B,MAP3K5,NTRK2,RPS6KA2,TNIK |
8.054e-03 | -4.82 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 49 |
CTNNA2 |
8.054e-03 | -4.82 | regulation of calcium:sodium antiporter activity | biological process | GO:1903279 | 3 | 1 | 18204 | 49 |
ATP1A2 |
8.054e-03 | -4.82 | protein targeting to lysosome involved in chaperone-mediated autophagy | biological process | GO:0061740 | 3 | 1 | 18204 | 49 |
CLU |
8.054e-03 | -4.82 | meiotic chromosome movement towards spindle pole | biological process | GO:0016344 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | UDP-N-acetylgalactosamine metabolic process | biological process | GO:0019276 | 3 | 1 | 18204 | 49 |
CSGALNACT1 |
8.054e-03 | -4.82 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 49 |
SLC1A2 |
8.054e-03 | -4.82 | mammary placode formation | biological process | GO:0060596 | 3 | 1 | 18204 | 49 |
NRG3 |
8.054e-03 | -4.82 | formin-nucleated actin cable organization | biological process | GO:0110009 | 3 | 1 | 18204 | 49 |
FMN2 |
8.054e-03 | -4.82 | cardiac muscle thin filament assembly | biological process | GO:0071691 | 3 | 1 | 18204 | 49 |
NEBL |
8.054e-03 | -4.82 | immune complex clearance | biological process | GO:0002434 | 3 | 1 | 18204 | 49 |
CLU |
8.054e-03 | -4.82 | trans-synaptic signaling by BDNF, modulating synaptic transmission | biological process | GO:0099183 | 3 | 1 | 18204 | 49 |
NTRK2 |
8.054e-03 | -4.82 | formin-nucleated actin cable assembly | biological process | GO:0070649 | 3 | 1 | 18204 | 49 |
FMN2 |
8.065e-03 | -4.82 | FBF1 (Fas binding factor 1) | protein interactions | 85302 | 160 | 3 | 19454 | 50 |
ABLIM1,MAP3K5,SORBS1 |
8.078e-03 | -4.82 | MAP3K_TRAF-bd | interpro domains | IPR025136 | 3 | 1 | 18521 | 50 |
MAP3K5 |
8.078e-03 | -4.82 | HIF_alpha-like | interpro domains | IPR021537 | 3 | 1 | 18521 | 50 |
HIF3A |
8.078e-03 | -4.82 | Reeler_sf | interpro domains | IPR042307 | 3 | 1 | 18521 | 50 |
SPON1 |
8.078e-03 | -4.82 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 50 |
CTNNA2 |
8.078e-03 | -4.82 | MAP3K_PH | interpro domains | IPR043969 | 3 | 1 | 18521 | 50 |
MAP3K5 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | NTRK | interpro domains | IPR020777 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | Nav/unc-53 | interpro domains | IPR039041 | 3 | 1 | 18521 | 50 |
NAV3 |
8.078e-03 | -4.82 | NTRK_LRRCT | interpro domains | IPR031635 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | HisK-N-like | interpro domains | IPR046873 | 3 | 1 | 18521 | 50 |
MAP3K5 |
8.078e-03 | -4.82 | SoHo_dom | interpro domains | IPR003127 | 3 | 1 | 18521 | 50 |
SORBS1 |
8.078e-03 | -4.82 | Reeler_dom | interpro domains | IPR002861 | 3 | 1 | 18521 | 50 |
SPON1 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | MAPK_JNK | interpro domains | IPR008351 | 3 | 1 | 18521 | 50 |
MAPK10 |
8.078e-03 | -4.82 | DRHyd-ASK | interpro domains | IPR046872 | 3 | 1 | 18521 | 50 |
MAP3K5 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6A |
8.078e-03 | -4.82 | Neuregulin | interpro domains | IPR040180 | 3 | 1 | 18521 | 50 |
NRG3 |
8.100e-03 | -4.82 | AFDN (afadin, adherens junction formation factor) | protein interactions | 4301 | 309 | 4 | 19454 | 50 |
PARD3,SORBS1,MACF1,DTNA |
8.103e-03 | -4.82 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | molecular function | GO:0008454 | 3 | 1 | 18094 | 49 |
MGAT4C |
8.103e-03 | -4.82 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 49 |
SLC1A2 |
8.103e-03 | -4.82 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | molecular function | GO:0047237 | 3 | 1 | 18094 | 49 |
CSGALNACT1 |
8.103e-03 | -4.82 | epidermal growth factor receptor activity | molecular function | GO:0005006 | 3 | 1 | 18094 | 49 |
EFEMP1 |
8.103e-03 | -4.82 | JUN kinase activity | molecular function | GO:0004705 | 3 | 1 | 18094 | 49 |
MAPK10 |
8.131e-03 | -4.81 | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma | 1485 | 10 | 16828 | 48 |
FMN2,DTNA,SORBS1,MACF1,NRG3,PTPRZ1,NRCAM,NPAS3,EFEMP1,GPC5 |
8.238e-03 | -4.80 | MAP3K_TRAF_bd | pfam domains | PF13281 | 3 | 1 | 17795 | 49 |
MAP3K5 |
8.238e-03 | -4.80 | HIF-1 | pfam domains | PF11413 | 3 | 1 | 17795 | 49 |
HIF3A |
8.238e-03 | -4.80 | LRRCT_2 | pfam domains | PF16920 | 3 | 1 | 17795 | 49 |
NTRK2 |
8.238e-03 | -4.80 | DRHyd-ASK | pfam domains | PF20309 | 3 | 1 | 17795 | 49 |
MAP3K5 |
8.238e-03 | -4.80 | SR_plectin_7 | pfam domains | PF21097 | 3 | 1 | 17795 | 49 |
MACF1 |
8.238e-03 | -4.80 | HisK-N-like | pfam domains | PF20302 | 3 | 1 | 17795 | 49 |
MAP3K5 |
8.238e-03 | -4.80 | Sorb | pfam domains | PF02208 | 3 | 1 | 17795 | 49 |
SORBS1 |
8.238e-03 | -4.80 | ASK_PH | pfam domains | PF19039 | 3 | 1 | 17795 | 49 |
MAP3K5 |
8.238e-03 | -4.80 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 49 |
GPM6A |
8.525e-03 | -4.76 | retina development in camera-type eye | biological process | GO:0060041 | 156 | 3 | 18204 | 49 |
BMPR1B,NTRK2,GPM6A |
8.607e-03 | -4.76 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 6 | 18204 | 49 |
NTRK2,GPM6A,NRCAM,CTNNA2,TNIK,MACF1 |
8.748e-03 | -4.74 | ZYX (zyxin) | protein interactions | 7791 | 316 | 4 | 19454 | 50 |
MACF1,NEBL,SORBS1,ABLIM1 |
8.917e-03 | -4.72 | SCLT1 (sodium channel and clathrin linker 1) | protein interactions | 132320 | 166 | 3 | 19454 | 50 |
ABLIM1,NEBL,ATP1A2 |
8.972e-03 | -4.71 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 3 | 18094 | 49 |
SLC1A2,SLC4A4,ATP1A2 |
9.066e-03 | -4.70 | ATPase-coupled monoatomic cation transmembrane transporter activity | molecular function | GO:0019829 | 53 | 2 | 18094 | 49 |
ATP1A2,ATP13A4 |
9.095e-03 | -4.70 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 44 |
CTNNA2 |
9.095e-03 | -4.70 | Reeler domain | gene3d domains | 2.60.40.4060 | 3 | 1 | 14470 | 44 |
SPON1 |
9.125e-03 | -4.70 | CSTL1 (cystatin like 1) | protein interactions | 128817 | 56 | 2 | 19454 | 50 |
CLU,CPE |
9.125e-03 | -4.70 | L1CAM (L1 cell adhesion molecule) | protein interactions | 3897 | 56 | 2 | 19454 | 50 |
RPS6KA2,GPM6A |
9.290e-03 | -4.68 | negative regulation of supramolecular fiber organization | biological process | GO:1902904 | 161 | 3 | 18204 | 49 |
NAV3,CTNNA2,CLU |
9.322e-03 | -4.68 | Angiopoietin Like Protein 8 Regulatory Pathway | WikiPathways | WP3915 | 132 | 3 | 5310 | 18 |
MAP3K5,MAPK10,RPS6KA2 |
9.401e-03 | -4.67 | postsynaptic density | cellular component | GO:0014069 | 317 | 4 | 19108 | 50 |
NTRK2,CTNND2,TNIK,NRCAM |
9.665e-03 | -4.64 | PPFIBP1 (PPFIA binding protein 1) | protein interactions | 8496 | 171 | 3 | 19454 | 50 |
PARD3,RPS6KA2,NTRK2 |
9.679e-03 | -4.64 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 6 | 18204 | 49 |
GPM6A,NTRK2,MACF1,CTNNA2,TNIK,NRCAM |
9.733e-03 | -4.63 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 15 | 16828 | 48 |
TRPS1,CTNND2,NKAIN3,CLU,DPP10,NRCAM,TRPM3,PARD3,MACF1,TNIK,SLC4A4,PITPNC1,PTPRZ1,NRG3,FMN2 |
9.733e-03 | -4.63 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 15 | 16828 | 48 |
FMN2,NRG3,PTPRZ1,PITPNC1,SLC4A4,TNIK,MACF1,PARD3,TRPM3,NRCAM,DPP10,NKAIN3,CLU,CTNND2,TRPS1 |
9.767e-03 | -4.63 | negative regulation of neuron apoptotic process | biological process | GO:0043524 | 164 | 3 | 18204 | 49 |
PTPRZ1,NTRK2,CLU |
9.838e-03 | -4.62 | HER-positive_carcinoma | COSMIC cancer mutations | HER-positive_carcinoma | 2025 | 12 | 16828 | 48 |
NRG3,RBMS3,MSI2,PAMR1,RORA,MAP3K5,ABLIM1,GPC5,RPS6KA2,NTRK2,NRCAM,BMPR1B |
9.838e-03 | -4.62 | breast-carcinoma-HER-positive_carcinoma | COSMIC cancer mutations | breast-carcinoma-HER-positive_carcinoma | 2025 | 12 | 16828 | 48 |
PAMR1,RORA,NRG3,RBMS3,BMPR1B,MSI2,MAP3K5,NTRK2,NRCAM,GPC5,ABLIM1,RPS6KA2 |
9.950e-03 | -4.61 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 6 | 19454 | 50 |
FMN2,RPS6KA2,DTNA,TNIK,PARD3,MACF1 |
1.002e-02 | -4.60 | Znf_NHR/GATA | interpro domains | IPR013088 | 56 | 2 | 18521 | 50 |
RORA,TRPS1 |
1.007e-02 | -4.60 | regulation of cell differentiation | biological process | GO:0045595 | 1622 | 10 | 18204 | 49 |
MACF1,TRPS1,RORA,PTPRZ1,EFEMP1,BMPR1B,MAP3K5,NRCAM,NTRK2,SOX5 |
1.009e-02 | -4.60 | VEGFA (vascular endothelial growth factor A) | protein interactions | 7422 | 59 | 2 | 19454 | 50 |
CLU,PTPRZ1 |
1.010e-02 | -4.59 | purine ribonucleotide binding | molecular function | GO:0032555 | 1871 | 11 | 18094 | 49 |
BMPR1B,NAV3,DCLK2,TNIK,ATP1A2,ATP13A4,RPS6KA2,MAP3K5,ADCY2,NTRK2,MAPK10 |
1.014e-02 | -4.59 | anion binding | molecular function | GO:0043168 | 2412 | 13 | 18094 | 49 |
MAP3K5,ATP13A4,RPS6KA2,PITPNC1,ATP1A2,TNIK,NTRK2,MAPK10,ADCY2,BMPR1B,PARD3,DCLK2,NAV3 |
1.023e-02 | -4.58 | Chondroitin sulfate/dermatan sulfate metabolism | REACTOME pathways | R-HSA-1793185 | 51 | 2 | 10285 | 31 |
GPC5,CSGALNACT1 |
1.023e-02 | -4.58 | positive regulation of cell differentiation | biological process | GO:0045597 | 906 | 7 | 18204 | 49 |
MACF1,BMPR1B,PTPRZ1,NRCAM,MAP3K5,SOX5,NTRK2 |
1.024e-02 | -4.58 | Naa20 (N(alpha)-acetyltransferase 20, NatB catalytic subunit) | protein interactions | 67877 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Cdk14 (cyclin dependent kinase 14) | protein interactions | 18647 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Dnaja1 (DnaJ heat shock protein family (Hsp40) member A1) | protein interactions | 15502 | 4 | 1 | 19454 | 50 |
GLIS3 |
1.024e-02 | -4.58 | Nkiras1 (NFKB inhibitor interacting Ras-like protein 1) | protein interactions | 69721 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | CCDC126 (coiled-coil domain containing 126) | protein interactions | 90693 | 4 | 1 | 19454 | 50 |
GPM6A |
1.024e-02 | -4.58 | Arhgef6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 73341 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 50 |
RORA |
1.024e-02 | -4.58 | Ilkap (integrin-linked kinase-associated serine/threonine phosphatase 2C) | protein interactions | 67444 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Rhebl1 (Ras homolog enriched in brain like 1) | protein interactions | 69159 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Srgap1 (SLIT-ROBO Rho GTPase activating protein 1) | protein interactions | 117600 | 4 | 1 | 19454 | 50 |
BMPR1B |
1.024e-02 | -4.58 | Ctbp2 (C-terminal binding protein 2) | protein interactions | 13017 | 4 | 1 | 19454 | 50 |
TRPS1 |
1.029e-02 | -4.58 | SLC4A7 (solute carrier family 4 member 7) | protein interactions | 9497 | 175 | 3 | 19454 | 50 |
SLC4A4,NTRK2,RPS6KA2 |
1.030e-02 | -4.58 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 42 |
CTNNA2 |
1.030e-02 | -4.58 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 42 |
GPM6A |
1.030e-02 | -4.58 | SOHO | prosite domains | PS50831 | 3 | 1 | 12186 | 42 |
SORBS1 |
1.030e-02 | -4.58 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 42 |
GPM6A |
1.030e-02 | -4.58 | REELIN | prosite domains | PS51019 | 3 | 1 | 12186 | 42 |
SPON1 |
1.031e-02 | -4.58 | dendritic spine | cellular component | GO:0043197 | 172 | 3 | 19108 | 50 |
GPM6A,ATP1A2,NTRK2 |
1.031e-02 | -4.57 | visual behavior | biological process | GO:0007632 | 57 | 2 | 18204 | 49 |
ATP1A2,SLC1A2 |
1.037e-02 | -4.57 | cellular component biogenesis | biological process | GO:0044085 | 2716 | 14 | 18204 | 49 |
NEBL,CLU,SORBS1,NRCAM,GPM6A,SLC1A2,TNIK,ABLIM1,RFX4,AQP4,FMN2,PARD3,NRG3,TRPM3 |
1.041e-02 | -4.57 | parathyroid-carcinoma | COSMIC cancer mutations | parathyroid-carcinoma | 300 | 4 | 16828 | 48 |
PAMR1,MACF1,GPC5,TRPS1 |
1.043e-02 | -4.56 | IRE1-TRAF2-ASK1 complex | cellular component | GO:1990604 | 4 | 1 | 19108 | 50 |
MAP3K5 |
1.043e-02 | -4.56 | internode region of axon | cellular component | GO:0033269 | 4 | 1 | 19108 | 50 |
PARD3 |
1.049e-02 | -4.56 | Cellular responses to stress | REACTOME pathways | R-HSA-2262752 | 451 | 5 | 10285 | 31 |
TNIK,MAP3K5,HIF3A,MAPK10,RPS6KA2 |
1.053e-02 | -4.55 | side of membrane | cellular component | GO:0098552 | 715 | 6 | 19108 | 50 |
GPC5,NRCAM,AQP4,MAP3K5,DTNA,LSAMP |
1.062e-02 | -4.55 | Aquaporin-mediated transport | REACTOME pathways | R-HSA-445717 | 52 | 2 | 10285 | 31 |
ADCY2,AQP4 |
1.063e-02 | -4.54 | neuron spine | cellular component | GO:0044309 | 174 | 3 | 19108 | 50 |
GPM6A,NTRK2,ATP1A2 |
1.066e-02 | -4.54 | JNK cascade | biological process | GO:0007254 | 58 | 2 | 18204 | 49 |
MAPK10,MAP3K5 |
1.072e-02 | -4.54 | regulation of glutamate uptake involved in transmission of nerve impulse | biological process | GO:0051946 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | brain-derived neurotrophic factor receptor signaling pathway | biological process | GO:0031547 | 4 | 1 | 18204 | 49 |
NTRK2 |
1.072e-02 | -4.54 | ovarian cumulus expansion | biological process | GO:0001550 | 4 | 1 | 18204 | 49 |
BMPR1B |
1.072e-02 | -4.54 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 49 |
SOX5 |
1.072e-02 | -4.54 | protein localization to secretory granule | biological process | GO:0033366 | 4 | 1 | 18204 | 49 |
CPE |
1.072e-02 | -4.54 | positive regulation of inclusion body assembly | biological process | GO:0090261 | 4 | 1 | 18204 | 49 |
CLU |
1.072e-02 | -4.54 | response to glycoside | biological process | GO:1903416 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.072e-02 | -4.54 | trans-synaptic signaling by BDNF | biological process | GO:0099191 | 4 | 1 | 18204 | 49 |
NTRK2 |
1.072e-02 | -4.54 | regulation of amino acid uptake involved in synaptic transmission | biological process | GO:0051941 | 4 | 1 | 18204 | 49 |
ATP1A2 |
1.073e-02 | -4.53 | cell-cell junction | cellular component | GO:0005911 | 513 | 5 | 19108 | 50 |
SORBS1,CTNNA2,PARD3,CTNND2,ATP1A2 |
1.076e-02 | -4.53 | Neurofascin/L1/NrCAM_C | interpro domains | IPR026966 | 4 | 1 | 18521 | 50 |
NRCAM |
1.076e-02 | -4.53 | Na/K-Atpase_Interacting | interpro domains | IPR008516 | 4 | 1 | 18521 | 50 |
NKAIN3 |
1.076e-02 | -4.53 | AbLIM_anchor | interpro domains | IPR032402 | 4 | 1 | 18521 | 50 |
ABLIM1 |
1.076e-02 | -4.53 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 50 |
CTNNA2 |
1.076e-02 | -4.53 | Nebulin_repeat | interpro domains | IPR000900 | 4 | 1 | 18521 | 50 |
NEBL |
1.076e-02 | -4.53 | PCN-like_spectrin-like_rpt | interpro domains | IPR049538 | 4 | 1 | 18521 | 50 |
MACF1 |
1.076e-02 | -4.53 | P5B-type_ATPase | interpro domains | IPR047821 | 4 | 1 | 18521 | 50 |
ATP13A4 |
1.076e-02 | -4.53 | TRPM_tetra | interpro domains | IPR032415 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | P5A-ATPase_N | interpro domains | IPR047819 | 4 | 1 | 18521 | 50 |
ATP13A4 |
1.076e-02 | -4.53 | RSK_N | interpro domains | IPR041906 | 4 | 1 | 18521 | 50 |
RPS6KA2 |
1.076e-02 | -4.53 | Glyco_transf_54 | interpro domains | IPR006759 | 4 | 1 | 18521 | 50 |
MGAT4C |
1.076e-02 | -4.53 | TRPM_tetra_sf | interpro domains | IPR037162 | 4 | 1 | 18521 | 50 |
TRPM3 |
1.076e-02 | -4.53 | Desmoplakin_Spectrin-like | interpro domains | IPR041573 | 4 | 1 | 18521 | 50 |
MACF1 |
1.076e-02 | -4.53 | MAPK8IP3 (mitogen-activated protein kinase 8 interacting protein 3) | protein interactions | 23162 | 61 | 2 | 19454 | 50 |
MAP3K5,MAPK10 |
1.077e-02 | -4.53 | oligodendroglioma_Grade_III | COSMIC cancer mutations | oligodendroglioma_Grade_III | 303 | 4 | 16828 | 48 |
MGAT4C,GLIS3,PTPRZ1,MACF1 |
1.078e-02 | -4.53 | ribonucleotide binding | molecular function | GO:0032553 | 1888 | 11 | 18094 | 49 |
ADCY2,NAV3,DCLK2,NTRK2,MAPK10,TNIK,ATP1A2,BMPR1B,ATP13A4,RPS6KA2,MAP3K5 |
1.079e-02 | -4.53 | brain-derived neurotrophic factor binding | molecular function | GO:0048403 | 4 | 1 | 18094 | 49 |
NTRK2 |
1.084e-02 | -4.52 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 47 | 16828 | 48 |
ATP1A2,SPON1,ATP13A4,ADCY2,GPM6A,TNIK,NPAS3,HPSE2,CSGALNACT1,TRPS1,GPC5,NAV3,EFEMP1,NTRK2,TRPM3,PARD3,HIF3A,DTNA,MSI2,SLC4A4,BMPR1B,DCLK2,NRG3,PAMR1,RORA,CTNND2,CLU,DPP10,MACF1,SOX5,CPE,PITPNC1,MGAT4C,FMN2,RFX4,ABLIM1,SLC1A2,NKAIN3,RPS6KA2,NRCAM,AQP4,MAP3K5,NEBL,PTPRZ1,SORBS1,LSAMP,GLIS3 |
1.092e-02 | -4.52 | Corticotropin Activation of Cortisol Production | SMPDB pathways | SMP0000310 | 5 | 1 | 1369 | 3 |
ADCY2 |
1.097e-02 | -4.51 | Nebulin | pfam domains | PF00880 | 4 | 1 | 17795 | 49 |
NEBL |
1.097e-02 | -4.51 | Spectrin_4 | pfam domains | PF21020 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Spectrin_2 | pfam domains | PF18373 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | Spectrin_3 | pfam domains | PF21019 | 4 | 1 | 17795 | 49 |
MACF1 |
1.097e-02 | -4.51 | TRPM_tetra | pfam domains | PF16519 | 4 | 1 | 17795 | 49 |
TRPM3 |
1.097e-02 | -4.51 | AbLIM_anchor | pfam domains | PF16182 | 4 | 1 | 17795 | 49 |
ABLIM1 |
1.097e-02 | -4.51 | Bravo_FIGEY | pfam domains | PF13882 | 4 | 1 | 17795 | 49 |
NRCAM |
1.097e-02 | -4.51 | NKAIN | pfam domains | PF05640 | 4 | 1 | 17795 | 49 |
NKAIN3 |
1.097e-02 | -4.51 | Glyco_transf_54 | pfam domains | PF04666 | 4 | 1 | 17795 | 49 |
MGAT4C |
1.097e-02 | -4.51 | P5-ATPase | pfam domains | PF12409 | 4 | 1 | 17795 | 49 |
ATP13A4 |
1.101e-02 | -4.51 | MAPK signaling pathway | KEGG pathways | ko04010 | 255 | 4 | 7161 | 25 |
MAP3K5,RPS6KA2,MAPK10,NTRK2 |
1.101e-02 | -4.51 | MAPK signaling pathway | KEGG pathways | hsa04010 | 255 | 4 | 7161 | 25 |
MAP3K5,RPS6KA2,MAPK10,NTRK2 |
1.101e-02 | -4.51 | endochondral bone morphogenesis | biological process | GO:0060350 | 59 | 2 | 18204 | 49 |
CSGALNACT1,BMPR1B |
1.106e-02 | -4.50 | chondroitin biosynthesis | BIOCYC pathways | META_PWY-6566 | 5 | 1 | 902 | 2 |
CSGALNACT1 |
1.107e-02 | -4.50 | Sorb | smart domains | SM00459 | 3 | 1 | 9717 | 36 |
SORBS1 |
1.107e-02 | -4.50 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 36 |
GPM6A |
1.111e-02 | -4.50 | asymmetric synapse | cellular component | GO:0032279 | 333 | 4 | 19108 | 50 |
TNIK,NRCAM,CTNND2,NTRK2 |
1.113e-02 | -4.50 | cell migration | biological process | GO:0016477 | 921 | 7 | 18204 | 49 |
GPC5,NTRK2,GPM6A,FMN2,NRCAM,CTNNA2,NRG3 |
1.113e-02 | -4.50 | functioning | COSMIC cancer mutations | functioning | 1803 | 11 | 16828 | 48 |
SLC1A2,TRPM3,NRCAM,NTRK2,EFEMP1,SOX5,PTPRZ1,HPSE2,NRG3,RFX4,FMN2 |
1.113e-02 | -4.50 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 11 | 16828 | 48 |
NTRK2,EFEMP1,PTPRZ1,NRCAM,TRPM3,SLC1A2,FMN2,RFX4,SOX5,NRG3,HPSE2 |
1.114e-02 | -4.50 | ovary-carcinoma-clear_cell_carcinoma | COSMIC cancer mutations | ovary-carcinoma-clear_cell_carcinoma | 665 | 6 | 16828 | 48 |
DCLK2,MAP3K5,RPS6KA2,TNIK,BMPR1B,NTRK2 |
1.117e-02 | -4.49 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 5 | 16828 | 48 |
MACF1,GPC5,TRPS1,GPM6A,PAMR1 |
1.121e-02 | -4.49 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 7 | 19454 | 50 |
PITPNC1,PARD3,MAP3K5,DCLK2,MACF1,ABLIM1,SORBS1 |
1.128e-02 | -4.48 | cartilage development | biological process | GO:0051216 | 173 | 3 | 18204 | 49 |
BMPR1B,SOX5,CSGALNACT1 |
1.128e-02 | -4.48 | regulation of cell size | biological process | GO:0008361 | 173 | 3 | 18204 | 49 |
MACF1,NRCAM,AQP4 |
1.137e-02 | -4.48 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 49 |
SLC4A4,ATP1A2 |
1.137e-02 | -4.48 | proteoglycan biosynthetic process | biological process | GO:0030166 | 60 | 2 | 18204 | 49 |
CSGALNACT1,BMPR1B |
1.137e-02 | -4.48 | regulation of glucose import | biological process | GO:0046324 | 60 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
1.141e-02 | -4.47 | Heparan sulfate/heparin (HS-GAG) metabolism | REACTOME pathways | R-HSA-1638091 | 54 | 2 | 10285 | 31 |
HPSE2,GPC5 |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.143e-02 | -4.47 | human chr4q34.2 | chromosome location | human chr4q34.2 | 6 | 1 | 26134 | 50 |
GPM6A |
1.144e-02 | -4.47 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 20 |
GPM6A |
1.144e-02 | -4.47 | JNKMAPKINASE | prints domains | PR01772 | 3 | 1 | 5227 | 20 |
MAPK10 |
1.144e-02 | -4.47 | NTKRECEPTOR | prints domains | PR01939 | 3 | 1 | 5227 | 20 |
NTRK2 |
1.144e-02 | -4.47 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 20 |
RORA |
1.145e-02 | -4.47 | clear_cell_carcinoma | COSMIC cancer mutations | clear_cell_carcinoma | 669 | 6 | 16828 | 48 |
RPS6KA2,TNIK,DCLK2,BMPR1B,MAP3K5,NTRK2 |
1.145e-02 | -4.47 | YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma) | protein interactions | 7532 | 1211 | 8 | 19454 | 50 |
DCLK2,FMN2,PITPNC1,PARD3,MAP3K5,MACF1,ABLIM1,SORBS1 |
1.161e-02 | -4.46 | MAPK9 (mitogen-activated protein kinase 9) | protein interactions | 5601 | 183 | 3 | 19454 | 50 |
MACF1,MAPK10,CLU |
1.165e-02 | -4.45 | metal ion binding | molecular function | GO:0046872 | 4239 | 19 | 18094 | 49 |
SLC1A2,EFEMP1,CSGALNACT1,BMPR1B,DTNA,MACF1,ADCY2,SPON1,TRPS1,GLIS3,PAMR1,CPE,ABLIM1,ATP1A2,MGAT4C,RORA,RPS6KA2,ATP13A4,MAP3K5 |
1.169e-02 | -4.45 | cell differentiation | biological process | GO:0030154 | 3645 | 17 | 18204 | 49 |
NEBL,CLU,RORA,BMPR1B,CTNNA2,NRCAM,NTRK2,MSI2,GPM6A,TNIK,CTNND2,PTPRZ1,FMN2,PARD3,SOX5,NAV3,DCLK2 |
1.179e-02 | -4.44 | cellular developmental process | biological process | GO:0048869 | 3648 | 17 | 18204 | 49 |
SOX5,NAV3,DCLK2,FMN2,PARD3,PTPRZ1,TNIK,CTNND2,NTRK2,MSI2,GPM6A,CTNNA2,NRCAM,BMPR1B,NEBL,CLU,RORA |
1.187e-02 | -4.43 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 31 | 16828 | 48 |
SORBS1,NRG3,DCLK2,RORA,PAMR1,PTPRZ1,NEBL,SLC4A4,AQP4,MAP3K5,NAV3,RPS6KA2,TRPS1,GPC5,PARD3,TRPM3,NTRK2,EFEMP1,HPSE2,FMN2,MGAT4C,NPAS3,MACF1,ATP1A2,ADCY2,ATP13A4,SOX5,CPE,SPON1,CTNND2,DPP10 |
1.200e-02 | -4.42 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 1 | 10285 | 31 |
SLC1A2 |
1.200e-02 | -4.42 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 1 | 10285 | 31 |
SLC1A2 |
1.202e-02 | -4.42 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 39 | 16828 | 48 |
TNIK,NPAS3,HPSE2,CSGALNACT1,MGAT4C,FMN2,CTNND2,CLU,DPP10,ATP1A2,MACF1,CPE,ADCY2,SOX5,ATP13A4,SLC4A4,NEBL,BMPR1B,PTPRZ1,DCLK2,NRG3,LSAMP,SORBS1,PAMR1,GLIS3,RORA,GPC5,TRPS1,SLC1A2,NAV3,RPS6KA2,EFEMP1,NTRK2,TRPM3,NRCAM,PARD3,DTNA,MSI2,MAP3K5 |
1.205e-02 | -4.42 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 48 | 16828 | 48 |
AQP4,MAP3K5,ABLIM1,NKAIN3,RPS6KA2,SLC1A2,NRCAM,SORBS1,LSAMP,GLIS3,PTPRZ1,NEBL,MACF1,SOX5,CPE,CLU,CTNND2,DPP10,MGAT4C,FMN2,RFX4,PITPNC1,HIF3A,MSI2,DTNA,GPC5,TRPS1,NAV3,NTRK2,EFEMP1,PARD3,TRPM3,NRG3,DCLK2,PAMR1,RORA,SLC4A4,BMPR1B,ATP1A2,SPON1,GPM6A,ATP13A4,ADCY2,HPSE2,RBMS3,CSGALNACT1,TNIK,NPAS3 |
1.211e-02 | -4.41 | TRPM, tetramerisation domain | gene3d domains | 1.20.5.1010 | 4 | 1 | 14470 | 44 |
TRPM3 |
1.211e-02 | -4.41 | - | gene3d domains | 1.20.58.1060 | 4 | 1 | 14470 | 44 |
MACF1 |
1.211e-02 | -4.41 | positive regulation of protein localization to plasma membrane | biological process | GO:1903078 | 62 | 2 | 18204 | 49 |
DPP10,SORBS1 |
1.215e-02 | -4.41 | PPP3R1 (protein phosphatase 3 regulatory subunit B, alpha) | protein interactions | 5534 | 65 | 2 | 19454 | 50 |
GPM6A,MAP3K5 |
1.221e-02 | -4.41 | synapse organization | biological process | GO:0050808 | 333 | 4 | 18204 | 49 |
NRG3,NRCAM,CTNND2,GPM6A |
1.221e-02 | -4.41 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 6 | 18094 | 49 |
SLC4A4,GPM6A,ATP1A2,AQP4,TRPM3,SLC1A2 |
1.225e-02 | -4.40 | transmembrane receptor protein tyrosine kinase activity | molecular function | GO:0004714 | 62 | 2 | 18094 | 49 |
NTRK2,EFEMP1 |
1.245e-02 | -4.39 | camera-type eye development | biological process | GO:0043010 | 335 | 4 | 18204 | 49 |
GPM6A,EFEMP1,NTRK2,BMPR1B |
1.250e-02 | -4.38 | cell adhesion | biological process | GO:0007155 | 942 | 7 | 18204 | 49 |
PARD3,SPON1,NRCAM,CTNNA2,SORBS1,CTNND2,LSAMP |
1.253e-02 | -4.38 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 4 | 19108 | 50 |
TNIK,NRCAM,NTRK2,CTNND2 |
1.254e-02 | -4.38 | Erythroid Transcription Factor GATA-1, subunit A | gene3d domains | 3.30.50.10 | 56 | 2 | 14470 | 44 |
RORA,TRPS1 |
1.276e-02 | -4.36 | Fluid shear stress and atherosclerosis | KEGG pathways | hsa05418 | 142 | 3 | 7161 | 25 |
MAPK10,MAP3K5,BMPR1B |
1.276e-02 | -4.36 | Fluid shear stress and atherosclerosis | KEGG pathways | ko05418 | 142 | 3 | 7161 | 25 |
BMPR1B,MAP3K5,MAPK10 |
1.279e-02 | -4.36 | DPP10 (dipeptidyl peptidase like 10) | protein interactions | 57628 | 5 | 1 | 19454 | 50 |
DPP10 |
1.279e-02 | -4.36 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 50 |
RFX4 |
1.279e-02 | -4.36 | Rnf166 (ring finger protein 166) | protein interactions | 68718 | 5 | 1 | 19454 | 50 |
MAP3K5 |
1.279e-02 | -4.36 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 50 |
TRPM3 |
1.279e-02 | -4.36 | Rhobtb1 (Rho-related BTB domain containing 1) | protein interactions | 69288 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | ADCYAP1R1 (ADCYAP receptor type I) | protein interactions | 117 | 5 | 1 | 19454 | 50 |
CLU |
1.279e-02 | -4.36 | Rab6b (RAB6B, member RAS oncogene family) | protein interactions | 270192 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | EPPIN (epididymal peptidase inhibitor) | protein interactions | 57119 | 5 | 1 | 19454 | 50 |
CLU |
1.279e-02 | -4.36 | Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) | protein interactions | 66894 | 5 | 1 | 19454 | 50 |
GLIS3 |
1.279e-02 | -4.36 | TRH (thyrotropin releasing hormone) | protein interactions | 7200 | 5 | 1 | 19454 | 50 |
CPE |
1.279e-02 | -4.36 | Rab38 (RAB38, member RAS oncogene family) | protein interactions | 72433 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rhoj (ras homolog family member J) | protein interactions | 80837 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Rras2 (related RAS viral (r-ras) oncogene 2) | protein interactions | 66922 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | Cdk4 (cyclin dependent kinase 4) | protein interactions | 12567 | 5 | 1 | 19454 | 50 |
BMPR1B |
1.279e-02 | -4.36 | SLC10A3 (solute carrier family 10 member 3) | protein interactions | 8273 | 5 | 1 | 19454 | 50 |
SORBS1 |
1.287e-02 | -4.35 | actin filament bundle assembly | biological process | GO:0051017 | 64 | 2 | 18204 | 49 |
SORBS1,FMN2 |
1.287e-02 | -4.35 | cellular senescence | biological process | GO:0090398 | 64 | 2 | 18204 | 49 |
MAPK10,MAP3K5 |
1.287e-02 | -4.35 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 2 | 18204 | 49 |
CTNNA2,CTNND2 |
1.292e-02 | -4.35 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 8 | 16828 | 48 |
ADCY2,ATP13A4,SOX5,FMN2,NRG3,PARD3,GPC5,SLC1A2 |
1.296e-02 | -4.35 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 49 |
GPC5,CTNND2,RBMS3,MACF1 |
1.302e-02 | -4.34 | neurofibrillary tangle | cellular component | GO:0097418 | 5 | 1 | 19108 | 50 |
CLU |
1.304e-02 | -4.34 | SH3_9 | pfam domains | PF14604 | 63 | 2 | 17795 | 49 |
SORBS1,NEBL |
1.309e-02 | -4.34 | Ion transport by P-type ATPases | REACTOME pathways | R-HSA-936837 | 58 | 2 | 10285 | 31 |
ATP1A2,ATP13A4 |
1.310e-02 | -4.34 | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | SMPDB pathways | SMP0000343 | 6 | 1 | 1369 | 3 |
ADCY2 |
1.310e-02 | -4.34 | Dopamine Activation of Neurological Reward System | SMPDB pathways | SMP0000308 | 6 | 1 | 1369 | 3 |
ADCY2 |
1.312e-02 | -4.33 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 3 | 18204 | 49 |
SORBS1,SLC4A4,RORA |
1.312e-02 | -4.33 | regulation of protein localization to membrane | biological process | GO:1905475 | 183 | 3 | 18204 | 49 |
DPP10,GPC5,SORBS1 |
1.324e-02 | -4.32 | PLCH1 (phospholipase C eta 1) | protein interactions | 23007 | 68 | 2 | 19454 | 50 |
NTRK2,PARD3 |
1.324e-02 | -4.32 | SHROOM3 (shroom family member 3) | protein interactions | 57619 | 68 | 2 | 19454 | 50 |
PARD3,RPS6KA2 |
1.324e-02 | -4.32 | CIB1 (calcium and integrin binding 1) | protein interactions | 10519 | 68 | 2 | 19454 | 50 |
GLIS3,MAP3K5 |
1.325e-02 | -4.32 | regulation of protein processing | biological process | GO:0070613 | 65 | 2 | 18204 | 49 |
RFX4,SPON1 |
1.328e-02 | -4.32 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 9 | 19454 | 50 |
MAP3K5,ADCY2,CTNNA2,SLC1A2,NTRK2,MAPK10,MGAT4C,EFEMP1,BMPR1B |
1.331e-02 | -4.32 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 8 | 16828 | 48 |
MAP3K5,RORA,MGAT4C,CTNND2,RPS6KA2,TNIK,NRCAM,NTRK2 |
1.332e-02 | -4.32 | human chr4q21.3 | chromosome location | human chr4q21.3 | 7 | 1 | 26134 | 50 |
MAPK10 |
1.336e-02 | -4.32 | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma | 323 | 4 | 16828 | 48 |
PTPRZ1,MAP3K5,ADCY2,SORBS1 |
1.339e-02 | -4.31 | polar body extrusion after meiotic divisions | biological process | GO:0040038 | 5 | 1 | 18204 | 49 |
FMN2 |
1.339e-02 | -4.31 | positive regulation of amyloid fibril formation | biological process | GO:1905908 | 5 | 1 | 18204 | 49 |
CLU |
1.339e-02 | -4.31 | amygdala development | biological process | GO:0021764 | 5 | 1 | 18204 | 49 |
ATP1A2 |
1.339e-02 | -4.31 | negative regulation of chondrocyte proliferation | biological process | GO:1902731 | 5 | 1 | 18204 | 49 |
BMPR1B |
1.339e-02 | -4.31 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 1 | 18204 | 49 |
SLC1A2 |
1.339e-02 | -4.31 | central nervous system myelin maintenance | biological process | GO:0032286 | 5 | 1 | 18204 | 49 |
CLU |
1.339e-02 | -4.31 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 1 | 18204 | 49 |
SLC1A2 |
1.339e-02 | -4.31 | synaptic signaling via neuropeptide | biological process | GO:0099538 | 5 | 1 | 18204 | 49 |
NTRK2 |
1.341e-02 | -4.31 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 26 | 16828 | 48 |
GPC5,TRPS1,RPS6KA2,NAV3,EFEMP1,NTRK2,TRPM3,PARD3,AQP4,NEBL,PTPRZ1,NRG3,SORBS1,PAMR1,RORA,CTNND2,DPP10,MACF1,SPON1,CPE,SOX5,ATP13A4,ADCY2,NPAS3,MGAT4C,FMN2 |
1.343e-02 | -4.31 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 50 |
CTNNA2 |
1.343e-02 | -4.31 | P-type_TPase_V | interpro domains | IPR006544 | 5 | 1 | 18521 | 50 |
ATP13A4 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.343e-02 | -4.31 | PI_transfer | interpro domains | IPR001666 | 5 | 1 | 18521 | 50 |
PITPNC1 |
1.344e-02 | -4.31 | Amyotrophic lateral sclerosis (ALS) | KEGG pathways | ko05014 | 51 | 2 | 7161 | 25 |
MAP3K5,SLC1A2 |
1.344e-02 | -4.31 | Amyotrophic lateral sclerosis (ALS) | KEGG pathways | hsa05014 | 51 | 2 | 7161 | 25 |
SLC1A2,MAP3K5 |
1.347e-02 | -4.31 | neurotrophin receptor activity | molecular function | GO:0005030 | 5 | 1 | 18094 | 49 |
NTRK2 |
1.347e-02 | -4.31 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.347e-02 | -4.31 | transforming growth factor beta receptor activity, type I | molecular function | GO:0005025 | 5 | 1 | 18094 | 49 |
BMPR1B |
1.347e-02 | -4.31 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 1 | 18094 | 49 |
SLC1A2 |
1.358e-02 | -4.30 | small_intestine-carcinoid-endocrine_tumour | COSMIC cancer mutations | small_intestine-carcinoid-endocrine_tumour | 175 | 3 | 16828 | 48 |
TNIK,MACF1,CSGALNACT1 |
1.359e-02 | -4.30 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 46 | 16828 | 48 |
SLC4A4,BMPR1B,NRG3,DCLK2,PAMR1,RORA,TRPS1,GPC5,NAV3,NTRK2,EFEMP1,PARD3,TRPM3,HIF3A,DTNA,TNIK,NPAS3,HPSE2,CSGALNACT1,ATP1A2,SPON1,GPM6A,ATP13A4,ADCY2,PTPRZ1,NEBL,SORBS1,LSAMP,GLIS3,ABLIM1,RPS6KA2,NKAIN3,SLC1A2,NRCAM,AQP4,MAP3K5,PITPNC1,MGAT4C,RFX4,FMN2,CLU,CTNND2,DPP10,MACF1,CPE,SOX5 |
1.361e-02 | -4.30 | cellular component organization | biological process | GO:0016043 | 5636 | 23 | 18204 | 49 |
DCLK2,TRPM3,NRG3,FMN2,PTPRZ1,AQP4,RFX4,MACF1,TNIK,CTNND2,CSGALNACT1,CTNNA2,SORBS1,CLU,NEBL,PARD3,PITPNC1,ABLIM1,GPM6A,SLC1A2,HPSE2,NRCAM,BMPR1B |
1.364e-02 | -4.29 | ERBB signaling pathway | biological process | GO:0038127 | 66 | 2 | 18204 | 49 |
NRG3,EFEMP1 |
1.369e-02 | -4.29 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 49 |
CTNNA2 |
1.369e-02 | -4.29 | IP_trans | pfam domains | PF02121 | 5 | 1 | 17795 | 49 |
PITPNC1 |
1.372e-02 | -4.29 | NEBULIN | prosite domains | PS51216 | 4 | 1 | 12186 | 42 |
NEBL |
1.386e-02 | -4.28 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 38 | 16828 | 48 |
TNIK,NPAS3,HPSE2,MGAT4C,CSGALNACT1,FMN2,RFX4,CTNND2,CLU,ATP1A2,MACF1,SPON1,CPE,ATP13A4,SOX5,ADCY2,GPM6A,NEBL,PTPRZ1,NRG3,SORBS1,LSAMP,PAMR1,RORA,TRPS1,GPC5,ABLIM1,SLC1A2,NAV3,NKAIN3,EFEMP1,NTRK2,NRCAM,TRPM3,PARD3,AQP4,DTNA,MAP3K5 |
1.388e-02 | -4.28 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 17 | 16828 | 48 |
HPSE2,DCLK2,FMN2,PTPRZ1,NPAS3,SLC4A4,MACF1,ATP1A2,MAP3K5,ADCY2,SPON1,NAV3,CTNND2,GPC5,PARD3,TRPM3,DPP10 |
1.399e-02 | -4.27 | PCDH20 (protocadherin 20) | protein interactions | 64881 | 70 | 2 | 19454 | 50 |
CTNNA2,MGAT4C |
1.425e-02 | -4.25 | DNAJC5 (DnaJ heat shock protein family (Hsp40) member C5) | protein interactions | 80331 | 365 | 4 | 19454 | 50 |
PARD3,DTNA,MACF1,CLU |
1.425e-02 | -4.25 | skin-ear-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-ear-carcinoma-squamous_cell_carcinoma | 506 | 5 | 16828 | 48 |
RPS6KA2,NPAS3,MGAT4C,DPP10,MAP3K5 |
1.426e-02 | -4.25 | purine nucleotide binding | molecular function | GO:0017076 | 1964 | 11 | 18094 | 49 |
BMPR1B,DCLK2,NAV3,ATP13A4,RPS6KA2,MAP3K5,TNIK,ATP1A2,MAPK10,NTRK2,ADCY2 |
1.437e-02 | -4.24 | AKR7L (aldo-keto reductase family 7 like (gene/pseudogene)) | protein interactions | 246181 | 71 | 2 | 19454 | 50 |
PARD3,MACF1 |
1.437e-02 | -4.24 | MAP2K4 (mitogen-activated protein kinase kinase 4) | protein interactions | 6416 | 71 | 2 | 19454 | 50 |
MAPK10,MAP3K5 |
1.440e-02 | -4.24 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 8 | 16828 | 48 |
NTRK2,NRCAM,TNIK,RPS6KA2,CTNND2,MGAT4C,RORA,MAP3K5 |
1.444e-02 | -4.24 | actin filament bundle organization | biological process | GO:0061572 | 68 | 2 | 18204 | 49 |
SORBS1,FMN2 |
1.450e-02 | -4.23 | marginal_zone_lymphoma | COSMIC cancer mutations | marginal_zone_lymphoma | 331 | 4 | 16828 | 48 |
PTPRZ1,ADCY2,MAP3K5,SORBS1 |
1.466e-02 | -4.22 | CH | pfam domains | PF00307 | 67 | 2 | 17795 | 49 |
NAV3,MACF1 |
1.474e-02 | -4.22 | NEBU | smart domains | SM00227 | 4 | 1 | 9717 | 36 |
NEBL |
1.476e-02 | -4.22 | DPYSL3 (dihydropyrimidinase like 3) | protein interactions | 1809 | 72 | 2 | 19454 | 50 |
GPM6A,TNIK |
1.476e-02 | -4.22 | Ppp1cb (protein phosphatase 1 catalytic subunit beta) | protein interactions | 19046 | 72 | 2 | 19454 | 50 |
PARD3,ABLIM1 |
1.479e-02 | -4.21 | cell body | cellular component | GO:0044297 | 556 | 5 | 19108 | 50 |
GPM6A,BMPR1B,CTNND2,ATP1A2,SLC1A2 |
1.485e-02 | -4.21 | regulation of protein maturation | biological process | GO:1903317 | 69 | 2 | 18204 | 49 |
SPON1,RFX4 |
1.486e-02 | -4.21 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 19 | 16828 | 48 |
GLIS3,LSAMP,PTPRZ1,TNIK,ADCY2,SOX5,CPE,ATP13A4,DTNA,HIF3A,AQP4,MACF1,ATP1A2,PARD3,TRPM3,NAV3,CTNND2,TRPS1,GPC5 |
1.492e-02 | -4.21 | TIAM1 (TIAM Rac1 associated GEF 1) | protein interactions | 7074 | 201 | 3 | 19454 | 50 |
PARD3,ATP1A2,DTNA |
1.495e-02 | -4.20 | carbohydrate derivative binding | molecular function | GO:0097367 | 2251 | 12 | 18094 | 49 |
NAV3,DCLK2,ADCY2,MAPK10,NTRK2,BMPR1B,ATP1A2,TNIK,MAP3K5,RPS6KA2,ATP13A4,HPSE2 |
1.498e-02 | -4.20 | NGF-independant TRKA activation | REACTOME pathways | R-HSA-187024 | 5 | 1 | 10285 | 31 |
NTRK2 |
1.500e-02 | -4.20 | cation binding | molecular function | GO:0043169 | 4341 | 19 | 18094 | 49 |
SLC1A2,MACF1,DTNA,EFEMP1,BMPR1B,CSGALNACT1,CPE,ABLIM1,SPON1,ADCY2,PAMR1,GLIS3,TRPS1,RORA,MAP3K5,ATP13A4,RPS6KA2,MGAT4C,ATP1A2 |
1.504e-02 | -4.20 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 25 | 16828 | 48 |
CTNND2,MACF1,ATP1A2,ADCY2,ATP13A4,SOX5,NPAS3,CSGALNACT1,NKAIN3,NAV3,ABLIM1,PARD3,TRPM3,NRCAM,NTRK2,MAP3K5,DTNA,PTPRZ1,NEBL,SLC4A4,NRG3,DCLK2,GLIS3,RORA,PAMR1 |
1.512e-02 | -4.19 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 4 | 19108 | 50 |
CTNND2,NTRK2,TNIK,NRCAM |
1.522e-02 | -4.19 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 20 |
CTNNA2 |
1.526e-02 | -4.18 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 46 | 16828 | 48 |
HPSE2,CSGALNACT1,TNIK,NPAS3,ATP1A2,SPON1,ATP13A4,ADCY2,GPM6A,DCLK2,NRG3,PAMR1,RORA,SLC4A4,BMPR1B,HIF3A,DTNA,TRPS1,GPC5,NAV3,EFEMP1,NTRK2,TRPM3,PARD3,MGAT4C,FMN2,RFX4,PITPNC1,MACF1,SOX5,CPE,CTNND2,CLU,DPP10,LSAMP,SORBS1,GLIS3,NEBL,PTPRZ1,AQP4,MAP3K5,ABLIM1,SLC1A2,NKAIN3,RPS6KA2,NRCAM |
1.526e-02 | -4.18 | transporter activity | molecular function | GO:0005215 | 1211 | 8 | 18094 | 49 |
AQP4,TRPM3,SLC1A2,ATP13A4,SLC4A4,GPM6A,PITPNC1,ATP1A2 |
1.527e-02 | -4.18 | Vasopressin Regulation of Water Homeostasis | SMPDB pathways | SMP0000322 | 7 | 1 | 1369 | 3 |
ADCY2 |
1.532e-02 | -4.18 | CYRIA (CYFIP related Rac1 interactor A) | protein interactions | 81553 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | GDF6 (growth differentiation factor 6) | protein interactions | 392255 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | DRP2 (dystrophin related protein 2) | protein interactions | 1821 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | Rhod (ras homolog family member D) | protein interactions | 11854 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 50 |
SOX5 |
1.532e-02 | -4.18 | Rara (retinoic acid receptor, alpha) | protein interactions | 19401 | 6 | 1 | 19454 | 50 |
MAPK10 |
1.532e-02 | -4.18 | Itch (itchy, E3 ubiquitin protein ligase) | protein interactions | 16396 | 6 | 1 | 19454 | 50 |
GLIS3 |
1.532e-02 | -4.18 | ADCY1 (adenylate cyclase 1) | protein interactions | 107 | 6 | 1 | 19454 | 50 |
ADCY2 |
1.532e-02 | -4.18 | Fancl (Fanconi anemia, complementation group L) | protein interactions | 67030 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.532e-02 | -4.18 | SLC12A5 (solute carrier family 12 member 5) | protein interactions | 57468 | 6 | 1 | 19454 | 50 |
GPM6A |
1.532e-02 | -4.18 | Zbtb2 (zinc finger and BTB domain containing 2) | protein interactions | 381990 | 6 | 1 | 19454 | 50 |
SORBS1 |
1.532e-02 | -4.18 | Tiam2 (T cell lymphoma invasion and metastasis 2) | protein interactions | 24001 | 6 | 1 | 19454 | 50 |
DTNA |
1.532e-02 | -4.18 | Taok2 (TAO kinase 2) | protein interactions | 381921 | 6 | 1 | 19454 | 50 |
CLU |
1.532e-02 | -4.18 | Map2k3 (mitogen-activated protein kinase kinase 3) | protein interactions | 26397 | 6 | 1 | 19454 | 50 |
BMPR1B |
1.538e-02 | -4.17 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 10 | 16828 | 48 |
SOX5,MACF1,HIF3A,DCLK2,NEBL,TRPM3,PTPRZ1,PARD3,NPAS3,GPC5 |
1.544e-02 | -4.17 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 6 | 18094 | 49 |
GPM6A,SLC4A4,ATP1A2,ATP13A4,TRPM3,SLC1A2 |
1.550e-02 | -4.17 | LIM | pfam domains | PF00412 | 69 | 2 | 17795 | 49 |
NEBL,ABLIM1 |
1.551e-02 | -4.17 | pancreas-carcinoma-adenocarcinoma | COSMIC cancer mutations | pancreas-carcinoma-adenocarcinoma | 517 | 5 | 16828 | 48 |
NEBL,MACF1,HPSE2,DCLK2,GPC5 |
1.554e-02 | -4.16 | TNF receptor signaling pathway | Pathway Interaction DB | tnfpathway | 44 | 2 | 2226 | 10 |
MAP3K5,TNIK |
1.560e-02 | -4.16 | PAR polarity complex | cellular component | GO:0120157 | 6 | 1 | 19108 | 50 |
PARD3 |
1.568e-02 | -4.16 | localization within membrane | biological process | GO:0051668 | 549 | 5 | 18204 | 49 |
TNIK,CPE,PARD3,MACF1,DPP10 |
1.573e-02 | -4.15 | caecum | COSMIC cancer mutations | caecum | 14248 | 46 | 16828 | 48 |
CLU,CTNND2,DPP10,MACF1,SOX5,CPE,PITPNC1,RFX4,FMN2,MGAT4C,RPS6KA2,NKAIN3,SLC1A2,ABLIM1,NRCAM,AQP4,MAP3K5,PTPRZ1,NEBL,LSAMP,SORBS1,GLIS3,ATP1A2,GPM6A,ATP13A4,ADCY2,SPON1,TNIK,NPAS3,HPSE2,CSGALNACT1,NAV3,GPC5,TRPS1,PARD3,TRPM3,NTRK2,EFEMP1,HIF3A,DTNA,BMPR1B,SLC4A4,NRG3,DCLK2,RORA,PAMR1 |
1.576e-02 | -4.15 | Znf_LIM | interpro domains | IPR001781 | 71 | 2 | 18521 | 50 |
NEBL,ABLIM1 |
1.578e-02 | -4.15 | MAP kinase activation in TLR cascade | REACTOME pathways | R-HSA-450294 | 64 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
1.586e-02 | -4.14 | Hippo signaling pathway | KEGG pathways | ko04390 | 154 | 3 | 7161 | 25 |
CTNNA2,BMPR1B,PARD3 |
1.586e-02 | -4.14 | Hippo signaling pathway | KEGG pathways | hsa04390 | 154 | 3 | 7161 | 25 |
PARD3,CTNNA2,BMPR1B |
1.597e-02 | -4.14 | protein localization to plasma membrane | biological process | GO:0072659 | 197 | 3 | 18204 | 49 |
DPP10,MACF1,TNIK |
1.604e-02 | -4.13 | fused antrum stage | biological process | GO:0048165 | 6 | 1 | 18204 | 49 |
BMPR1B |
1.604e-02 | -4.13 | intracellular water homeostasis | biological process | GO:0009992 | 6 | 1 | 18204 | 49 |
AQP4 |
1.604e-02 | -4.13 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 49 |
NRG3 |
1.604e-02 | -4.13 | establishment of meiotic spindle localization | biological process | GO:0051295 | 6 | 1 | 18204 | 49 |
FMN2 |
1.604e-02 | -4.13 | clustering of voltage-gated sodium channels | biological process | GO:0045162 | 6 | 1 | 18204 | 49 |
NRCAM |
1.604e-02 | -4.13 | D-amino acid transport | biological process | GO:0042940 | 6 | 1 | 18204 | 49 |
SLC1A2 |
1.604e-02 | -4.13 | protein targeting to vacuole involved in autophagy | biological process | GO:0071211 | 6 | 1 | 18204 | 49 |
CLU |
1.604e-02 | -4.13 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 1 | 18204 | 49 |
SLC1A2 |
1.604e-02 | -4.13 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 49 |
SOX5 |
1.604e-02 | -4.13 | mammary gland formation | biological process | GO:0060592 | 6 | 1 | 18204 | 49 |
NRG3 |
1.609e-02 | -4.13 | TSP1_spondin_dom | interpro domains | IPR044004 | 6 | 1 | 18521 | 50 |
SPON1 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Desmoplakin_SH3 | interpro domains | IPR041615 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Adcy_conserved_dom | interpro domains | IPR009398 | 6 | 1 | 18521 | 50 |
ADCY2 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | EF-hand_dom_typ2 | interpro domains | IPR015154 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | GAR_dom_sf | interpro domains | IPR036534 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | Ribosomal_S6_kinase_II | interpro domains | IPR016239 | 6 | 1 | 18521 | 50 |
RPS6KA2 |
1.609e-02 | -4.13 | GAR_dom | interpro domains | IPR003108 | 6 | 1 | 18521 | 50 |
MACF1 |
1.609e-02 | -4.13 | P-type_ATPase_IIC | interpro domains | IPR005775 | 6 | 1 | 18521 | 50 |
ATP1A2 |
1.609e-02 | -4.13 | Peptidase_S9B_N | interpro domains | IPR002469 | 6 | 1 | 18521 | 50 |
DPP10 |
1.609e-02 | -4.13 | EF-hand_dom_typ1 | interpro domains | IPR015153 | 6 | 1 | 18521 | 50 |
DTNA |
1.609e-02 | -4.13 | GLI-like | interpro domains | IPR043359 | 6 | 1 | 18521 | 50 |
GLIS3 |
1.614e-02 | -4.13 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | molecular function | GO:0047238 | 6 | 1 | 18094 | 49 |
CSGALNACT1 |
1.614e-02 | -4.13 | steroid hormone binding | molecular function | GO:1990239 | 6 | 1 | 18094 | 49 |
ATP1A2 |
1.614e-02 | -4.13 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 49 |
SLC4A4 |
1.615e-02 | -4.13 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 42 | 16828 | 48 |
NAV3,NKAIN3,SLC1A2,ABLIM1,TRPS1,GPC5,PARD3,NRCAM,TRPM3,NTRK2,EFEMP1,HIF3A,AQP4,MAP3K5,PTPRZ1,NEBL,BMPR1B,SORBS1,LSAMP,NRG3,RORA,GLIS3,PAMR1,CLU,CTNND2,DPP10,MACF1,ATP1A2,GPM6A,CPE,ATP13A4,SOX5,ADCY2,SPON1,TNIK,PITPNC1,NPAS3,HPSE2,RFX4,FMN2,MGAT4C,CSGALNACT1 |
1.624e-02 | -4.12 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 3 | 5310 | 18 |
AQP4,NTRK2,RORA |
1.629e-02 | -4.12 | MKRN2 (makorin ring finger protein 2) | protein interactions | 23609 | 380 | 4 | 19454 | 50 |
BMPR1B,PARD3,NRCAM,MACF1 |
1.634e-02 | -4.11 | system process | biological process | GO:0003008 | 2015 | 11 | 18204 | 49 |
SLC4A4,ATP1A2,PTPRZ1,AQP4,EFEMP1,ABLIM1,SLC1A2,NTRK2,CTNNA2,NRCAM,DTNA |
1.641e-02 | -4.11 | EF-hand_3 | pfam domains | PF09069 | 6 | 1 | 17795 | 49 |
DTNA |
1.641e-02 | -4.11 | Plectin | pfam domains | PF00681 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | DPPIV_N | pfam domains | PF00930 | 6 | 1 | 17795 | 49 |
DPP10 |
1.641e-02 | -4.11 | TSP1_spondin | pfam domains | PF19028 | 6 | 1 | 17795 | 49 |
SPON1 |
1.641e-02 | -4.11 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 49 |
GPC5 |
1.641e-02 | -4.11 | Adcy_cons_dom | pfam domains | PF06327 | 6 | 1 | 17795 | 49 |
ADCY2 |
1.641e-02 | -4.11 | SH3_10 | pfam domains | PF17902 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | GAS2 | pfam domains | PF02187 | 6 | 1 | 17795 | 49 |
MACF1 |
1.641e-02 | -4.11 | EF-hand_2 | pfam domains | PF09068 | 6 | 1 | 17795 | 49 |
DTNA |
1.652e-02 | -4.10 | peptide metabolic process | biological process | GO:0006518 | 73 | 2 | 18204 | 49 |
CPE,SLC1A2 |
1.654e-02 | -4.10 | MACF1 (microtubule actin crosslinking factor 1) | protein interactions | 23499 | 209 | 3 | 19454 | 50 |
RPS6KA2,NRCAM,TNIK |
1.670e-02 | -4.09 | KIF20A (kinesin family member 20A) | protein interactions | 10112 | 1044 | 7 | 19454 | 50 |
NEBL,MSI2,PARD3,MACF1,ABLIM1,RORA,NAV3 |
1.676e-02 | -4.09 | Htt (huntingtin) | protein interactions | 15194 | 77 | 2 | 19454 | 50 |
GPM6A,LSAMP |
1.692e-02 | -4.08 | breast-carcinoma-ductal_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductal_carcinoma | 14824 | 47 | 16828 | 48 |
TNIK,NPAS3,HPSE2,RBMS3,ATP1A2,SPON1,ADCY2,ATP13A4,GPM6A,SLC4A4,BMPR1B,DCLK2,NRG3,PAMR1,RORA,GPC5,TRPS1,NAV3,EFEMP1,NTRK2,TRPM3,PARD3,HIF3A,DTNA,MSI2,PITPNC1,MGAT4C,RFX4,FMN2,CTNND2,CLU,DPP10,MACF1,CPE,SOX5,NEBL,PTPRZ1,SORBS1,LSAMP,GLIS3,ABLIM1,SLC1A2,NKAIN3,RPS6KA2,NRCAM,AQP4,MAP3K5 |
1.695e-02 | -4.08 | positive regulation of protein localization to cell periphery | biological process | GO:1904377 | 74 | 2 | 18204 | 49 |
DPP10,SORBS1 |
1.696e-02 | -4.08 | CDK6 (cyclin dependent kinase 6) | protein interactions | 1021 | 211 | 3 | 19454 | 50 |
SORBS1,MAP3K5,SOX5 |
1.705e-02 | -4.07 | HAD_sf | interpro domains | IPR023214 | 74 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
1.709e-02 | -4.07 | human chr4q22.3 | chromosome location | human chr4q22.3 | 9 | 1 | 26134 | 50 |
BMPR1B |
1.717e-02 | -4.06 | Nedd4 (NEDD4 E3 ubiquitin protein ligase) | protein interactions | 25489 | 78 | 2 | 19454 | 50 |
NTRK2,BMPR1B |
1.717e-02 | -4.06 | ATP2B3 (ATPase plasma membrane Ca2+ transporting 3) | protein interactions | 492 | 78 | 2 | 19454 | 50 |
GPM6A,CSGALNACT1 |
1.717e-02 | -4.06 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 50 |
MSI2,SOX5 |
1.744e-02 | -4.05 | Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin | SMPDB pathways | SMP0000354 | 8 | 1 | 1369 | 3 |
ADCY2 |
1.767e-02 | -4.04 | mannosyl-glycoprotein N-acetylglucosaminyltransferases | BIOCYC pathways | META_PWY-7426 | 8 | 1 | 902 | 2 |
MGAT4C |
1.771e-02 | -4.03 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 9 | 18204 | 49 |
MAPK10,ADCY2,TNIK,RPS6KA2,DCLK2,MAP3K5,FMN2,NRG3,ATP1A2 |
1.782e-02 | -4.03 | regulation of axon extension | biological process | GO:0030516 | 76 | 2 | 18204 | 49 |
MACF1,NRCAM |
1.786e-02 | -4.03 | CYP4F8 (cytochrome P450 family 4 subfamily F member 8) | protein interactions | 11283 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | SOAT2 (sterol O-acyltransferase 2) | protein interactions | 8435 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | Smad7 (SMAD family member 7) | protein interactions | 17131 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Fbxo3 (F-box protein 3) | protein interactions | 57443 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | Smurf1 (SMAD specific E3 ubiquitin protein ligase 1) | protein interactions | 75788 | 7 | 1 | 19454 | 50 |
GLIS3 |
1.786e-02 | -4.03 | SASH3 (SAM and SH3 domain containing 3) | protein interactions | 54440 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | RGMB (repulsive guidance molecule BMP co-receptor b) | protein interactions | 285704 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | C8B (complement C8 beta chain) | protein interactions | 732 | 7 | 1 | 19454 | 50 |
CLU |
1.786e-02 | -4.03 | Uhmk1 (U2AF homology motif (UHM) kinase 1) | protein interactions | 16589 | 7 | 1 | 19454 | 50 |
BMPR1B |
1.786e-02 | -4.03 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 50 |
NPAS3 |
1.786e-02 | -4.03 | SLC16A5 (solute carrier family 16 member 5) | protein interactions | 9121 | 7 | 1 | 19454 | 50 |
PTPRZ1 |
1.786e-02 | -4.03 | C7 (complement C7) | protein interactions | 730 | 7 | 1 | 19454 | 50 |
CLU |
1.795e-02 | -4.02 | RSK activation | REACTOME pathways | R-HSA-444257 | 6 | 1 | 10285 | 31 |
RPS6KA2 |
1.795e-02 | -4.02 | Activation of TRKA receptors | REACTOME pathways | R-HSA-187015 | 6 | 1 | 10285 | 31 |
NTRK2 |
1.811e-02 | -4.01 | Dipeptidylpeptidase IV, N-terminal domain | gene3d domains | 2.140.10.30 | 6 | 1 | 14470 | 44 |
DPP10 |
1.811e-02 | -4.01 | Plakin repeat | gene3d domains | 3.90.1290.10 | 6 | 1 | 14470 | 44 |
MACF1 |
1.811e-02 | -4.01 | Gas2-like domain | gene3d domains | 3.30.920.20 | 6 | 1 | 14470 | 44 |
MACF1 |
1.820e-02 | -4.01 | catalytic activity, acting on a protein | molecular function | GO:0140096 | 2312 | 12 | 18094 | 49 |
NTRK2,CPE,MAPK10,TNIK,MGAT4C,DPP10,MAP3K5,PTPRZ1,RPS6KA2,DCLK2,EFEMP1,BMPR1B |
1.826e-02 | -4.00 | GFAP (glial fibrillary acidic protein) | protein interactions | 2670 | 217 | 3 | 19454 | 50 |
RORA,ABLIM1,NKAIN3 |
1.827e-02 | -4.00 | neural retina development | biological process | GO:0003407 | 77 | 2 | 18204 | 49 |
NTRK2,GPM6A |
1.827e-02 | -4.00 | positive regulation of axonogenesis | biological process | GO:0050772 | 77 | 2 | 18204 | 49 |
MACF1,NTRK2 |
1.858e-02 | -3.99 | skin-nipple-malignant_melanoma | COSMIC cancer mutations | skin-nipple-malignant_melanoma | 197 | 3 | 16828 | 48 |
FMN2,BMPR1B,EFEMP1 |
1.858e-02 | -3.99 | nipple | COSMIC cancer mutations | nipple | 197 | 3 | 16828 | 48 |
EFEMP1,BMPR1B,FMN2 |
1.860e-02 | -3.98 | acral_lentiginous | COSMIC cancer mutations | acral_lentiginous | 745 | 6 | 16828 | 48 |
MACF1,NAV3,NRG3,ATP13A4,PARD3,CSGALNACT1 |
1.869e-02 | -3.98 | chaperone-mediated autophagy | biological process | GO:0061684 | 7 | 1 | 18204 | 49 |
CLU |
1.869e-02 | -3.98 | interneuron migration from the subpallium to the cortex | biological process | GO:0021830 | 7 | 1 | 18204 | 49 |
NRG3 |
1.869e-02 | -3.98 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 49 |
CTNNA2 |
1.869e-02 | -3.98 | regulation of oligodendrocyte progenitor proliferation | biological process | GO:0070445 | 7 | 1 | 18204 | 49 |
PTPRZ1 |
1.869e-02 | -3.98 | post-embryonic eye morphogenesis | biological process | GO:0048050 | 7 | 1 | 18204 | 49 |
EFEMP1 |
1.869e-02 | -3.98 | chromosome movement towards spindle pole | biological process | GO:0051305 | 7 | 1 | 18204 | 49 |
FMN2 |
1.869e-02 | -3.98 | parallel actin filament bundle assembly | biological process | GO:0030046 | 7 | 1 | 18204 | 49 |
FMN2 |
1.872e-02 | -3.98 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 2 | 18204 | 49 |
NTRK2,SLC1A2 |
1.872e-02 | -3.98 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 2 | 18204 | 49 |
SLC4A4,SORBS1 |
1.872e-02 | -3.98 | regulation of glucose transmembrane transport | biological process | GO:0010827 | 78 | 2 | 18204 | 49 |
SLC1A2,SORBS1 |
1.875e-02 | -3.98 | Plakin_repeat_sf | interpro domains | IPR035915 | 7 | 1 | 18521 | 50 |
MACF1 |
1.875e-02 | -3.98 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 50 |
CTNNA2 |
1.875e-02 | -3.98 | GS_dom | interpro domains | IPR003605 | 7 | 1 | 18521 | 50 |
BMPR1B |
1.875e-02 | -3.98 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Plectin_repeat | interpro domains | IPR001101 | 7 | 1 | 18521 | 50 |
MACF1 |
1.875e-02 | -3.98 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 1 | 18521 | 50 |
SLC1A2 |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.875e-02 | -3.98 | Hud_Sxl_RNA | interpro domains | IPR002343 | 7 | 1 | 18521 | 50 |
RBMS3 |
1.875e-02 | -3.98 | Aquaporin_transptr | interpro domains | IPR034294 | 7 | 1 | 18521 | 50 |
AQP4 |
1.881e-02 | -3.97 | LBD domain binding | molecular function | GO:0050693 | 7 | 1 | 18094 | 49 |
SPON1 |
1.881e-02 | -3.97 | ribosomal protein S6 kinase activity | molecular function | GO:0004711 | 7 | 1 | 18094 | 49 |
RPS6KA2 |
1.881e-02 | -3.97 | P-type sodium:potassium-exchanging transporter activity | molecular function | GO:0005391 | 7 | 1 | 18094 | 49 |
ATP1A2 |
1.881e-02 | -3.97 | P-type sodium transporter activity | molecular function | GO:0008554 | 7 | 1 | 18094 | 49 |
ATP1A2 |
1.881e-02 | -3.97 | phosphatidic acid transfer activity | molecular function | GO:1990050 | 7 | 1 | 18094 | 49 |
PITPNC1 |
1.882e-02 | -3.97 | HAD-like_sf | interpro domains | IPR036412 | 78 | 2 | 18521 | 50 |
ATP1A2,ATP13A4 |
1.886e-02 | -3.97 | GSC (goosecoid homeobox) | protein interactions | 145258 | 82 | 2 | 19454 | 50 |
SOX5,TRPS1 |
1.893e-02 | -3.97 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 48 |
PTPRZ1,SLC4A4,GPC5,ADCY2,FMN2,SPON1,HPSE2,NRG3 |
1.897e-02 | -3.96 | human chr9p24.2 | chromosome location | human chr9p24.2 | 10 | 1 | 26134 | 50 |
GLIS3 |
1.899e-02 | -3.96 | PITRANSFER | prints domains | PR00391 | 5 | 1 | 5227 | 20 |
PITPNC1 |
1.899e-02 | -3.96 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 20 |
SLC4A4 |
1.909e-02 | -3.96 | eye development | biological process | GO:0001654 | 381 | 4 | 18204 | 49 |
BMPR1B,NTRK2,EFEMP1,GPM6A |
1.912e-02 | -3.96 | SDF | pfam domains | PF00375 | 7 | 1 | 17795 | 49 |
SLC1A2 |
1.912e-02 | -3.96 | TGF_beta_GS | pfam domains | PF08515 | 7 | 1 | 17795 | 49 |
BMPR1B |
1.917e-02 | -3.95 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 37 | 16828 | 48 |
FMN2,RFX4,CSGALNACT1,RBMS3,HPSE2,NPAS3,TNIK,ADCY2,CPE,ATP13A4,SOX5,SPON1,MACF1,ATP1A2,DPP10,CTNND2,RORA,GLIS3,PAMR1,LSAMP,NRG3,NEBL,PTPRZ1,SLC4A4,MAP3K5,MSI2,HIF3A,TRPM3,PARD3,EFEMP1,NTRK2,SLC1A2,RPS6KA2,NAV3,NKAIN3,GPC5,ABLIM1 |
1.917e-02 | -3.95 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 37 | 16828 | 48 |
HIF3A,MSI2,MAP3K5,ABLIM1,GPC5,SLC1A2,NAV3,RPS6KA2,NKAIN3,EFEMP1,NTRK2,TRPM3,PARD3,NRG3,LSAMP,PAMR1,RORA,GLIS3,SLC4A4,NEBL,PTPRZ1,ATP1A2,MACF1,SPON1,CPE,ADCY2,ATP13A4,SOX5,CTNND2,DPP10,HPSE2,RBMS3,CSGALNACT1,FMN2,RFX4,TNIK,NPAS3 |
1.918e-02 | -3.95 | leg | COSMIC cancer mutations | leg | 969 | 7 | 16828 | 48 |
PTPRZ1,NEBL,SLC4A4,FMN2,ATP13A4,HIF3A,NRG3 |
1.925e-02 | -3.95 | RHOB (ras homolog family member B) | protein interactions | 388 | 832 | 6 | 19454 | 50 |
ABLIM1,MACF1,PARD3,TNIK,DTNA,FMN2 |
1.961e-02 | -3.93 | Intracellular Signalling Through Histamine H2 Receptor and Histamine | SMPDB pathways | SMP0000335 | 9 | 1 | 1369 | 3 |
ADCY2 |
1.961e-02 | -3.93 | Excitatory Neural Signalling Through 5-HTR 6 and Serotonin | SMPDB pathways | SMP0000312 | 9 | 1 | 1369 | 3 |
ADCY2 |
1.961e-02 | -3.93 | Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone | SMPDB pathways | SMP0000333 | 9 | 1 | 1369 | 3 |
ADCY2 |
1.961e-02 | -3.93 | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | SMPDB pathways | SMP0000309 | 9 | 1 | 1369 | 3 |
ADCY2 |
1.961e-02 | -3.93 | Excitatory Neural Signalling Through 5-HTR 7 and Serotonin | SMPDB pathways | SMP0000311 | 9 | 1 | 1369 | 3 |
ADCY2 |
1.966e-02 | -3.93 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 48 |
CTNND2,MACF1,CPE,TRPM3 |
1.976e-02 | -3.92 | visual system development | biological process | GO:0150063 | 385 | 4 | 18204 | 49 |
GPM6A,BMPR1B,NTRK2,EFEMP1 |
1.985e-02 | -3.92 | MAPRE3 (microtubule associated protein RP/EB family member 3) | protein interactions | 22924 | 224 | 3 | 19454 | 50 |
MACF1,ABLIM1,GPM6A |
1.985e-02 | -3.92 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 2 | 18094 | 49 |
SLC1A2,SLC4A4 |
1.989e-02 | -3.92 | plasma membrane protein complex | cellular component | GO:0098797 | 600 | 5 | 19108 | 50 |
SORBS1,DPP10,CTNNA2,BMPR1B,ATP1A2 |
1.996e-02 | -3.91 | caveola | cellular component | GO:0005901 | 83 | 2 | 19108 | 50 |
SORBS1,ATP1A2 |
2.018e-02 | -3.90 | CFAP298 (cilia and flagella associated protein 298) | protein interactions | 56683 | 85 | 2 | 19454 | 50 |
FMN2,TRPS1 |
2.020e-02 | -3.90 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 8 | 19454 | 50 |
MSI2,NAV3,CLU,SOX5,TRPS1,GLIS3,LSAMP,MACF1 |
2.021e-02 | -3.90 | CH_dom | interpro domains | IPR001715 | 81 | 2 | 18521 | 50 |
NAV3,MACF1 |
2.023e-02 | -3.90 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 6 | 18204 | 49 |
ATP13A4,ATP1A2,TRPM3,SLC1A2,GPM6A,SLC4A4 |
2.038e-02 | -3.89 | Rasd2 (RASD family, member 2) | protein interactions | 75141 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | BMP15 (bone morphogenetic protein 15) | protein interactions | 9210 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.038e-02 | -3.89 | Melk (maternal embryonic leucine zipper kinase) | protein interactions | 17279 | 8 | 1 | 19454 | 50 |
MAP3K5 |
2.038e-02 | -3.89 | Chmp2a (charged multivesicular body protein 2A) | protein interactions | 68953 | 8 | 1 | 19454 | 50 |
CLU |
2.038e-02 | -3.89 | CCK (cholecystokinin) | protein interactions | 885 | 8 | 1 | 19454 | 50 |
CPE |
2.038e-02 | -3.89 | INSM1 (INSM transcriptional repressor 1) | protein interactions | 3642 | 8 | 1 | 19454 | 50 |
SORBS1 |
2.038e-02 | -3.89 | Rps27a (ribosomal protein S27A) | protein interactions | 78294 | 8 | 1 | 19454 | 50 |
BMPR1B |
2.051e-02 | -3.89 | GAR | prosite domains | PS51460 | 6 | 1 | 12186 | 42 |
MACF1 |
2.051e-02 | -3.89 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 42 |
GPC5 |
2.060e-02 | -3.88 | Tight junction | KEGG pathways | ko04530 | 170 | 3 | 7161 | 25 |
PARD3,MAPK10,MAP3K5 |
2.060e-02 | -3.88 | Tight junction | KEGG pathways | hsa04530 | 170 | 3 | 7161 | 25 |
MAPK10,PARD3,MAP3K5 |
2.063e-02 | -3.88 | FAM171A1 (family with sequence similarity 171 member A1) | protein interactions | 221061 | 86 | 2 | 19454 | 50 |
NTRK2,PARD3 |
2.063e-02 | -3.88 | SYNJ1 (synaptojanin 1) | protein interactions | 8867 | 86 | 2 | 19454 | 50 |
GPM6A,SORBS1 |
2.067e-02 | -3.88 | lobular_carcinoma | COSMIC cancer mutations | lobular_carcinoma | 763 | 6 | 16828 | 48 |
TNIK,RPS6KA2,NTRK2,BMPR1B,DCLK2,MAP3K5 |
2.067e-02 | -3.88 | breast-carcinoma-lobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-lobular_carcinoma | 763 | 6 | 16828 | 48 |
MAP3K5,DCLK2,NTRK2,BMPR1B,TNIK,RPS6KA2 |
2.068e-02 | -3.88 | CH_dom_sf | interpro domains | IPR036872 | 82 | 2 | 18521 | 50 |
MACF1,NAV3 |
2.072e-02 | -3.88 | Cysteine Rich Protein | gene3d domains | 2.10.110.10 | 73 | 2 | 14470 | 44 |
NEBL,ABLIM1 |
2.075e-02 | -3.88 | zonula adherens | cellular component | GO:0005915 | 8 | 1 | 19108 | 50 |
SORBS1 |
2.075e-02 | -3.88 | spherical high-density lipoprotein particle | cellular component | GO:0034366 | 8 | 1 | 19108 | 50 |
CLU |
2.075e-02 | -3.88 | HFE-transferrin receptor complex | cellular component | GO:1990712 | 8 | 1 | 19108 | 50 |
BMPR1B |
2.077e-02 | -3.87 | Glycosaminoglycan biosynthesis, chondroitin sulfate backbone | KEGG pathways | hsa_M00058 | 6 | 1 | 7161 | 25 |
CSGALNACT1 |
2.077e-02 | -3.87 | Glycosaminoglycan biosynthesis, chondroitin sulfate backbone | KEGG pathways | M00058 | 6 | 1 | 7161 | 25 |
CSGALNACT1 |
2.078e-02 | -3.87 | sensory system development | biological process | GO:0048880 | 391 | 4 | 18204 | 49 |
EFEMP1,NTRK2,BMPR1B,GPM6A |
2.078e-02 | -3.87 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 22 | 16828 | 48 |
NPAS3,PTPRZ1,BMPR1B,PITPNC1,TNIK,RORA,DCLK2,LSAMP,NTRK2,PARD3,TRPS1,ABLIM1,CLU,RPS6KA2,NAV3,CTNND2,MSI2,MAP3K5,SOX5,ATP13A4,ADCY2,HIF3A |
2.078e-02 | -3.87 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 22 | 16828 | 48 |
DCLK2,LSAMP,RORA,BMPR1B,PTPRZ1,HIF3A,MSI2,MAP3K5,ABLIM1,TRPS1,NAV3,RPS6KA2,NTRK2,PARD3,TNIK,NPAS3,PITPNC1,SOX5,ATP13A4,ADCY2,CTNND2,CLU |
2.091e-02 | -3.87 | NrCAM interactions | REACTOME pathways | R-HSA-447038 | 7 | 1 | 10285 | 31 |
NRCAM |
2.091e-02 | -3.87 | CREB phosphorylation | REACTOME pathways | R-HSA-199920 | 7 | 1 | 10285 | 31 |
RPS6KA2 |
2.091e-02 | -3.87 | Neurofascin interactions | REACTOME pathways | R-HSA-447043 | 7 | 1 | 10285 | 31 |
NRCAM |
2.103e-02 | -3.86 | VANGL1 (VANGL planar cell polarity protein 1) | protein interactions | 81839 | 229 | 3 | 19454 | 50 |
PARD3,NTRK2,RPS6KA2 |
2.109e-02 | -3.86 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 5 | 18094 | 49 |
SLC4A4,GPM6A,ATP1A2,TRPM3,SLC1A2 |
2.110e-02 | -3.86 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 1 | 14470 | 44 |
SLC1A2 |
2.121e-02 | -3.85 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 11 | 16828 | 48 |
SOX5,FMN2,CSGALNACT1,SPON1,ATP1A2,BMPR1B,TRPM3,PTPRZ1,DPP10,CTNND2,NAV3 |
2.121e-02 | -3.85 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 11 | 16828 | 48 |
DPP10,BMPR1B,TRPM3,PTPRZ1,CTNND2,NAV3,CSGALNACT1,SPON1,SOX5,FMN2,ATP1A2 |
2.125e-02 | -3.85 | HAD superfamily/HAD-like | gene3d domains | 3.40.50.1000 | 74 | 2 | 14470 | 44 |
ATP13A4,ATP1A2 |
2.126e-02 | -3.85 | skin-neck-malignant_melanoma | COSMIC cancer mutations | skin-neck-malignant_melanoma | 1223 | 8 | 16828 | 48 |
TRPM3,DPP10,CTNND2,GPC5,ATP13A4,ADCY2,MAP3K5,ATP1A2 |
2.130e-02 | -3.85 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 5 | 16828 | 48 |
NTRK2,MAP3K5,NRCAM,TNIK,RPS6KA2 |
2.134e-02 | -3.85 | regulation of L-glutamate import across plasma membrane | biological process | GO:0002036 | 8 | 1 | 18204 | 49 |
ATP1A2 |
2.134e-02 | -3.85 | insulin processing | biological process | GO:0030070 | 8 | 1 | 18204 | 49 |
CPE |
2.134e-02 | -3.85 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 49 |
NRG3 |
2.134e-02 | -3.85 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 49 |
CTNNA2 |
2.134e-02 | -3.85 | meiotic cytokinesis | biological process | GO:0033206 | 8 | 1 | 18204 | 49 |
FMN2 |
2.134e-02 | -3.85 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 1 | 18204 | 49 |
RORA |
2.134e-02 | -3.85 | dermatan sulfate proteoglycan biosynthetic process | biological process | GO:0050651 | 8 | 1 | 18204 | 49 |
CSGALNACT1 |
2.134e-02 | -3.85 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | biological process | GO:0015014 | 8 | 1 | 18204 | 49 |
CSGALNACT1 |
2.134e-02 | -3.85 | protein import | biological process | GO:0017038 | 8 | 1 | 18204 | 49 |
CLU |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.140e-02 | -3.84 | Adcy | interpro domains | IPR030672 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | Plakin | interpro domains | IPR043197 | 8 | 1 | 18521 | 50 |
MACF1 |
2.140e-02 | -3.84 | Villin_headpiece_dom_sf | interpro domains | IPR036886 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.140e-02 | -3.84 | Chond_GalNAc | interpro domains | IPR008428 | 8 | 1 | 18521 | 50 |
CSGALNACT1 |
2.140e-02 | -3.84 | TRPM_SLOG | interpro domains | IPR041491 | 8 | 1 | 18521 | 50 |
TRPM3 |
2.140e-02 | -3.84 | AC_N | interpro domains | IPR032628 | 8 | 1 | 18521 | 50 |
ADCY2 |
2.140e-02 | -3.84 | Villin_headpiece | interpro domains | IPR003128 | 8 | 1 | 18521 | 50 |
ABLIM1 |
2.146e-02 | -3.84 | BMP receptor activity | molecular function | GO:0098821 | 8 | 1 | 18094 | 49 |
BMPR1B |
2.146e-02 | -3.84 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 49 |
ATP1A2 |
2.146e-02 | -3.84 | P-type potassium transmembrane transporter activity | molecular function | GO:0008556 | 8 | 1 | 18094 | 49 |
ATP1A2 |
2.147e-02 | -3.84 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 23 | 18204 | 49 |
CSGALNACT1,CTNNA2,CLU,NEBL,SORBS1,NRG3,FMN2,DCLK2,TRPM3,RFX4,MACF1,TNIK,CTNND2,PTPRZ1,AQP4,NRCAM,SLC1A2,GPM6A,HPSE2,BMPR1B,PARD3,ABLIM1,PITPNC1 |
2.151e-02 | -3.84 | regulation of sodium ion transport | biological process | GO:0002028 | 84 | 2 | 18204 | 49 |
NKAIN3,ATP1A2 |
2.151e-02 | -3.84 | peripheral nervous system development | biological process | GO:0007422 | 84 | 2 | 18204 | 49 |
NTRK2,PARD3 |
2.151e-02 | -3.84 | proteoglycan metabolic process | biological process | GO:0006029 | 84 | 2 | 18204 | 49 |
CSGALNACT1,BMPR1B |
2.153e-02 | -3.84 | RAP2A (RAP2A, member of RAS oncogene family) | protein interactions | 5911 | 88 | 2 | 19454 | 50 |
TNIK,BMPR1B |
2.157e-02 | -3.84 | FYN (FYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 2534 | 414 | 4 | 19454 | 50 |
NTRK2,RPS6KA2,PTPRZ1,CTNND2 |
2.175e-02 | -3.83 | PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) | protein interactions | 5563 | 232 | 3 | 19454 | 50 |
MAP3K5,PARD3,SLC4A4 |
2.177e-02 | -3.83 | Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin | SMPDB pathways | SMP0000338 | 10 | 1 | 1369 | 3 |
ADCY2 |
2.182e-02 | -3.82 | AC_N | pfam domains | PF16214 | 8 | 1 | 17795 | 49 |
ADCY2 |
2.182e-02 | -3.82 | VHP | pfam domains | PF02209 | 8 | 1 | 17795 | 49 |
ABLIM1 |
2.182e-02 | -3.82 | DCX | pfam domains | PF03607 | 8 | 1 | 17795 | 49 |
DCLK2 |
2.182e-02 | -3.82 | CHGN | pfam domains | PF05679 | 8 | 1 | 17795 | 49 |
CSGALNACT1 |
2.182e-02 | -3.82 | LSDAT_euk | pfam domains | PF18139 | 8 | 1 | 17795 | 49 |
TRPM3 |
2.185e-02 | -3.82 | MAPK cascade | biological process | GO:0000165 | 222 | 3 | 18204 | 49 |
TNIK,MAP3K5,MAPK10 |
2.190e-02 | -3.82 | Axon guidance | KEGG pathways | hsa04360 | 174 | 3 | 7161 | 25 |
PARD3,ABLIM1,BMPR1B |
2.190e-02 | -3.82 | Axon guidance | KEGG pathways | ko04360 | 174 | 3 | 7161 | 25 |
ABLIM1,BMPR1B,PARD3 |
2.199e-02 | -3.82 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 49 |
BMPR1B,SOX5 |
2.202e-02 | -3.82 | neck | COSMIC cancer mutations | neck | 1231 | 8 | 16828 | 48 |
ATP13A4,MAP3K5,ADCY2,ATP1A2,TRPM3,DPP10,CTNND2,GPC5 |
2.203e-02 | -3.82 | GAS2 | smart domains | SM00243 | 6 | 1 | 9717 | 36 |
MACF1 |
2.203e-02 | -3.82 | SH3_domain | interpro domains | IPR001452 | 222 | 3 | 18521 | 50 |
SORBS1,MACF1,NEBL |
2.246e-02 | -3.80 | CTDSPL (CTD small phosphatase like) | protein interactions | 10217 | 90 | 2 | 19454 | 50 |
DTNA,FMN2 |
2.247e-02 | -3.80 | central nervous system neuron development | biological process | GO:0021954 | 86 | 2 | 18204 | 49 |
NTRK2,DCLK2 |
2.272e-02 | -3.78 | human chr11p15.2 | chromosome location | human chr11p15.2 | 12 | 1 | 26134 | 50 |
SPON1 |
2.272e-02 | -3.78 | human chr3p24.1 | chromosome location | human chr3p24.1 | 12 | 1 | 26134 | 50 |
RBMS3 |
2.275e-02 | -3.78 | ACTIVIN2R | prints domains | PR00653 | 6 | 1 | 5227 | 20 |
BMPR1B |
2.290e-02 | -3.78 | NEGR1 (neuronal growth regulator 1) | protein interactions | 257194 | 9 | 1 | 19454 | 50 |
LSAMP |
2.290e-02 | -3.78 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 50 |
CTNNA2 |
2.290e-02 | -3.78 | LSAMP (limbic system associated membrane protein) | protein interactions | 4045 | 9 | 1 | 19454 | 50 |
LSAMP |
2.290e-02 | -3.78 | BIN2 (bridging integrator 2) | protein interactions | 51411 | 9 | 1 | 19454 | 50 |
EFEMP1 |
2.290e-02 | -3.78 | ZNF778 (zinc finger protein 778) | protein interactions | 197320 | 9 | 1 | 19454 | 50 |
EFEMP1 |
2.290e-02 | -3.78 | VEPH1 (ventricular zone expressed PH domain containing 1) | protein interactions | 79674 | 9 | 1 | 19454 | 50 |
BMPR1B |
2.290e-02 | -3.78 | CUX2 (cut like homeobox 2) | protein interactions | 23316 | 9 | 1 | 19454 | 50 |
NAV3 |
2.290e-02 | -3.78 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 50 |
MACF1 |
2.292e-02 | -3.78 | SOS1 (SOS Ras/Rac guanine nucleotide exchange factor 1) | protein interactions | 6654 | 91 | 2 | 19454 | 50 |
TNIK,SORBS1 |
2.292e-02 | -3.78 | THUMPD3 (THUMP domain containing 3) | protein interactions | 25917 | 91 | 2 | 19454 | 50 |
RPS6KA2,CTNND2 |
2.292e-02 | -3.78 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 2 | 19454 | 50 |
PARD3,NAV3 |
2.316e-02 | -3.77 | Epithelial cell signaling in Helicobacter pylori infection | KEGG pathways | hsa05120 | 68 | 2 | 7161 | 25 |
PTPRZ1,MAPK10 |
2.316e-02 | -3.77 | Epithelial cell signaling in Helicobacter pylori infection | KEGG pathways | ko05120 | 68 | 2 | 7161 | 25 |
MAPK10,PTPRZ1 |
2.322e-02 | -3.76 | single-stranded RNA binding | molecular function | GO:0003727 | 87 | 2 | 18094 | 49 |
RBMS3,MSI2 |
2.331e-02 | -3.76 | flotillin complex | cellular component | GO:0016600 | 9 | 1 | 19108 | 50 |
SORBS1 |
2.331e-02 | -3.76 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 1 | 19108 | 50 |
AQP4 |
2.341e-02 | -3.75 | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 48 |
MAP3K5,NTRK2,RPS6KA2,TNIK |
2.341e-02 | -3.75 | salivary_gland-carcinoma | COSMIC cancer mutations | salivary_gland-carcinoma | 383 | 4 | 16828 | 48 |
TNIK,RPS6KA2,NTRK2,MAP3K5 |
2.341e-02 | -3.75 | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 48 |
RPS6KA2,TNIK,MAP3K5,NTRK2 |
2.341e-02 | -3.75 | upper_aerodigestive_tract-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-carcinoma | 383 | 4 | 16828 | 48 |
TNIK,RPS6KA2,NTRK2,MAP3K5 |
2.341e-02 | -3.75 | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-lymph_node-carcinoma-adenoid_cystic_carcinoma | 383 | 4 | 16828 | 48 |
NTRK2,MAP3K5,TNIK,RPS6KA2 |
2.341e-02 | -3.75 | skeletal system morphogenesis | biological process | GO:0048705 | 228 | 3 | 18204 | 49 |
CSGALNACT1,SOX5,BMPR1B |
2.366e-02 | -3.74 | TRAF6 (TNF receptor associated factor 6) | protein interactions | 7189 | 426 | 4 | 19454 | 50 |
TNIK,MAP3K5,NTRK2,BMPR1B |
2.378e-02 | -3.74 | magnesium ion binding | molecular function | GO:0000287 | 228 | 3 | 18094 | 49 |
RPS6KA2,MAP3K5,ADCY2 |
2.387e-02 | -3.74 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 31 |
GPC5 |
2.387e-02 | -3.74 | ARHGEF6 (Rac/Cdc42 guanine nucleotide exchange factor 6) | protein interactions | 9459 | 93 | 2 | 19454 | 50 |
BMPR1B,ABLIM1 |
2.387e-02 | -3.74 | parotid | COSMIC cancer mutations | parotid | 578 | 5 | 16828 | 48 |
NRCAM,MAP3K5,NTRK2,RPS6KA2,TNIK |
2.388e-02 | -3.73 | GS | prosite domains | PS51256 | 7 | 1 | 12186 | 42 |
BMPR1B |
2.388e-02 | -3.73 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 1 | 12186 | 42 |
SLC1A2 |
2.388e-02 | -3.73 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 1 | 12186 | 42 |
SLC1A2 |
2.391e-02 | -3.73 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-NK-T_cell_lymphoma | 217 | 3 | 16828 | 48 |
MGAT4C,DTNA,RFX4 |
2.393e-02 | -3.73 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 3 |
RORA |
2.397e-02 | -3.73 | microglial cell proliferation | biological process | GO:0061518 | 9 | 1 | 18204 | 49 |
CLU |
2.397e-02 | -3.73 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 49 |
ATP1A2 |
2.397e-02 | -3.73 | macrophage proliferation | biological process | GO:0061517 | 9 | 1 | 18204 | 49 |
CLU |
2.397e-02 | -3.73 | polyamine transmembrane transport | biological process | GO:1902047 | 9 | 1 | 18204 | 49 |
ATP13A4 |
2.397e-02 | -3.73 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.397e-02 | -3.73 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 49 |
CTNNA2 |
2.400e-02 | -3.73 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 48 |
CPE,TRPM3,MACF1,CTNND2 |
2.401e-02 | -3.73 | ERBIN (erbb2 interacting protein) | protein interactions | 55914 | 241 | 3 | 19454 | 50 |
CTNND2,NTRK2,PARD3 |
2.401e-02 | -3.73 | Calponin-like domain | gene3d domains | 1.10.418.10 | 79 | 2 | 14470 | 44 |
MACF1,NAV3 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.404e-02 | -3.73 | Doublecortin_dom | interpro domains | IPR003533 | 9 | 1 | 18521 | 50 |
DCLK2 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.404e-02 | -3.73 | Peptidase_S9 | interpro domains | IPR001375 | 9 | 1 | 18521 | 50 |
DPP10 |
2.404e-02 | -3.73 | Activin_recp | interpro domains | IPR000472 | 9 | 1 | 18521 | 50 |
BMPR1B |
2.407e-02 | -3.73 | Villin headpiece domain | gene3d domains | 1.10.950.10 | 8 | 1 | 14470 | 44 |
ABLIM1 |
2.435e-02 | -3.72 | WWC1 (WW and C2 domain containing 1) | protein interactions | 23286 | 94 | 2 | 19454 | 50 |
ABLIM1,TNIK |
2.435e-02 | -3.72 | TTR (transthyretin) | protein interactions | 7276 | 94 | 2 | 19454 | 50 |
CLU,CTNND2 |
2.448e-02 | -3.71 | Ion channel transport | REACTOME pathways | R-HSA-983712 | 209 | 3 | 10285 | 31 |
ATP1A2,TRPM3,ATP13A4 |
2.449e-02 | -3.71 | connective tissue development | biological process | GO:0061448 | 232 | 3 | 18204 | 49 |
BMPR1B,SOX5,CSGALNACT1 |
2.452e-02 | -3.71 | Activin_recp | pfam domains | PF01064 | 9 | 1 | 17795 | 49 |
BMPR1B |
2.452e-02 | -3.71 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 49 |
SLC4A4 |
2.452e-02 | -3.71 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 49 |
RFX4 |
2.452e-02 | -3.71 | Peptidase_S9 | pfam domains | PF00326 | 9 | 1 | 17795 | 49 |
DPP10 |
2.464e-02 | -3.70 | nucleotide binding | molecular function | GO:0000166 | 2128 | 11 | 18094 | 49 |
ATP13A4,RPS6KA2,MAP3K5,ATP1A2,TNIK,NTRK2,MAPK10,ADCY2,BMPR1B,NAV3,DCLK2 |
2.468e-02 | -3.70 | CH | smart domains | SM00033 | 66 | 2 | 9717 | 36 |
MACF1,NAV3 |
2.470e-02 | -3.70 | EGF-like_dom | interpro domains | IPR000742 | 232 | 3 | 18521 | 50 |
EFEMP1,PAMR1,NRG3 |
2.472e-02 | -3.70 | nucleoside phosphate binding | molecular function | GO:1901265 | 2129 | 11 | 18094 | 49 |
MAPK10,NTRK2,ADCY2,MAP3K5,RPS6KA2,ATP13A4,TNIK,ATP1A2,DCLK2,NAV3,BMPR1B |
2.480e-02 | -3.70 | LIM_DOMAIN_1 | prosite domains | PS00478 | 71 | 2 | 12186 | 42 |
ABLIM1,NEBL |
2.480e-02 | -3.70 | LIM_DOMAIN_2 | prosite domains | PS50023 | 71 | 2 | 12186 | 42 |
ABLIM1,NEBL |
2.531e-02 | -3.68 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 48 |
CTNND2,MACF1,CPE,ADCY2,TRPM3 |
2.537e-02 | -3.67 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 10 | 19454 | 50 |
ABLIM1,TRPS1,NRG3,MACF1,BMPR1B,PARD3,MSI2,RPS6KA2,DTNA,DCLK2 |
2.541e-02 | -3.67 | CALB2 (calbindin 2) | protein interactions | 794 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | SERPINB11 (serpin family B member 11) | protein interactions | 89778 | 10 | 1 | 19454 | 50 |
CPE |
2.541e-02 | -3.67 | Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) | protein interactions | 66313 | 10 | 1 | 19454 | 50 |
GLIS3 |
2.541e-02 | -3.67 | Vbp1 (von Hippel-Lindau binding protein 1) | protein interactions | 22327 | 10 | 1 | 19454 | 50 |
ABLIM1 |
2.541e-02 | -3.67 | SLC8A2 (solute carrier family 8 member A2) | protein interactions | 6543 | 10 | 1 | 19454 | 50 |
GPM6A |
2.541e-02 | -3.67 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 50 |
PTPRZ1 |
2.541e-02 | -3.67 | GSG1 (germ cell associated 1) | protein interactions | 83445 | 10 | 1 | 19454 | 50 |
PITPNC1 |
2.548e-02 | -3.67 | protein tetramerization | biological process | GO:0051262 | 92 | 2 | 18204 | 49 |
AQP4,TRPM3 |
2.566e-02 | -3.66 | GS | smart domains | SM00467 | 7 | 1 | 9717 | 36 |
BMPR1B |
2.566e-02 | -3.66 | PLEC | smart domains | SM00250 | 7 | 1 | 9717 | 36 |
MACF1 |
2.568e-02 | -3.66 | ATP hydrolysis activity | molecular function | GO:0016887 | 415 | 4 | 18094 | 49 |
CLU,ATP13A4,NAV3,ATP1A2 |
2.581e-02 | -3.66 | BTG3 (BTG anti-proliferation factor 3) | protein interactions | 10950 | 97 | 2 | 19454 | 50 |
DCLK2,CLU |
2.587e-02 | -3.65 | perineuronal net | cellular component | GO:0072534 | 10 | 1 | 19108 | 50 |
PTPRZ1 |
2.595e-02 | -3.65 | pancreas-other-adenoma | COSMIC cancer mutations | pancreas-other-adenoma | 224 | 3 | 16828 | 48 |
BMPR1B,NAV3,CTNND2 |
2.599e-02 | -3.65 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 5 | 18204 | 49 |
EFEMP1,NTRK2,SORBS1,BMPR1B,NRG3 |
2.599e-02 | -3.65 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 2 | 18204 | 49 |
NRCAM,MACF1 |
2.609e-02 | -3.65 | Lactose Degradation | SMPDB pathways | SMP0000457 | 12 | 1 | 1369 | 3 |
ATP1A2 |
2.609e-02 | -3.65 | Lactose Intolerance | SMPDB pathways | SMP0000458 | 12 | 1 | 1369 | 3 |
ATP1A2 |
2.616e-02 | -3.64 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 49 |
TNIK,MACF1,DPP10 |
2.625e-02 | -3.64 | NK-T_cell_lymphoma | COSMIC cancer mutations | NK-T_cell_lymphoma | 225 | 3 | 16828 | 48 |
DTNA,MGAT4C,RFX4 |
2.630e-02 | -3.64 | Toll Like Receptor 5 (TLR5) Cascade | REACTOME pathways | R-HSA-168176 | 84 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
2.630e-02 | -3.64 | MyD88 cascade initiated on plasma membrane | REACTOME pathways | R-HSA-975871 | 84 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
2.630e-02 | -3.64 | Toll Like Receptor 10 (TLR10) Cascade | REACTOME pathways | R-HSA-168142 | 84 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
2.631e-02 | -3.64 | FRAS1 (Fraser extracellular matrix complex subunit 1) | protein interactions | 80144 | 98 | 2 | 19454 | 50 |
HPSE2,MGAT4C |
2.631e-02 | -3.64 | DMD (dystrophin) | protein interactions | 1756 | 98 | 2 | 19454 | 50 |
MAP3K5,DTNA |
2.631e-02 | -3.64 | DNAAF2 (dynein axonemal assembly factor 2) | protein interactions | 55172 | 98 | 2 | 19454 | 50 |
GPM6A,LSAMP |
2.645e-02 | -3.63 | dermatan sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6571 | 12 | 1 | 902 | 2 |
CSGALNACT1 |
2.647e-02 | -3.63 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 5 | 16828 | 48 |
TRPS1,MACF1,CTNND2,SPON1,MAP3K5 |
2.649e-02 | -3.63 | EDTRNSPORT | prints domains | PR00173 | 7 | 1 | 5227 | 20 |
SLC1A2 |
2.649e-02 | -3.63 | HUDSXLRNA | prints domains | PR00961 | 7 | 1 | 5227 | 20 |
RBMS3 |
2.660e-02 | -3.63 | cellular response to cocaine | biological process | GO:0071314 | 10 | 1 | 18204 | 49 |
SLC1A2 |
2.660e-02 | -3.63 | cellular response to brain-derived neurotrophic factor stimulus | biological process | GO:1990416 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential migration | biological process | GO:0021826 | 10 | 1 | 18204 | 49 |
NRG3 |
2.660e-02 | -3.63 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | cAMP biosynthetic process | biological process | GO:0006171 | 10 | 1 | 18204 | 49 |
ADCY2 |
2.660e-02 | -3.63 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 49 |
SOX5 |
2.660e-02 | -3.63 | establishment of centrosome localization | biological process | GO:0051660 | 10 | 1 | 18204 | 49 |
PARD3 |
2.660e-02 | -3.63 | retinal rod cell development | biological process | GO:0046548 | 10 | 1 | 18204 | 49 |
NTRK2 |
2.660e-02 | -3.63 | substrate-independent telencephalic tangential interneuron migration | biological process | GO:0021843 | 10 | 1 | 18204 | 49 |
NRG3 |
2.666e-02 | -3.62 | Ig_sub2 | interpro domains | IPR003598 | 239 | 3 | 18521 | 50 |
NTRK2,LSAMP,NRCAM |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | MIP_CS | interpro domains | IPR022357 | 10 | 1 | 18521 | 50 |
AQP4 |
2.668e-02 | -3.62 | Doublecortin_dom_sf | interpro domains | IPR036572 | 10 | 1 | 18521 | 50 |
DCLK2 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.676e-02 | -3.62 | phosphatidylinositol transfer activity | molecular function | GO:0008526 | 10 | 1 | 18094 | 49 |
PITPNC1 |
2.676e-02 | -3.62 | neurotrophin binding | molecular function | GO:0043121 | 10 | 1 | 18094 | 49 |
NTRK2 |
2.676e-02 | -3.62 | polyamine transmembrane transporter activity | molecular function | GO:0015203 | 10 | 1 | 18094 | 49 |
ATP13A4 |
2.680e-02 | -3.62 | ZFHX3 (zinc finger homeobox 3) | protein interactions | 463 | 99 | 2 | 19454 | 50 |
TRPS1,SOX5 |
2.681e-02 | -3.62 | Terminal pathway of complement | REACTOME pathways | R-HSA-166665 | 9 | 1 | 10285 | 31 |
CLU |
2.688e-02 | -3.62 | Diseases of glycosylation | REACTOME pathways | R-HSA-3781865 | 85 | 2 | 10285 | 31 |
SPON1,GPC5 |
2.693e-02 | -3.61 | NCK2 (NCK adaptor protein 2) | protein interactions | 8440 | 252 | 3 | 19454 | 50 |
NTRK2,SORBS1,TNIK |
2.697e-02 | -3.61 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 3 | 10285 | 31 |
ADCY2,RPS6KA2,SLC1A2 |
2.702e-02 | -3.61 | cell motility | biological process | GO:0048870 | 1101 | 7 | 18204 | 49 |
NTRK2,GPM6A,FMN2,NRCAM,CTNNA2,NRG3,GPC5 |
2.704e-02 | -3.61 | Doublecortin domain | gene3d domains | 3.10.20.230 | 9 | 1 | 14470 | 44 |
DCLK2 |
2.711e-02 | -3.61 | Thyroid hormone synthesis | KEGG pathways | hsa04918 | 74 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
2.711e-02 | -3.61 | Thyroid hormone synthesis | KEGG pathways | ko04918 | 74 | 2 | 7161 | 25 |
ADCY2,ATP1A2 |
2.720e-02 | -3.60 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 49 |
SLC4A4 |
2.720e-02 | -3.60 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 49 |
NPAS3 |
2.721e-02 | -3.60 | PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) | protein interactions | 5562 | 253 | 3 | 19454 | 50 |
SLC4A4,RPS6KA2,CPE |
2.725e-02 | -3.60 | GATA_ZN_FINGER_1 | prosite domains | PS00344 | 8 | 1 | 12186 | 42 |
TRPS1 |
2.725e-02 | -3.60 | HP | prosite domains | PS51089 | 8 | 1 | 12186 | 42 |
ABLIM1 |
2.731e-02 | -3.60 | ATP4A (ATPase H+/K+ transporting subunit alpha) | protein interactions | 495 | 100 | 2 | 19454 | 50 |
GPM6A,ATP1A2 |
2.731e-02 | -3.60 | EDEM2 (ER degradation enhancing alpha-mannosidase like protein 2) | protein interactions | 55741 | 100 | 2 | 19454 | 50 |
HPSE2,CLU |
2.758e-02 | -3.59 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 5 | 18204 | 49 |
ATP1A2,TRPM3,ATP13A4,SLC4A4,GPM6A |
2.779e-02 | -3.58 | Gastric acid secretion | KEGG pathways | ko04971 | 75 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
2.779e-02 | -3.58 | Gastric acid secretion | KEGG pathways | hsa04971 | 75 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
2.780e-02 | -3.58 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 49 |
NTRK2,EFEMP1,SORBS1,NRG3 |
2.783e-02 | -3.58 | NGF signalling via TRKA from the plasma membrane | REACTOME pathways | R-HSA-187037 | 387 | 4 | 10285 | 31 |
RPS6KA2,NRG3,NTRK2,ADCY2 |
2.787e-02 | -3.58 | ATPase-coupled transmembrane transporter activity | molecular function | GO:0042626 | 96 | 2 | 18094 | 49 |
ATP13A4,ATP1A2 |
2.788e-02 | -3.58 | regulation of neuron apoptotic process | biological process | GO:0043523 | 244 | 3 | 18204 | 49 |
PTPRZ1,NTRK2,CLU |
2.792e-02 | -3.58 | Wipi2 (WD repeat domain, phosphoinositide interacting 2) | protein interactions | 74781 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | AQP5 (aquaporin 5) | protein interactions | 362 | 11 | 1 | 19454 | 50 |
ATP1A2 |
2.792e-02 | -3.58 | Cobll1 (Cobl-like 1) | protein interactions | 319876 | 11 | 1 | 19454 | 50 |
ABLIM1 |
2.792e-02 | -3.58 | Batf3 (basic leucine zipper transcription factor, ATF-like 3) | protein interactions | 381319 | 11 | 1 | 19454 | 50 |
MACF1 |
2.792e-02 | -3.58 | NTS (neurotensin) | protein interactions | 4922 | 11 | 1 | 19454 | 50 |
CPE |
2.792e-02 | -3.58 | SYN3 (synapsin III) | protein interactions | 8224 | 11 | 1 | 19454 | 50 |
GPM6A |
2.792e-02 | -3.58 | ADCY5 (adenylate cyclase 5) | protein interactions | 111 | 11 | 1 | 19454 | 50 |
ADCY2 |
2.792e-02 | -3.58 | MSRB1 (methionine sulfoxide reductase B1) | protein interactions | 51734 | 11 | 1 | 19454 | 50 |
CLU |
2.810e-02 | -3.57 | positive regulation of JNK cascade | biological process | GO:0046330 | 97 | 2 | 18204 | 49 |
TNIK,MAP3K5 |
2.814e-02 | -3.57 | PROKAR_LIPOPROTEIN | prosite domains | PS51257 | 76 | 2 | 12186 | 42 |
CPE,GLIS3 |
2.822e-02 | -3.57 | extrinsic component of plasma membrane | cellular component | GO:0019897 | 100 | 2 | 19108 | 50 |
DTNA,CTNNA2 |
2.824e-02 | -3.57 | Trehalose Degradation | SMPDB pathways | SMP0000467 | 13 | 1 | 1369 | 3 |
ATP1A2 |
2.826e-02 | -3.57 | LIM | smart domains | SM00132 | 71 | 2 | 9717 | 36 |
NEBL,ABLIM1 |
2.832e-02 | -3.56 | human chr8q12.3 | chromosome location | human chr8q12.3 | 15 | 1 | 26134 | 50 |
NKAIN3 |
2.832e-02 | -3.56 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 50 |
NEBL |
2.832e-02 | -3.56 | human chr12q21.2 | chromosome location | human chr12q21.2 | 15 | 1 | 26134 | 50 |
NAV3 |
2.832e-02 | -3.56 | KRTAP6-1 (keratin associated protein 6-1) | protein interactions | 337966 | 102 | 2 | 19454 | 50 |
EFEMP1,GLIS3 |
2.832e-02 | -3.56 | TMPRSS13 (transmembrane serine protease 13) | protein interactions | 84000 | 102 | 2 | 19454 | 50 |
SPON1,CPE |
2.842e-02 | -3.56 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 50 |
PTPRZ1 |
2.842e-02 | -3.56 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 49 |
SLC1A2,RPS6KA2,NTRK2,DTNA |
2.847e-02 | -3.56 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 3 | 18204 | 49 |
MACF1,NTRK2,PTPRZ1 |
2.853e-02 | -3.56 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 48 |
MACF1,CTNND2,CPE,ADCY2,TRPM3 |
2.884e-02 | -3.55 | ZDHHC5 (zinc finger DHHC-type palmitoyltransferase 5) | protein interactions | 25921 | 103 | 2 | 19454 | 50 |
NTRK2,PARD3 |
2.884e-02 | -3.55 | RAB6B (RAB6B, member RAS oncogene family) | protein interactions | 51560 | 103 | 2 | 19454 | 50 |
BMPR1B,GPM6A |
2.884e-02 | -3.55 | CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) | protein interactions | 55454 | 103 | 2 | 19454 | 50 |
MGAT4C,CSGALNACT1 |
2.891e-02 | -3.54 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 7 | 18094 | 49 |
AQP4,TRPM3,ATP13A4,SLC1A2,GPM6A,SLC4A4,ATP1A2 |
2.917e-02 | -3.53 | bone morphogenesis | biological process | GO:0060349 | 99 | 2 | 18204 | 49 |
BMPR1B,CSGALNACT1 |
2.920e-02 | -3.53 | FGFR4 (fibroblast growth factor receptor 4) | protein interactions | 2264 | 455 | 4 | 19454 | 50 |
SORBS1,MAP3K5,TNIK,ABLIM1 |
2.922e-02 | -3.53 | establishment or maintenance of transmembrane electrochemical gradient | biological process | GO:0010248 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | antral ovarian follicle growth | biological process | GO:0001547 | 11 | 1 | 18204 | 49 |
BMPR1B |
2.922e-02 | -3.53 | heparin biosynthetic process | biological process | GO:0030210 | 11 | 1 | 18204 | 49 |
CSGALNACT1 |
2.922e-02 | -3.53 | ectodermal placode formation | biological process | GO:0060788 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | ectodermal placode morphogenesis | biological process | GO:0071697 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | polyamine transport | biological process | GO:0015846 | 11 | 1 | 18204 | 49 |
ATP13A4 |
2.922e-02 | -3.53 | lactone metabolic process | biological process | GO:1901334 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 1 | 18204 | 49 |
SLC1A2 |
2.922e-02 | -3.53 | endothelial cell apoptotic process | biological process | GO:0072577 | 11 | 1 | 18204 | 49 |
MAP3K5 |
2.922e-02 | -3.53 | pyramidal neuron development | biological process | GO:0021860 | 11 | 1 | 18204 | 49 |
DCLK2 |
2.922e-02 | -3.53 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 49 |
NTRK2 |
2.922e-02 | -3.53 | negative regulation of neuron migration | biological process | GO:2001223 | 11 | 1 | 18204 | 49 |
NRG3 |
2.922e-02 | -3.53 | L-ascorbic acid metabolic process | biological process | GO:0019852 | 11 | 1 | 18204 | 49 |
ATP1A2 |
2.922e-02 | -3.53 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 1 | 18204 | 49 |
SLC1A2 |
2.927e-02 | -3.53 | VHP | smart domains | SM00153 | 8 | 1 | 9717 | 36 |
ABLIM1 |
2.927e-02 | -3.53 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 4 | 18204 | 49 |
RORA,NRCAM,HIF3A,NTRK2 |
2.931e-02 | -3.53 | Tyr_kinase_rcpt_2_CS | interpro domains | IPR002011 | 11 | 1 | 18521 | 50 |
NTRK2 |
2.934e-02 | -3.53 | nervous system process | biological process | GO:0050877 | 1376 | 8 | 18204 | 49 |
EFEMP1,PTPRZ1,AQP4,ABLIM1,NTRK2,NRCAM,CTNNA2,ATP1A2 |
2.940e-02 | -3.53 | JUN kinase kinase kinase activity | molecular function | GO:0004706 | 11 | 1 | 18094 | 49 |
MAP3K5 |
2.940e-02 | -3.53 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 49 |
SLC1A2 |
2.972e-02 | -3.52 | EGF_3 | prosite domains | PS50026 | 196 | 3 | 12186 | 42 |
PAMR1,EFEMP1,NRG3 |
2.975e-02 | -3.51 | Adenylate cyclase activating pathway | REACTOME pathways | R-HSA-170660 | 10 | 1 | 10285 | 31 |
ADCY2 |
2.975e-02 | -3.51 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 31 |
SLC4A4 |
2.975e-02 | -3.51 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 31 |
NRG3 |
2.975e-02 | -3.51 | Activation of the AP-1 family of transcription factors | REACTOME pathways | R-HSA-450341 | 10 | 1 | 10285 | 31 |
MAPK10 |
2.988e-02 | -3.51 | BEND3 (BEN domain containing 3) | protein interactions | 57673 | 105 | 2 | 19454 | 50 |
TRPS1,TNIK |
2.988e-02 | -3.51 | PAS_11 | pfam domains | PF14598 | 11 | 1 | 17795 | 49 |
HIF3A |
3.000e-02 | -3.51 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 44 |
SLC4A4 |
3.010e-02 | -3.50 | SH3 Domains | gene3d domains | 2.30.30.40 | 223 | 3 | 14470 | 44 |
MACF1,SORBS1,NEBL |
3.022e-02 | -3.50 | GATAZNFINGER | prints domains | PR00619 | 8 | 1 | 5227 | 20 |
TRPS1 |
3.027e-02 | -3.50 | regulation of glucose metabolic process | biological process | GO:0010906 | 101 | 2 | 18204 | 49 |
RORA,SORBS1 |
3.033e-02 | -3.50 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 8 | 16828 | 48 |
TRPS1,TRPM3,DPP10,SLC4A4,NPAS3,MACF1,SORBS1,ATP1A2 |
3.040e-02 | -3.49 | USP6NL (USP6 N-terminal like) | protein interactions | 9712 | 106 | 2 | 19454 | 50 |
NTRK2,PARD3 |
3.042e-02 | -3.49 | ART4 (ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)) | protein interactions | 420 | 12 | 1 | 19454 | 50 |
GPM6A |
3.042e-02 | -3.49 | BAMBI (BMP and activin membrane bound inhibitor) | protein interactions | 25805 | 12 | 1 | 19454 | 50 |
BMPR1B |
3.042e-02 | -3.49 | PROK2 (prokineticin 2) | protein interactions | 60675 | 12 | 1 | 19454 | 50 |
CPE |
3.042e-02 | -3.49 | KIF26A (kinesin family member 26A) | protein interactions | 26153 | 12 | 1 | 19454 | 50 |
MAPK10 |
3.042e-02 | -3.49 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 50 |
SLC4A4 |
3.042e-02 | -3.49 | LMP-1 (latent membrane protein LMP-1) | protein interactions | 3783750 | 12 | 1 | 19454 | 50 |
TNIK |
3.042e-02 | -3.49 | MMP25 (matrix metallopeptidase 25) | protein interactions | 64386 | 12 | 1 | 19454 | 50 |
CLU |
3.042e-02 | -3.49 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 50 |
CLU |
3.042e-02 | -3.49 | CDHR2 (cadherin related family member 2) | protein interactions | 54825 | 12 | 1 | 19454 | 50 |
RPS6KA2 |
3.042e-02 | -3.49 | NTF4 (neurotrophin 4) | protein interactions | 4909 | 12 | 1 | 19454 | 50 |
NTRK2 |
3.042e-02 | -3.49 | Pard6b (par-6 family cell polarity regulator beta) | protein interactions | 58220 | 12 | 1 | 19454 | 50 |
PARD3 |
3.042e-02 | -3.49 | NPY4R (neuropeptide Y receptor Y4) | protein interactions | 5540 | 12 | 1 | 19454 | 50 |
MAP3K5 |
3.049e-02 | -3.49 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | REACTOME pathways | R-HSA-975138 | 91 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.054e-02 | -3.49 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 43 | 16828 | 48 |
TNIK,NPAS3,HPSE2,RFX4,FMN2,CSGALNACT1,MGAT4C,CTNND2,CLU,DPP10,MACF1,ATP1A2,ATP13A4,ADCY2,SOX5,CPE,GPM6A,SPON1,BMPR1B,NEBL,PTPRZ1,SLC4A4,LSAMP,SORBS1,DCLK2,NRG3,RORA,GLIS3,PAMR1,SLC1A2,NAV3,NKAIN3,RPS6KA2,TRPS1,GPC5,NRCAM,TRPM3,PARD3,EFEMP1,NTRK2,AQP4,HIF3A,MAP3K5 |
3.058e-02 | -3.49 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 6 | 19454 | 50 |
PARD3,DTNA,PTPRZ1,CTNND2,CTNNA2,SORBS1 |
3.060e-02 | -3.49 | DC | prosite domains | PS50309 | 9 | 1 | 12186 | 42 |
DCLK2 |
3.060e-02 | -3.49 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 42 |
RFX4 |
3.061e-02 | -3.49 | cAMP signaling pathway | KEGG pathways | ko04024 | 198 | 3 | 7161 | 25 |
ATP1A2,ADCY2,MAPK10 |
3.061e-02 | -3.49 | cAMP signaling pathway | KEGG pathways | hsa04024 | 198 | 3 | 7161 | 25 |
MAPK10,ATP1A2,ADCY2 |
3.093e-02 | -3.48 | EFR3A (EFR3 homolog A) | protein interactions | 23167 | 107 | 2 | 19454 | 50 |
PARD3,RPS6KA2 |
3.096e-02 | -3.48 | sodium:potassium-exchanging ATPase complex | cellular component | GO:0005890 | 12 | 1 | 19108 | 50 |
ATP1A2 |
3.096e-02 | -3.48 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 50 |
PTPRZ1 |
3.100e-02 | -3.47 | Heparan sulfate degradation | KEGG pathways | M00078 | 9 | 1 | 7161 | 25 |
HPSE2 |
3.100e-02 | -3.47 | Heparan sulfate degradation | KEGG pathways | hsa_M00078 | 9 | 1 | 7161 | 25 |
HPSE2 |
3.114e-02 | -3.47 | Laminin | gene3d domains | 2.10.25.10 | 226 | 3 | 14470 | 44 |
NRG3,PAMR1,EFEMP1 |
3.118e-02 | -3.47 | bone-femur-chondrosarcoma | COSMIC cancer mutations | bone-femur-chondrosarcoma | 419 | 4 | 16828 | 48 |
HPSE2,ADCY2,SPON1,SLC4A4 |
3.147e-02 | -3.46 | CLASP1 (cytoplasmic linker associated protein 1) | protein interactions | 23332 | 108 | 2 | 19454 | 50 |
DCLK2,MACF1 |
3.147e-02 | -3.46 | BIN1 (bridging integrator 1) | protein interactions | 274 | 108 | 2 | 19454 | 50 |
CLU,GPM6A |
3.151e-02 | -3.46 | VCL (vinculin) | protein interactions | 7414 | 268 | 3 | 19454 | 50 |
MACF1,NEBL,SORBS1 |
3.151e-02 | -3.46 | protein complex oligomerization | biological process | GO:0051259 | 256 | 3 | 18204 | 49 |
TRPM3,AQP4,SLC1A2 |
3.165e-02 | -3.45 | CH | prosite domains | PS50021 | 81 | 2 | 12186 | 42 |
NAV3,MACF1 |
3.174e-02 | -3.45 | Toll Like Receptor 7/8 (TLR7/8) Cascade | REACTOME pathways | R-HSA-168181 | 93 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
3.174e-02 | -3.45 | MyD88 dependent cascade initiated on endosome | REACTOME pathways | R-HSA-975155 | 93 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.182e-02 | -3.45 | ear | COSMIC cancer mutations | ear | 624 | 5 | 16828 | 48 |
MAP3K5,MGAT4C,NPAS3,DPP10,RPS6KA2 |
3.183e-02 | -3.45 | active transmembrane transporter activity | molecular function | GO:0022804 | 444 | 4 | 18094 | 49 |
ATP1A2,SLC4A4,ATP13A4,SLC1A2 |
3.184e-02 | -3.45 | neuronal ion channel clustering | biological process | GO:0045161 | 12 | 1 | 18204 | 49 |
NRCAM |
3.184e-02 | -3.45 | mammalian oogenesis stage | biological process | GO:0022605 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.184e-02 | -3.45 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 49 |
SLC1A2 |
3.184e-02 | -3.45 | dermatan sulfate proteoglycan metabolic process | biological process | GO:0050655 | 12 | 1 | 18204 | 49 |
CSGALNACT1 |
3.184e-02 | -3.45 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | biological process | GO:1902043 | 12 | 1 | 18204 | 49 |
BMPR1B |
3.185e-02 | -3.45 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 48 |
NPAS3,PTPRZ1,FMN2,GLIS3,RORA,SORBS1,TRPM3,CTNND2,SPON1,MAP3K5,ADCY2,AQP4,MACF1 |
3.185e-02 | -3.45 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 48 |
SORBS1,FMN2,RORA,GLIS3,PTPRZ1,NPAS3,AQP4,MACF1,MAP3K5,ADCY2,SPON1,CTNND2,TRPM3 |
3.193e-02 | -3.44 | MAP_kinase_CS | interpro domains | IPR003527 | 12 | 1 | 18521 | 50 |
MAPK10 |
3.193e-02 | -3.44 | TGFB_receptor | interpro domains | IPR000333 | 12 | 1 | 18521 | 50 |
BMPR1B |
3.200e-02 | -3.44 | PRR20A (proline rich 20A) | protein interactions | 122183 | 109 | 2 | 19454 | 50 |
TRPM3,SOX5 |
3.203e-02 | -3.44 | protein binding involved in heterotypic cell-cell adhesion | molecular function | GO:0086080 | 12 | 1 | 18094 | 49 |
NRCAM |
3.203e-02 | -3.44 | adenylate cyclase binding | molecular function | GO:0008179 | 12 | 1 | 18094 | 49 |
ADCY2 |
3.203e-02 | -3.44 | dipeptidyl-peptidase activity | molecular function | GO:0008239 | 12 | 1 | 18094 | 49 |
DPP10 |
3.204e-02 | -3.44 | human chr9q21.33 | chromosome location | human chr9q21.33 | 17 | 1 | 26134 | 50 |
NTRK2 |
3.211e-02 | -3.44 | WDR6 (WD repeat domain 6) | protein interactions | 11180 | 270 | 3 | 19454 | 50 |
NTRK2,RPS6KA2,PARD3 |
3.230e-02 | -3.43 | exopeptidase activity | molecular function | GO:0008238 | 104 | 2 | 18094 | 49 |
DPP10,CPE |
3.246e-02 | -3.43 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 45 | 16828 | 48 |
HPSE2,CSGALNACT1,TNIK,NPAS3,ATP1A2,SPON1,GPM6A,ATP13A4,ADCY2,NRG3,DCLK2,PAMR1,RORA,SLC4A4,BMPR1B,HIF3A,MSI2,DTNA,TRPS1,GPC5,NAV3,NTRK2,EFEMP1,PARD3,TRPM3,MGAT4C,RFX4,FMN2,PITPNC1,MACF1,CPE,SOX5,CLU,CTNND2,DPP10,LSAMP,SORBS1,GLIS3,PTPRZ1,NEBL,MAP3K5,ABLIM1,RPS6KA2,SLC1A2,NRCAM |
3.251e-02 | -3.43 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 2 | 18204 | 49 |
SOX5,RORA |
3.251e-02 | -3.43 | positive regulation of protein localization to membrane | biological process | GO:1905477 | 105 | 2 | 18204 | 49 |
SORBS1,DPP10 |
3.256e-02 | -3.42 | SNCA (synuclein alpha) | protein interactions | 6622 | 696 | 5 | 19454 | 50 |
TNIK,GPM6A,NTRK2,MACF1,CLU |
3.256e-02 | -3.42 | CarboxypepD_reg | pfam domains | PF13620 | 12 | 1 | 17795 | 49 |
CPE |
3.287e-02 | -3.42 | DCX | smart domains | SM00537 | 9 | 1 | 9717 | 36 |
DCLK2 |
3.291e-02 | -3.41 | JAM2 (junctional adhesion molecule 2) | protein interactions | 58494 | 13 | 1 | 19454 | 50 |
PARD3 |
3.291e-02 | -3.41 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 50 |
GPM6A |
3.291e-02 | -3.41 | SPINK5 (serine peptidase inhibitor Kazal type 5) | protein interactions | 11005 | 13 | 1 | 19454 | 50 |
CSGALNACT1 |
3.291e-02 | -3.41 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 50 |
NAV3 |
3.291e-02 | -3.41 | DDIAS (DNA damage induced apoptosis suppressor) | protein interactions | 220042 | 13 | 1 | 19454 | 50 |
EFEMP1 |
3.296e-02 | -3.41 | Carboxypeptidase-like, regulatory domain | gene3d domains | 2.60.40.1120 | 11 | 1 | 14470 | 44 |
CPE |
3.300e-02 | -3.41 | Toll Like Receptor TLR1:TLR2 Cascade | REACTOME pathways | R-HSA-168179 | 95 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
3.300e-02 | -3.41 | MyD88:Mal cascade initiated on plasma membrane | REACTOME pathways | R-HSA-166058 | 95 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
3.300e-02 | -3.41 | Toll Like Receptor TLR6:TLR2 Cascade | REACTOME pathways | R-HSA-168188 | 95 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.300e-02 | -3.41 | Toll Like Receptor 2 (TLR2) Cascade | REACTOME pathways | R-HSA-181438 | 95 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.300e-02 | -3.41 | dermatan sulfate biosynthesis | BIOCYC pathways | META_PWY-6571 | 15 | 1 | 902 | 2 |
CSGALNACT1 |
3.307e-02 | -3.41 | oogenesis | biological process | GO:0048477 | 106 | 2 | 18204 | 49 |
FMN2,BMPR1B |
3.319e-02 | -3.41 | arm | COSMIC cancer mutations | arm | 1331 | 8 | 16828 | 48 |
SORBS1,MACF1,ATP1A2,TRPM3,SLC4A4,NPAS3,DPP10,TRPS1 |
3.363e-02 | -3.39 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 2 | 19454 | 50 |
RPS6KA2,GPM6A |
3.363e-02 | -3.39 | CEP170P1 (centrosomal protein 170 pseudogene 1) | protein interactions | 645455 | 112 | 2 | 19454 | 50 |
MACF1,TRPS1 |
3.363e-02 | -3.39 | MPP1 (MAGUK p55 scaffold protein 1) | protein interactions | 4354 | 112 | 2 | 19454 | 50 |
TRPS1,RPS6KA2 |
3.363e-02 | -3.39 | TBR1 (T-box brain transcription factor 1) | protein interactions | 10716 | 112 | 2 | 19454 | 50 |
SOX5,TRPS1 |
3.363e-02 | -3.39 | TSC22D4 (TSC22 domain family member 4) | protein interactions | 81628 | 112 | 2 | 19454 | 50 |
CLU,ABLIM1 |
3.374e-02 | -3.39 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 5 | 16828 | 48 |
NEBL,PTPRZ1,FMN2,RPS6KA2,SORBS1 |
3.388e-02 | -3.38 | regulation of developmental process | biological process | GO:0050793 | 2540 | 12 | 18204 | 49 |
NTRK2,MAP3K5,NRCAM,BMPR1B,RORA,SOX5,PARD3,PTPRZ1,EFEMP1,MACF1,TRPS1,TNIK |
3.389e-02 | -3.38 | human chr7q31.32 | chromosome location | human chr7q31.32 | 18 | 1 | 26134 | 50 |
PTPRZ1 |
3.394e-02 | -3.38 | CDK4 (cyclin dependent kinase 4) | protein interactions | 1019 | 276 | 3 | 19454 | 50 |
BMPR1B,MAP3K5,SORBS1 |
3.395e-02 | -3.38 | MIP | prosite domains | PS00221 | 10 | 1 | 12186 | 42 |
AQP4 |
3.396e-02 | -3.38 | regulation of nervous system development | biological process | GO:0051960 | 456 | 4 | 18204 | 49 |
PARD3,MACF1,PTPRZ1,NTRK2 |
3.402e-02 | -3.38 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 49 |
RORA,ATP1A2 |
3.418e-02 | -3.38 | GFI1B (growth factor independent 1B transcriptional repressor) | protein interactions | 8328 | 113 | 2 | 19454 | 50 |
DTNA,EFEMP1 |
3.418e-02 | -3.38 | KIRREL1 (kirre like nephrin family adhesion molecule 1) | protein interactions | 55243 | 113 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
3.428e-02 | -3.37 | Toll Like Receptor 9 (TLR9) Cascade | REACTOME pathways | R-HSA-168138 | 97 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.439e-02 | -3.37 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 49 |
CTNND2,RBMS3,GPC5 |
3.444e-02 | -3.37 | defense response to tumor cell | biological process | GO:0002357 | 13 | 1 | 18204 | 49 |
RBMS3 |
3.444e-02 | -3.37 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 49 |
CTNNA2 |
3.444e-02 | -3.37 | negative regulation of amyloid fibril formation | biological process | GO:1905907 | 13 | 1 | 18204 | 49 |
CLU |
3.444e-02 | -3.37 | ectodermal placode development | biological process | GO:0071696 | 13 | 1 | 18204 | 49 |
NRG3 |
3.444e-02 | -3.37 | regulation of respiratory gaseous exchange by nervous system process | biological process | GO:0002087 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | negative regulation of cytosolic calcium ion concentration | biological process | GO:0051481 | 13 | 1 | 18204 | 49 |
ATP1A2 |
3.444e-02 | -3.37 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 49 |
RORA |
3.444e-02 | -3.37 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 49 |
RORA |
3.457e-02 | -3.36 | TJP2 (tight junction protein 2) | protein interactions | 9414 | 278 | 3 | 19454 | 50 |
NEBL,SORBS1,PARD3 |
3.462e-02 | -3.36 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 9 | 18204 | 49 |
NTRK2,SOX5,ATP1A2,PARD3,BMPR1B,PTPRZ1,CLU,RORA,MACF1 |
3.465e-02 | -3.36 | transforming growth factor beta receptor activity | molecular function | GO:0005024 | 13 | 1 | 18094 | 49 |
BMPR1B |
3.465e-02 | -3.36 | potassium ion binding | molecular function | GO:0030955 | 13 | 1 | 18094 | 49 |
ATP1A2 |
3.465e-02 | -3.36 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 1 | 18094 | 49 |
SLC4A4 |
3.466e-02 | -3.36 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 49 |
NTRK2,RPS6KA2,SLC1A2,DTNA |
3.474e-02 | -3.36 | TNFSF13B (TNF superfamily member 13b) | protein interactions | 10673 | 114 | 2 | 19454 | 50 |
CLU,MAP3K5 |
3.481e-02 | -3.36 | regulation of protein localization to plasma membrane | biological process | GO:1903076 | 109 | 2 | 18204 | 49 |
DPP10,SORBS1 |
3.501e-02 | -3.35 | ErbB signaling pathway | KEGG pathways | hsa04012 | 85 | 2 | 7161 | 25 |
MAPK10,NRG3 |
3.501e-02 | -3.35 | ErbB signaling pathway | KEGG pathways | ko04012 | 85 | 2 | 7161 | 25 |
NRG3,MAPK10 |
3.501e-02 | -3.35 | Insulin secretion | KEGG pathways | hsa04911 | 85 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
3.518e-02 | -3.35 | chondroitin sulfate biosynthesis | BIOCYC pathways | HUMAN_PWY-6569 | 16 | 1 | 902 | 2 |
CSGALNACT1 |
3.527e-02 | -3.34 | ACTB (actin beta) | protein interactions | 60 | 958 | 6 | 19454 | 50 |
DTNA,NEBL,FMN2,MACF1,SORBS1,ABLIM1 |
3.530e-02 | -3.34 | CDH2 (cadherin 2) | protein interactions | 1000 | 115 | 2 | 19454 | 50 |
PARD3,CTNND2 |
3.530e-02 | -3.34 | DTNA (dystrobrevin alpha) | protein interactions | 1837 | 115 | 2 | 19454 | 50 |
PARD3,NTRK2 |
3.540e-02 | -3.34 | Stag2 (STAG2 cohesin complex component) | protein interactions | 20843 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | Nedd4 (neural precursor cell expressed, developmentally down-regulated 4) | protein interactions | 17999 | 14 | 1 | 19454 | 50 |
GLIS3 |
3.540e-02 | -3.34 | ZNF628 (zinc finger protein 628) | protein interactions | 89887 | 14 | 1 | 19454 | 50 |
EFEMP1 |
3.540e-02 | -3.34 | C9 (complement C9) | protein interactions | 735 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | Aifm1 (apoptosis-inducing factor, mitochondrion-associated 1) | protein interactions | 26926 | 14 | 1 | 19454 | 50 |
CLU |
3.540e-02 | -3.34 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 50 |
SLC1A2 |
3.540e-02 | -3.34 | Asap1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain1) | protein interactions | 13196 | 14 | 1 | 19454 | 50 |
MACF1 |
3.540e-02 | -3.34 | BOD1L2 (biorientation of chromosomes in cell division 1 like 2) | protein interactions | 284257 | 14 | 1 | 19454 | 50 |
FMN2 |
3.540e-02 | -3.34 | RHEBL1 (RHEB like 1) | protein interactions | 121268 | 14 | 1 | 19454 | 50 |
BMPR1B |
3.559e-02 | -3.34 | Toll Like Receptor 3 (TLR3) Cascade | REACTOME pathways | R-HSA-168164 | 99 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
3.559e-02 | -3.34 | TRIF-mediated TLR3/TLR4 signaling | REACTOME pathways | R-HSA-937061 | 99 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
3.559e-02 | -3.34 | MyD88-independent TLR3/TLR4 cascade | REACTOME pathways | R-HSA-166166 | 99 | 2 | 10285 | 31 |
MAPK10,RPS6KA2 |
3.559e-02 | -3.34 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 31 |
GPC5 |
3.559e-02 | -3.34 | Regulation of gene expression by Hypoxia-inducible Factor | REACTOME pathways | R-HSA-1234158 | 12 | 1 | 10285 | 31 |
HIF3A |
3.559e-02 | -3.34 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 31 |
GPC5 |
3.561e-02 | -3.34 | regulation of membrane potential | biological process | GO:0042391 | 463 | 4 | 18204 | 49 |
ATP1A2,NRCAM,SLC4A4,NTRK2 |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.585e-02 | -3.33 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 4 | 18204 | 49 |
RORA,ATP1A2,ADCY2,SLC1A2 |
3.586e-02 | -3.33 | RBBP8 (RB binding protein 8, endonuclease) | protein interactions | 5932 | 116 | 2 | 19454 | 50 |
CTNNA2,CLU |
3.589e-02 | -3.33 | plasma membrane raft | cellular component | GO:0044853 | 114 | 2 | 19108 | 50 |
ATP1A2,SORBS1 |
3.590e-02 | -3.33 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 44 |
CTNNA2 |
3.603e-02 | -3.32 | chromaffin granule | cellular component | GO:0042583 | 14 | 1 | 19108 | 50 |
CLU |
3.627e-02 | -3.32 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 10 | 16828 | 48 |
NTRK2,PARD3,PTPRZ1,PITPNC1,NEBL,NAV3,FMN2,ADCY2,ATP13A4,HPSE2 |
3.638e-02 | -3.31 | extremity | COSMIC cancer mutations | extremity | 1876 | 10 | 16828 | 48 |
ADCY2,ATP13A4,FMN2,HPSE2,NTRK2,PITPNC1,NEBL,PARD3,PTPRZ1,NAV3 |
3.642e-02 | -3.31 | ZMYND19 (zinc finger MYND-type containing 19) | protein interactions | 116225 | 117 | 2 | 19454 | 50 |
SPON1,CTNND2 |
3.647e-02 | -3.31 | HYOU1 (hypoxia up-regulated 1) | protein interactions | 10525 | 284 | 3 | 19454 | 50 |
CLU,CPE,EFEMP1 |
3.647e-02 | -3.31 | LATS2 (large tumor suppressor kinase 2) | protein interactions | 26524 | 284 | 3 | 19454 | 50 |
SORBS1,MAP3K5,PARD3 |
3.670e-02 | -3.31 | EGF_2 | prosite domains | PS01186 | 213 | 3 | 12186 | 42 |
EFEMP1,NRG3,PAMR1 |
3.675e-02 | -3.30 | superficial_spreading | COSMIC cancer mutations | superficial_spreading | 1110 | 7 | 16828 | 48 |
ATP13A4,ADCY2,MGAT4C,SORBS1,MACF1,SLC4A4,CTNND2 |
3.676e-02 | -3.30 | heterocyclic compound binding | molecular function | GO:1901363 | 2263 | 11 | 18094 | 49 |
BMPR1B,DCLK2,NAV3,MAP3K5,ATP13A4,RPS6KA2,ATP1A2,TNIK,MAPK10,NTRK2,ADCY2 |
3.678e-02 | -3.30 | bHLH_dom | interpro domains | IPR011598 | 112 | 2 | 18521 | 50 |
HIF3A,NPAS3 |
3.678e-02 | -3.30 | HLH_DNA-bd_sf | interpro domains | IPR036638 | 112 | 2 | 18521 | 50 |
HIF3A,NPAS3 |
3.691e-02 | -3.30 | L1CAM interactions | REACTOME pathways | R-HSA-373760 | 101 | 2 | 10285 | 31 |
NRCAM,RPS6KA2 |
3.699e-02 | -3.30 | CEACAM8 (CEA cell adhesion molecule 8) | protein interactions | 1088 | 118 | 2 | 19454 | 50 |
CPE,CLU |
3.704e-02 | -3.30 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 10 | 18204 | 49 |
NTRK2,NRG3,BMPR1B,SORBS1,EFEMP1,MAPK10,TNIK,CTNND2,MACF1,CPE |
3.704e-02 | -3.30 | response to forskolin | biological process | GO:1904321 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.704e-02 | -3.30 | cerebrospinal fluid circulation | biological process | GO:0090660 | 14 | 1 | 18204 | 49 |
AQP4 |
3.704e-02 | -3.30 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 49 |
SLC1A2 |
3.704e-02 | -3.30 | cellular response to forskolin | biological process | GO:1904322 | 14 | 1 | 18204 | 49 |
ADCY2 |
3.704e-02 | -3.30 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.704e-02 | -3.30 | negative regulation of sodium ion transmembrane transporter activity | biological process | GO:2000650 | 14 | 1 | 18204 | 49 |
ATP1A2 |
3.706e-02 | -3.30 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 49 |
ATP1A2,SLC1A2,SLC4A4 |
3.715e-02 | -3.29 | Aquaporin-like | interpro domains | IPR023271 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | MIP | interpro domains | IPR000425 | 14 | 1 | 18521 | 50 |
AQP4 |
3.717e-02 | -3.29 | dendrite development | biological process | GO:0016358 | 113 | 2 | 18204 | 49 |
CTNND2,CTNNA2 |
3.727e-02 | -3.29 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 1 | 18094 | 49 |
SLC1A2 |
3.727e-02 | -3.29 | microtubule minus-end binding | molecular function | GO:0051011 | 14 | 1 | 18094 | 49 |
MACF1 |
3.728e-02 | -3.29 | RECEPTOR_TYR_KIN_II | prosite domains | PS00239 | 11 | 1 | 12186 | 42 |
NTRK2 |
3.728e-02 | -3.29 | GATA_ZN_FINGER_2 | prosite domains | PS50114 | 11 | 1 | 12186 | 42 |
TRPS1 |
3.735e-02 | -3.29 | bladder | COSMIC cancer mutations | bladder | 14112 | 45 | 16828 | 48 |
PITPNC1,MGAT4C,RFX4,FMN2,DPP10,CTNND2,CLU,CPE,SOX5,MACF1,NEBL,PTPRZ1,GLIS3,SORBS1,LSAMP,NRCAM,ABLIM1,SLC1A2,RPS6KA2,MAP3K5,NPAS3,TNIK,CSGALNACT1,HPSE2,SPON1,ADCY2,ATP13A4,GPM6A,ATP1A2,SLC4A4,BMPR1B,PAMR1,RORA,DCLK2,NRG3,EFEMP1,NTRK2,TRPM3,PARD3,GPC5,TRPS1,NAV3,DTNA,MSI2,HIF3A |
3.735e-02 | -3.29 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 45 | 16828 | 48 |
GLIS3,LSAMP,SORBS1,PTPRZ1,NEBL,MAP3K5,NRCAM,RPS6KA2,SLC1A2,ABLIM1,FMN2,RFX4,MGAT4C,PITPNC1,CPE,SOX5,MACF1,DPP10,CLU,CTNND2,RORA,PAMR1,NRG3,DCLK2,BMPR1B,SLC4A4,MSI2,DTNA,HIF3A,PARD3,TRPM3,NTRK2,EFEMP1,NAV3,TRPS1,GPC5,CSGALNACT1,HPSE2,NPAS3,TNIK,GPM6A,ADCY2,ATP13A4,SPON1,ATP1A2 |
3.738e-02 | -3.29 | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-humerus-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 107 | 2 | 16828 | 48 |
NEBL,HIF3A |
3.756e-02 | -3.28 | ANKRD26 (ankyrin repeat domain containing 26) | protein interactions | 22852 | 119 | 2 | 19454 | 50 |
PARD3,NTRK2 |
3.759e-02 | -3.28 | human chr8p21.1 | chromosome location | human chr8p21.1 | 20 | 1 | 26134 | 50 |
CLU |
3.764e-02 | -3.28 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 20 |
SLC4A4 |
3.777e-02 | -3.28 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 49 |
MAPK10,RORA |
3.788e-02 | -3.27 | PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) | protein interactions | 27344 | 15 | 1 | 19454 | 50 |
MGAT4C |
3.788e-02 | -3.27 | GSTM1 (glutathione S-transferase mu 1) | protein interactions | 2944 | 15 | 1 | 19454 | 50 |
MAP3K5 |
3.788e-02 | -3.27 | TAFA5 (TAFA chemokine like family member 5) | protein interactions | 25817 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | XIRP1 (xin actin binding repeat containing 1) | protein interactions | 165904 | 15 | 1 | 19454 | 50 |
NEBL |
3.788e-02 | -3.27 | IGSF1 (immunoglobulin superfamily member 1) | protein interactions | 3547 | 15 | 1 | 19454 | 50 |
BMPR1B |
3.788e-02 | -3.27 | MIP | pfam domains | PF00230 | 14 | 1 | 17795 | 49 |
AQP4 |
3.788e-02 | -3.27 | GATA | pfam domains | PF00320 | 14 | 1 | 17795 | 49 |
TRPS1 |
3.808e-02 | -3.27 | learning or memory | biological process | GO:0007611 | 276 | 3 | 18204 | 49 |
ATP1A2,PTPRZ1,NTRK2 |
3.810e-02 | -3.27 | CEP128 (centrosomal protein 128) | protein interactions | 145508 | 289 | 3 | 19454 | 50 |
NEBL,SORBS1,ABLIM1 |
3.819e-02 | -3.27 | circulatory system development | biological process | GO:0072359 | 933 | 6 | 18204 | 49 |
NRCAM,NEBL,RORA,CPE,HIF3A,NTRK2 |
3.850e-02 | -3.26 | Passive transport by Aquaporins | REACTOME pathways | R-HSA-432047 | 13 | 1 | 10285 | 31 |
AQP4 |
3.850e-02 | -3.26 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 31 |
NRG3 |
3.855e-02 | -3.26 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 50 |
SLC1A2 |
3.870e-02 | -3.25 | neuronal cell body | cellular component | GO:0043025 | 489 | 4 | 19108 | 50 |
ATP1A2,CTNND2,BMPR1B,GPM6A |
3.878e-02 | -3.25 | actin filament organization | biological process | GO:0007015 | 278 | 3 | 18204 | 49 |
SORBS1,NEBL,FMN2 |
3.884e-02 | -3.25 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 47 | 16828 | 48 |
PTPRZ1,NEBL,GLIS3,SORBS1,LSAMP,NRCAM,RPS6KA2,NKAIN3,SLC1A2,ABLIM1,MAP3K5,AQP4,PITPNC1,RFX4,FMN2,MGAT4C,DPP10,CLU,CTNND2,CPE,SOX5,MACF1,BMPR1B,SLC4A4,RORA,PAMR1,NRG3,DCLK2,PARD3,TRPM3,NTRK2,EFEMP1,NAV3,TRPS1,GPC5,MSI2,DTNA,HIF3A,NPAS3,TNIK,CSGALNACT1,HPSE2,GPM6A,ADCY2,ATP13A4,SPON1,ATP1A2 |
3.886e-02 | -3.25 | Salivary secretion | KEGG pathways | hsa04970 | 90 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
3.886e-02 | -3.25 | Salivary secretion | KEGG pathways | ko04970 | 90 | 2 | 7161 | 25 |
ATP1A2,ADCY2 |
3.887e-02 | -3.25 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 18 | 16828 | 48 |
NPAS3,PTPRZ1,PAMR1,RORA,FMN2,GLIS3,SORBS1,DPP10,PARD3,TRPM3,TRPS1,CLU,CTNND2,SPON1,ADCY2,MAP3K5,MACF1,AQP4 |
3.894e-02 | -3.25 | localization | biological process | GO:0051179 | 4474 | 18 | 18204 | 49 |
PARD3,ATP1A2,FMN2,SLC4A4,DCLK2,TRPM3,MACF1,CPE,TNIK,AQP4,ATP13A4,PITPNC1,DPP10,NRCAM,SLC1A2,GPM6A,NTRK2,CLU |
3.934e-02 | -3.24 | SH3DOMAIN | prints domains | PR00452 | 83 | 2 | 5227 | 20 |
SORBS1,NEBL |
3.943e-02 | -3.23 | human chr10q23.1 | chromosome location | human chr10q23.1 | 21 | 1 | 26134 | 50 |
NRG3 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.943e-02 | -3.23 | human chr4q32.3 | chromosome location | human chr4q32.3 | 21 | 1 | 26134 | 50 |
CPE |
3.948e-02 | -3.23 | glycoprotein biosynthetic process | biological process | GO:0009101 | 280 | 3 | 18204 | 49 |
CSGALNACT1,MGAT4C,BMPR1B |
3.953e-02 | -3.23 | chondroitin sulfate biosynthesis | BIOCYC pathways | META_PWY-6569 | 18 | 1 | 902 | 2 |
CSGALNACT1 |
3.964e-02 | -3.23 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 49 |
SLC1A2 |
3.964e-02 | -3.23 | peripheral nervous system neuron differentiation | biological process | GO:0048934 | 15 | 1 | 18204 | 49 |
NTRK2 |
3.964e-02 | -3.23 | intracellular potassium ion homeostasis | biological process | GO:0030007 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 49 |
RORA |
3.964e-02 | -3.23 | pyramidal neuron differentiation | biological process | GO:0021859 | 15 | 1 | 18204 | 49 |
DCLK2 |
3.964e-02 | -3.23 | p38MAPK cascade | biological process | GO:0038066 | 15 | 1 | 18204 | 49 |
MAP3K5 |
3.964e-02 | -3.23 | positive regulation of glycogen biosynthetic process | biological process | GO:0045725 | 15 | 1 | 18204 | 49 |
SORBS1 |
3.964e-02 | -3.23 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 49 |
MACF1 |
3.964e-02 | -3.23 | negative regulation of sodium ion transmembrane transport | biological process | GO:1902306 | 15 | 1 | 18204 | 49 |
ATP1A2 |
3.964e-02 | -3.23 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 49 |
SOX5 |
3.964e-02 | -3.23 | peripheral nervous system neuron development | biological process | GO:0048935 | 15 | 1 | 18204 | 49 |
NTRK2 |
3.972e-02 | -3.23 | microtubule binding | molecular function | GO:0008017 | 279 | 3 | 18094 | 49 |
MACF1,DCLK2,NAV3 |
3.975e-02 | -3.23 | Znf_GATA | interpro domains | IPR000679 | 15 | 1 | 18521 | 50 |
TRPS1 |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | ATPase_P-typ_cation-transptr_C | interpro domains | IPR006068 | 15 | 1 | 18521 | 50 |
ATP1A2 |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FMN2 |
3.975e-02 | -3.23 | CNH_dom | interpro domains | IPR001180 | 15 | 1 | 18521 | 50 |
TNIK |
3.988e-02 | -3.22 | filamin binding | molecular function | GO:0031005 | 15 | 1 | 18094 | 49 |
NEBL |
3.988e-02 | -3.22 | tropomyosin binding | molecular function | GO:0005523 | 15 | 1 | 18094 | 49 |
NEBL |
3.988e-02 | -3.22 | phosphatidylglycerol binding | molecular function | GO:1901611 | 15 | 1 | 18094 | 49 |
PITPNC1 |
3.988e-02 | -3.22 | neurexin family protein binding | molecular function | GO:0042043 | 15 | 1 | 18094 | 49 |
CPE |
3.997e-02 | -3.22 | Bone Morphogenic Protein (BMP) Signalling and Regulation | WikiPathways | WP1425 | 12 | 1 | 5310 | 18 |
BMPR1B |
4.002e-02 | -3.22 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 2 | 18094 | 49 |
SLC4A4,SLC1A2 |
4.002e-02 | -3.22 | calcium channel activity | molecular function | GO:0005262 | 117 | 2 | 18094 | 49 |
TRPM3,GPM6A |
4.035e-02 | -3.21 | ADAM18 (ADAM metallopeptidase domain 18) | protein interactions | 8749 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | KLHL25 (kelch like family member 25) | protein interactions | 64410 | 16 | 1 | 19454 | 50 |
RPS6KA2 |
4.035e-02 | -3.21 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 50 |
CTNNA2 |
4.035e-02 | -3.21 | AMMECR1L (AMMECR1 like) | protein interactions | 83607 | 16 | 1 | 19454 | 50 |
MACF1 |
4.035e-02 | -3.21 | GALNT13 (polypeptide N-acetylgalactosaminyltransferase 13) | protein interactions | 114805 | 16 | 1 | 19454 | 50 |
TNIK |
4.045e-02 | -3.21 | GnRH signaling pathway | KEGG pathways | hsa04912 | 92 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.045e-02 | -3.21 | GnRH signaling pathway | KEGG pathways | ko04912 | 92 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.053e-02 | -3.21 | Cation_ATPase_C | pfam domains | PF00689 | 15 | 1 | 17795 | 49 |
ATP1A2 |
4.053e-02 | -3.21 | CNH | pfam domains | PF00780 | 15 | 1 | 17795 | 49 |
TNIK |
4.053e-02 | -3.21 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 49 |
FMN2 |
4.060e-02 | -3.20 | MAPK | prosite domains | PS01351 | 12 | 1 | 12186 | 42 |
MAPK10 |
4.061e-02 | -3.20 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 47 | 16828 | 48 |
DPP10,CTNND2,CLU,CPE,SOX5,MACF1,PITPNC1,MGAT4C,RFX4,FMN2,NRCAM,ABLIM1,SLC1A2,RPS6KA2,MAP3K5,AQP4,NEBL,PTPRZ1,GLIS3,LSAMP,SORBS1,SPON1,ATP13A4,ADCY2,GPM6A,ATP1A2,NPAS3,TNIK,CSGALNACT1,HPSE2,RBMS3,EFEMP1,NTRK2,TRPM3,PARD3,TRPS1,GPC5,NAV3,DTNA,MSI2,HIF3A,SLC4A4,BMPR1B,PAMR1,RORA,DCLK2,NRG3 |
4.070e-02 | -3.20 | SH3 | prosite domains | PS50002 | 222 | 3 | 12186 | 42 |
NEBL,SORBS1,MACF1 |
4.079e-02 | -3.20 | TJP1 (tight junction protein 1) | protein interactions | 7082 | 297 | 3 | 19454 | 50 |
PARD3,NEBL,DTNA |
4.099e-02 | -3.19 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 2 | 10285 | 31 |
SLC4A4,SLC1A2 |
4.106e-02 | -3.19 | SOCS6 (suppressor of cytokine signaling 6) | protein interactions | 9306 | 125 | 2 | 19454 | 50 |
EFEMP1,BMPR1B |
4.107e-02 | -3.19 | postsynaptic density, intracellular component | cellular component | GO:0099092 | 16 | 1 | 19108 | 50 |
TNIK |
4.112e-02 | -3.19 | regulation of transmembrane transport | biological process | GO:0034762 | 485 | 4 | 18204 | 49 |
SORBS1,SLC1A2,DPP10,ATP1A2 |
4.112e-02 | -3.19 | export from cell | biological process | GO:0140352 | 485 | 4 | 18204 | 49 |
ATP1A2,CPE,NTRK2,SLC4A4 |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
LSAMP |
4.141e-02 | -3.18 | DCC mediated attractive signaling | REACTOME pathways | R-HSA-418885 | 14 | 1 | 10285 | 31 |
ABLIM1 |
4.141e-02 | -3.18 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 31 |
NRG3 |
4.144e-02 | -3.18 | striated muscle contraction | biological process | GO:0006941 | 120 | 2 | 18204 | 49 |
ATP1A2,DTNA |
4.166e-02 | -3.18 | SYP (synaptophysin) | protein interactions | 6855 | 126 | 2 | 19454 | 50 |
GPM6A,PITPNC1 |
4.176e-02 | -3.18 | Glycerol uptake facilitator protein | gene3d domains | 1.20.1080.10 | 14 | 1 | 14470 | 44 |
AQP4 |
4.192e-02 | -3.17 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 2 | 16828 | 48 |
SOX5,SLC1A2 |
4.223e-02 | -3.16 | regulation of respiratory system process | biological process | GO:0044065 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | insulin metabolic process | biological process | GO:1901142 | 16 | 1 | 18204 | 49 |
CPE |
4.223e-02 | -3.16 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 49 |
SLC1A2 |
4.223e-02 | -3.16 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | regulation of amino acid transmembrane transport | biological process | GO:1903789 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.223e-02 | -3.16 | cardiac left ventricle morphogenesis | biological process | GO:0003214 | 16 | 1 | 18204 | 49 |
CPE |
4.223e-02 | -3.16 | regulation of amino acid import across plasma membrane | biological process | GO:0010958 | 16 | 1 | 18204 | 49 |
ATP1A2 |
4.230e-02 | -3.16 | EGF-like_Ca-bd_dom | interpro domains | IPR001881 | 121 | 2 | 18521 | 50 |
EFEMP1,PAMR1 |
4.235e-02 | -3.16 | CarboxyPept-like_regulatory | interpro domains | IPR008969 | 16 | 1 | 18521 | 50 |
CPE |
4.248e-02 | -3.16 | MAP kinase activity | molecular function | GO:0004707 | 16 | 1 | 18094 | 49 |
MAPK10 |
4.248e-02 | -3.16 | water channel activity | molecular function | GO:0015250 | 16 | 1 | 18094 | 49 |
AQP4 |
4.248e-02 | -3.16 | MAP kinase kinase activity | molecular function | GO:0004708 | 16 | 1 | 18094 | 49 |
MAPK10 |
4.248e-02 | -3.16 | adenylate cyclase activity | molecular function | GO:0004016 | 16 | 1 | 18094 | 49 |
ADCY2 |
4.248e-02 | -3.16 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 49 |
RORA |
4.248e-02 | -3.16 | misfolded protein binding | molecular function | GO:0051787 | 16 | 1 | 18094 | 49 |
CLU |
4.251e-02 | -3.16 | TRAF1 (TNF receptor associated factor 1) | protein interactions | 7185 | 302 | 3 | 19454 | 50 |
GLIS3,MAP3K5,NEBL |
4.282e-02 | -3.15 | CNTN2 (contactin 2) | protein interactions | 6900 | 17 | 1 | 19454 | 50 |
NRCAM |
4.282e-02 | -3.15 | NFASC (neurofascin) | protein interactions | 23114 | 17 | 1 | 19454 | 50 |
NRCAM |
4.282e-02 | -3.15 | DPP6 (dipeptidyl peptidase like 6) | protein interactions | 1804 | 17 | 1 | 19454 | 50 |
GPM6A |
4.282e-02 | -3.15 | ZNF358 (zinc finger protein 358) | protein interactions | 140467 | 17 | 1 | 19454 | 50 |
EFEMP1 |
4.282e-02 | -3.15 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 50 |
DTNA |
4.282e-02 | -3.15 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 50 |
GPC5 |
4.282e-02 | -3.15 | RASL12 (RAS like family 12) | protein interactions | 51285 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | TNNT2 (troponin T2, cardiac type) | protein interactions | 7139 | 17 | 1 | 19454 | 50 |
MAP3K5 |
4.282e-02 | -3.15 | Sqstm1 (sequestosome 1) | protein interactions | 18412 | 17 | 1 | 19454 | 50 |
BMPR1B |
4.282e-02 | -3.15 | SEPSECS (Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase) | protein interactions | 51091 | 17 | 1 | 19454 | 50 |
ABLIM1 |
4.282e-02 | -3.15 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 50 |
SOX5 |
4.286e-02 | -3.15 | TEAD2 (TEA domain transcription factor 2) | protein interactions | 8463 | 128 | 2 | 19454 | 50 |
TRPS1,MAP3K5 |
4.286e-02 | -3.15 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 50 |
SOX5,MACF1 |
4.287e-02 | -3.15 | Endocrine resistance | KEGG pathways | ko01522 | 95 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.287e-02 | -3.15 | Endocrine resistance | KEGG pathways | hsa01522 | 95 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.311e-02 | -3.14 | human chr5p15.31 | chromosome location | human chr5p15.31 | 23 | 1 | 26134 | 50 |
ADCY2 |
4.312e-02 | -3.14 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 8 | 18204 | 49 |
PTPRZ1,EFEMP1,BMPR1B,MACF1,TRPS1,SOX5,NTRK2,PARD3 |
4.346e-02 | -3.14 | SLC38A2 (solute carrier family 38 member 2) | protein interactions | 54407 | 129 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
4.358e-02 | -3.13 | apical dendrite | cellular component | GO:0097440 | 17 | 1 | 19108 | 50 |
CLU |
4.359e-02 | -3.13 | ZnF_GATA | smart domains | SM00401 | 12 | 1 | 9717 | 36 |
TRPS1 |
4.367e-02 | -3.13 | monoatomic ion transport | biological process | GO:0006811 | 964 | 6 | 18204 | 49 |
ATP13A4,GPM6A,SLC4A4,SLC1A2,TRPM3,ATP1A2 |
4.391e-02 | -3.13 | CARBOXYPEPT_ZN_2 | prosite domains | PS00133 | 13 | 1 | 12186 | 42 |
CPE |
4.391e-02 | -3.13 | CARBOXYPEPT_ZN_1 | prosite domains | PS00132 | 13 | 1 | 12186 | 42 |
CPE |
4.407e-02 | -3.12 | DVL1 (dishevelled segment polarity protein 1) | protein interactions | 1855 | 130 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
4.407e-02 | -3.12 | RSPH1 (radial spoke head component 1) | protein interactions | 89765 | 130 | 2 | 19454 | 50 |
CLU,NRCAM |
4.426e-02 | -3.12 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 50 |
SLC1A2,NTRK2 |
4.430e-02 | -3.12 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 31 |
NRG3 |
4.430e-02 | -3.12 | Inhibition of adenylate cyclase pathway | REACTOME pathways | R-HSA-997269 | 15 | 1 | 10285 | 31 |
ADCY2 |
4.430e-02 | -3.12 | N-Glycan antennae elongation | REACTOME pathways | R-HSA-975577 | 15 | 1 | 10285 | 31 |
MGAT4C |
4.430e-02 | -3.12 | Adenylate cyclase inhibitory pathway | REACTOME pathways | R-HSA-170670 | 15 | 1 | 10285 | 31 |
ADCY2 |
4.448e-02 | -3.11 | cytoskeleton | cellular component | GO:0005856 | 2412 | 11 | 19108 | 50 |
PARD3,CLU,SORBS1,NAV3,DTNA,NEBL,ABLIM1,MACF1,TNIK,CTNNA2,FMN2 |
4.452e-02 | -3.11 | Inflammatory mediator regulation of TRP channels | KEGG pathways | ko04750 | 97 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.452e-02 | -3.11 | Inflammatory mediator regulation of TRP channels | KEGG pathways | hsa04750 | 97 | 2 | 7161 | 25 |
MAPK10,ADCY2 |
4.459e-02 | -3.11 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 4 | 18204 | 49 |
AQP4,NRCAM,MACF1,ATP1A2 |
4.461e-02 | -3.11 | actomyosin structure organization | biological process | GO:0031032 | 125 | 2 | 18204 | 49 |
SORBS1,NEBL |
4.467e-02 | -3.11 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 44 |
FMN2 |
4.468e-02 | -3.11 | membrane protein complex | cellular component | GO:0098796 | 1261 | 7 | 19108 | 50 |
BMPR1B,CTNNA2,DPP10,SORBS1,MAP3K5,SLC1A2,ATP1A2 |
4.477e-02 | -3.11 | Helix-loop-helix DNA-binding domain | gene3d domains | 4.10.280.10 | 111 | 2 | 14470 | 44 |
HIF3A,NPAS3 |
4.481e-02 | -3.11 | positive regulation of cardiac muscle cell apoptotic process | biological process | GO:0010666 | 17 | 1 | 18204 | 49 |
MAP3K5 |
4.481e-02 | -3.11 | positive regulation of striated muscle cell apoptotic process | biological process | GO:0010663 | 17 | 1 | 18204 | 49 |
MAP3K5 |
4.481e-02 | -3.11 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 49 |
SLC1A2 |
4.481e-02 | -3.11 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 49 |
CTNNA2 |
4.481e-02 | -3.11 | cellular response to reactive nitrogen species | biological process | GO:1902170 | 17 | 1 | 18204 | 49 |
MAP3K5 |
4.481e-02 | -3.11 | retinal rod cell differentiation | biological process | GO:0060221 | 17 | 1 | 18204 | 49 |
NTRK2 |
4.481e-02 | -3.11 | regulation of inclusion body assembly | biological process | GO:0090083 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | regulation of amyloid fibril formation | biological process | GO:1905906 | 17 | 1 | 18204 | 49 |
CLU |
4.481e-02 | -3.11 | microvillus assembly | biological process | GO:0030033 | 17 | 1 | 18204 | 49 |
TNIK |
4.481e-02 | -3.11 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | membrane depolarization during cardiac muscle cell action potential | biological process | GO:0086012 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.481e-02 | -3.11 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 49 |
RORA |
4.481e-02 | -3.11 | heparin metabolic process | biological process | GO:0030202 | 17 | 1 | 18204 | 49 |
CSGALNACT1 |
4.481e-02 | -3.11 | positive regulation of glycogen metabolic process | biological process | GO:0070875 | 17 | 1 | 18204 | 49 |
SORBS1 |
4.481e-02 | -3.11 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 49 |
ATP1A2 |
4.484e-02 | -3.10 | protein modification process | biological process | GO:0036211 | 2058 | 10 | 18204 | 49 |
NTRK2,RPS6KA2,MGAT4C,MAP3K5,PTPRZ1,MAPK10,BMPR1B,EFEMP1,CPE,TNIK |
4.493e-02 | -3.10 | A/G_cyclase_CS | interpro domains | IPR018297 | 17 | 1 | 18521 | 50 |
ADCY2 |
4.493e-02 | -3.10 | PAC | interpro domains | IPR001610 | 17 | 1 | 18521 | 50 |
HIF3A |
4.493e-02 | -3.10 | CA_dom_sf | interpro domains | IPR036398 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.493e-02 | -3.10 | CA_dom | interpro domains | IPR001148 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.507e-02 | -3.10 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 49 |
PTPRZ1 |
4.507e-02 | -3.10 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 49 |
PTPRZ1 |
4.514e-02 | -3.10 | skeletal system development | biological process | GO:0001501 | 500 | 4 | 18204 | 49 |
SOX5,BMPR1B,CSGALNACT1,TRPS1 |
4.525e-02 | -3.10 | limbic system development | biological process | GO:0021761 | 126 | 2 | 18204 | 49 |
DCLK2,ATP1A2 |
4.529e-02 | -3.09 | IRGC (immunity related GTPase cinema) | protein interactions | 56269 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.529e-02 | -3.09 | ORF45 (ORF45) | protein interactions | 4961474 | 18 | 1 | 19454 | 50 |
RPS6KA2 |
4.529e-02 | -3.09 | TTC29 (tetratricopeptide repeat domain 29) | protein interactions | 83894 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | CYP2E1 (cytochrome P450 family 2 subfamily E member 1) | protein interactions | 1571 | 18 | 1 | 19454 | 50 |
CLU |
4.529e-02 | -3.09 | Cnot2 (CCR4-NOT transcription complex, subunit 2) | protein interactions | 72068 | 18 | 1 | 19454 | 50 |
MACF1 |
4.529e-02 | -3.09 | NECTIN1 (nectin cell adhesion molecule 1) | protein interactions | 5818 | 18 | 1 | 19454 | 50 |
PARD3 |
4.529e-02 | -3.09 | NKIRAS1 (NFKB inhibitor interacting Ras like 1) | protein interactions | 28512 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 50 |
NEBL |
4.529e-02 | -3.09 | Tgfbr1 (transforming growth factor, beta receptor I) | protein interactions | 21812 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
BMPR1B |
4.531e-02 | -3.09 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 3 | 18204 | 49 |
MACF1,PTPRZ1,NTRK2 |
4.573e-02 | -3.08 | carbohydrate derivative metabolic process | biological process | GO:1901135 | 975 | 6 | 18204 | 49 |
ADCY2,BMPR1B,CSGALNACT1,ATP1A2,RORA,MGAT4C |
4.581e-02 | -3.08 | Carb_anhydrase | pfam domains | PF00194 | 17 | 1 | 17795 | 49 |
PTPRZ1 |
4.581e-02 | -3.08 | ZZ | pfam domains | PF00569 | 17 | 1 | 17795 | 49 |
DTNA |
4.586e-02 | -3.08 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 8 | 16828 | 48 |
PARD3,TRPM3,GPC5,PAMR1,MAP3K5,ADCY2,NRG3,HPSE2 |
4.590e-02 | -3.08 | response to amino acid | biological process | GO:0043200 | 127 | 2 | 18204 | 49 |
NTRK2,SLC1A2 |
4.598e-02 | -3.08 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 2 | 16828 | 48 |
CTNND2,FMN2 |
4.620e-02 | -3.07 | skin-head_neck-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-head_neck-malignant_melanoma-superficial_spreading | 923 | 6 | 16828 | 48 |
CTNND2,MACF1,SORBS1,MGAT4C,ATP13A4,ADCY2 |
4.642e-02 | -3.07 | extracellular region | cellular component | GO:0005576 | 4350 | 17 | 19108 | 50 |
NRCAM,GPM6A,EFEMP1,PAMR1,TNIK,NRG3,HPSE2,CPE,SPON1,NEBL,PTPRZ1,GPC5,SLC4A4,LSAMP,CLU,AQP4,ATP1A2 |
4.648e-02 | -3.07 | ERK Pathway in Huntington's Disease | WikiPathways | WP3853 | 14 | 1 | 5310 | 18 |
NTRK2 |
4.653e-02 | -3.07 | NUFIP1 (nuclear FMR1 interacting protein 1) | protein interactions | 26747 | 134 | 2 | 19454 | 50 |
GPM6A,CPE |
4.659e-02 | -3.07 | Integrin-mediated Cell Adhesion | WikiPathways | WP185 | 103 | 2 | 5310 | 18 |
SORBS1,MAPK10 |
4.669e-02 | -3.06 | Activated TLR4 signalling | REACTOME pathways | R-HSA-166054 | 115 | 2 | 10285 | 31 |
RPS6KA2,MAPK10 |
4.677e-02 | -3.06 | human chr7q31.1 | chromosome location | human chr7q31.1 | 25 | 1 | 26134 | 50 |
NRCAM |
4.716e-02 | -3.05 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 50 |
ABLIM1,TRPS1 |
4.716e-02 | -3.05 | BMP4 (bone morphogenetic protein 4) | protein interactions | 652 | 135 | 2 | 19454 | 50 |
CLU,BMPR1B |
4.718e-02 | -3.05 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 31 |
NRG3 |
4.718e-02 | -3.05 | PKA activation | REACTOME pathways | R-HSA-163615 | 16 | 1 | 10285 | 31 |
ADCY2 |
4.718e-02 | -3.05 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 31 |
NRG3 |
4.738e-02 | -3.05 | negative regulation of anoikis | biological process | GO:2000811 | 18 | 1 | 18204 | 49 |
NTRK2 |
4.738e-02 | -3.05 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 49 |
NEBL |
4.738e-02 | -3.05 | positive regulation of myelination | biological process | GO:0031643 | 18 | 1 | 18204 | 49 |
PARD3 |
4.738e-02 | -3.05 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 49 |
RORA |
4.738e-02 | -3.05 | response to misfolded protein | biological process | GO:0051788 | 18 | 1 | 18204 | 49 |
CLU |
4.738e-02 | -3.05 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 49 |
CTNND2 |
4.738e-02 | -3.05 | negative regulation of sodium ion transport | biological process | GO:0010766 | 18 | 1 | 18204 | 49 |
ATP1A2 |
4.738e-02 | -3.05 | myelin maintenance | biological process | GO:0043217 | 18 | 1 | 18204 | 49 |
CLU |
4.752e-02 | -3.05 | A/G_cyclase | interpro domains | IPR001054 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.752e-02 | -3.05 | Nucleotide_cyclase | interpro domains | IPR029787 | 18 | 1 | 18521 | 50 |
ADCY2 |
4.766e-02 | -3.04 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 49 |
NRG3 |
4.766e-02 | -3.04 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 49 |
HPSE2 |
4.766e-02 | -3.04 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 1 | 18094 | 49 |
SLC1A2 |
4.766e-02 | -3.04 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 49 |
PITPNC1 |
4.774e-02 | -3.04 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | FBXO27 (F-box protein 27) | protein interactions | 126433 | 19 | 1 | 19454 | 50 |
CLU |
4.774e-02 | -3.04 | Trp53 (transformation related protein 53) | protein interactions | 22059 | 19 | 1 | 19454 | 50 |
MAPK10 |
4.774e-02 | -3.04 | APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) | protein interactions | 60489 | 19 | 1 | 19454 | 50 |
MAP3K5 |
4.774e-02 | -3.04 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 50 |
PTPRZ1 |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
DTNA |
4.774e-02 | -3.04 | ZNF791 (zinc finger protein 791) | protein interactions | 163049 | 19 | 1 | 19454 | 50 |
EFEMP1 |
4.774e-02 | -3.04 | CNTNAP4 (contactin associated protein family member 4) | protein interactions | 85445 | 19 | 1 | 19454 | 50 |
MACF1 |
4.774e-02 | -3.04 | PHYHIPL (phytanoyl-CoA 2-hydroxylase interacting protein like) | protein interactions | 84457 | 19 | 1 | 19454 | 50 |
GPM6A |
4.774e-02 | -3.04 | C3orf62 (chromosome 3 open reading frame 62) | protein interactions | 375341 | 19 | 1 | 19454 | 50 |
ATP1A2 |
4.774e-02 | -3.04 | ZNF627 (zinc finger protein 627) | protein interactions | 199692 | 19 | 1 | 19454 | 50 |
EFEMP1 |
4.774e-02 | -3.04 | GCHFR (GTP cyclohydrolase I feedback regulator) | protein interactions | 2644 | 19 | 1 | 19454 | 50 |
NEBL |
4.774e-02 | -3.04 | OSM (oncostatin M) | protein interactions | 5008 | 19 | 1 | 19454 | 50 |
TRPM3 |
4.788e-02 | -3.04 | Retrograde endocannabinoid signaling | KEGG pathways | hsa04723 | 101 | 2 | 7161 | 25 |
ADCY2,MAPK10 |
4.788e-02 | -3.04 | Retrograde endocannabinoid signaling | KEGG pathways | ko04723 | 101 | 2 | 7161 | 25 |
MAPK10,ADCY2 |
4.802e-02 | -3.04 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 48 | 16828 | 48 |
DPP10,CTNND2,CLU,CPE,SOX5,MACF1,PITPNC1,MGAT4C,FMN2,RFX4,NRCAM,ABLIM1,SLC1A2,NKAIN3,RPS6KA2,MAP3K5,AQP4,NEBL,PTPRZ1,GLIS3,LSAMP,SORBS1,SPON1,ADCY2,ATP13A4,GPM6A,ATP1A2,NPAS3,TNIK,CSGALNACT1,HPSE2,RBMS3,EFEMP1,NTRK2,TRPM3,PARD3,TRPS1,GPC5,NAV3,DTNA,MSI2,HIF3A,SLC4A4,BMPR1B,PAMR1,RORA,DCLK2,NRG3 |
4.844e-02 | -3.03 | Guanylate_cyc | pfam domains | PF00211 | 18 | 1 | 17795 | 49 |
ADCY2 |
4.859e-02 | -3.02 | cation-transporting ATPase complex | cellular component | GO:0090533 | 19 | 1 | 19108 | 50 |
ATP1A2 |
4.859e-02 | -3.02 | parallel fiber to Purkinje cell synapse | cellular component | GO:0098688 | 19 | 1 | 19108 | 50 |
GPM6A |
4.859e-02 | -3.02 | postsynaptic specialization, intracellular component | cellular component | GO:0099091 | 19 | 1 | 19108 | 50 |
TNIK |
4.859e-02 | -3.02 | human chr2p16.1 | chromosome location | human chr2p16.1 | 26 | 1 | 26134 | 50 |
EFEMP1 |
4.859e-02 | -3.02 | human chr6q23.3 | chromosome location | human chr6q23.3 | 26 | 1 | 26134 | 50 |
MAP3K5 |
4.859e-02 | -3.02 | human chr18q12.1 | chromosome location | human chr18q12.1 | 26 | 1 | 26134 | 50 |
DTNA |
4.875e-02 | -3.02 | chondrosarcoma | COSMIC cancer mutations | chondrosarcoma | 1181 | 7 | 16828 | 48 |
SPON1,ADCY2,CPE,HPSE2,LSAMP,SLC4A4,NAV3 |
4.905e-02 | -3.01 | NFIB (nuclear factor I B) | protein interactions | 4781 | 138 | 2 | 19454 | 50 |
TRPS1,SOX5 |
4.918e-02 | -3.01 | amino acid transport | biological process | GO:0006865 | 132 | 2 | 18204 | 49 |
SLC1A2,NTRK2 |
4.934e-02 | -3.01 | organonitrogen compound metabolic process | biological process | GO:1901564 | 4594 | 18 | 18204 | 49 |
ATP1A2,MGAT4C,RPS6KA2,CPE,TNIK,PTPRZ1,MAPK10,EFEMP1,CSGALNACT1,DPP10,MAP3K5,SPON1,SLC1A2,NTRK2,CLU,RORA,ADCY2,BMPR1B |
4.937e-02 | -3.01 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 4 | 18204 | 49 |
CLU,GPM6A,NAV3,NTRK2 |
4.940e-02 | -3.01 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 3 | 19454 | 50 |
DTNA,MACF1,SORBS1 |
4.968e-02 | -3.00 | SPCS2 (signal peptidase complex subunit 2) | protein interactions | 9789 | 139 | 2 | 19454 | 50 |
MGAT4C,GPC5 |
4.968e-02 | -3.00 | MAGI1 (membrane associated guanylate kinase, WW and PDZ domain containing 1) | protein interactions | 9223 | 139 | 2 | 19454 | 50 |
RPS6KA2,PARD3 |
4.983e-02 | -3.00 | PK_Tyr_Ser-Thr | pfam domains | PF07714 | 130 | 2 | 17795 | 49 |
NTRK2,BMPR1B |
4.995e-02 | -3.00 | response to potassium ion | biological process | GO:0035864 | 19 | 1 | 18204 | 49 |
ATP1A2 |
4.995e-02 | -3.00 | negative regulation of peptidyl-threonine phosphorylation | biological process | GO:0010801 | 19 | 1 | 18204 | 49 |
PARD3 |
4.995e-02 | -3.00 | microvillus organization | biological process | GO:0032528 | 19 | 1 | 18204 | 49 |
TNIK |
4.995e-02 | -3.00 | regulation of amyloid-beta clearance | biological process | GO:1900221 | 19 | 1 | 18204 | 49 |
CLU |
4.995e-02 | -3.00 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 1 | 18204 | 49 |
ATP1A2 |
4.995e-02 | -3.00 | chondroitin sulfate biosynthetic process | biological process | GO:0030206 | 19 | 1 | 18204 | 49 |
CSGALNACT1 |
4.995e-02 | -3.00 | cerebellar Purkinje cell layer morphogenesis | biological process | GO:0021692 | 19 | 1 | 18204 | 49 |
RORA |